Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.8303923834860888,2.6070280193171653,0.0,0.0,0.0,17/29,8.86%,GRID2;GRIA4;GRIK5;GRIK2;GABRB3;GRIK1;GABRB1;GABRG3;GABRA2;GRID1;GRIA2;GRIK4;GABRA3;GABRA5;GABRB2;GABRG2;GLRA2
prerank,ligand-gated ion channel activity (GO:0015276),0.8348664590955233,2.5987227816157077,0.0,0.0,0.0,14/30,3.60%,GRID2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;GABRB1;GRIN2B;GRIA3;GRIN3A;GRID1;GRIA2;GRIK4;GRIA1
prerank,ligand-gated channel activity (GO:0022834),0.8348686709970132,2.5847096609445592,0.0,0.0,0.0,14/29,3.60%,GRID2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;GABRB1;GRIN2B;GRIA3;GRIN3A;GRID1;GRIA2;GRIK4;GRIA1
prerank,glutamate receptor activity (GO:0008066),0.8953847943859439,2.48803949527443,0.0,0.0,0.0,13/19,3.60%,GRM7;GRID2;GRIA4;GRIK5;GRIK2;GRM5;GRIK1;GRM8;GRM1;GRID1;GRIA2;GRIK4;GRIA1
prerank,potassium channel activity (GO:0005267),0.6193926746900437,2.450694999762629,0.0,0.0,0.0,34/89,15.80%,KCND2;GRIK5;GRIK2;KCNB2;GRIK1;KCNQ3;KCNN2;KCNQ5;KCNC2;KCNK10;KCND3;KCNT2;KCNMB3;KCNMB2;KCNH7;KCNH5;KCNH1;GRIK4;KCNK2;HCN2;KCNA1;KCNH4;KCNF1;HCN1;TMEM175;KCNG1;KCNMA1;KCNV1;KCNH8;KCNA2;KCNS3;TMEM38A;GRIK3;KCNK12
prerank,voltage-gated cation channel activity (GO:0022843),0.6056153615605296,2.4371374958441856,0.0,0.0,0.0,34/97,13.91%,KCND2;KCNB2;GRIN2A;CACNA2D3;KCNQ3;CACNA1C;CACNA1E;KCNQ5;GRIN2B;KCNC2;CACNA2D1;KCND3;GRIN3A;KCNH7;KCNH5;CACNB2;KCNH1;NCS1;CACHD1;TMC1;HCN2;KCNA1;CACNG4;CACNG2;KCNH4;RYR1;KCNF1;HCN1;KCNG1;KCNMA1;KCNV1;KCNH8;KCNA2;KCNS3
prerank,voltage-gated potassium channel activity (GO:0005249),0.6212304540187324,2.403412244428817,0.0,0.0,0.0,30/80,13.91%,KCND2;KCNB2;KCNQ3;KCNN2;KCNQ5;KCNC2;KCND3;KCNT2;KCNH7;KCNH5;KCNH1;KCNJ3;KCNJ10;KCNJ6;KCNK2;KCNJ9;HCN2;KCNIP2;KCNA1;KCNH4;KCNJ16;KCNF1;HCN1;KCNG1;KCNMA1;KCNJ12;KCNV1;KCNH8;KCNA2;KCNS3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.8448676997265007,2.3947808751312496,0.0,0.0,0.0,11/19,7.52%,GRID2;GRIK5;GRIK2;GRIK1;GABRG3;GABRA2;GRID1;GRIK4;GABRA3;GABRA5;GABRG2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.7811870077562366,2.391869741903968,0.0,0.0,0.0,12/28,7.67%,GRID2;GRIK5;GRIK2;GRIK1;GABRG3;GABRA2;GRID1;GRIK4;GABRA3;GABRA5;GABRG2;CHRNA5
prerank,ion channel activity (GO:0005216),0.6003658253137011,2.3143399762041965,0.0,0.0,0.0,22/80,8.42%,GRID2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;UNC80;TRPM3;GABRB1;GRIN2B;GRIA3;GRIN3A;NALCN;TRPC1;GRID1;GRIA2;GRIK4;GRIA1;TMC1;CHRNA5;PKD1L3;TRPM1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.8661995427069588,2.311080970890957,0.0,0.0,0.0,11/17,3.60%,GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;GRIN2B;GRIA3;GRIN3A;GRIA2;GRIK4;GRIA1
prerank,ligand-gated cation channel activity (GO:0099094),0.6023386551932242,2.3018117333586408,0.0,7.175826261672291e-05,0.001,19/75,7.72%,ASIC2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;KCNN2;GRIN2B;GRIA3;GRIN3A;GRIA2;GRIK4;GRIA1;KCNJ3;KCNJ10;KCNJ6;KCNJ9;CHRNA5;KCNJ16
prerank,neuropeptide receptor activity (GO:0008188),0.693978672790881,2.182659778101815,0.0,0.00013247679252318076,0.002,12/29,15.71%,SORCS1;HCRTR2;SORCS3;GPR37;NPY2R;NTSR1;GPR143;NPSR1;GALR1;NPY1R;TACR3;OPRM1
prerank,GABA receptor activity (GO:0016917),0.7349278274899514,2.159577548760796,0.0,0.00024602832897162145,0.004,10/21,8.53%,GABRB3;GABRB1;GABRG3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABBR1;GPR156
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.8044248251027953,2.1396287472773454,0.0,0.00034443966056027,0.006,8/15,3.81%,HS3ST6;HS3ST5;HS6ST3;HS3ST4;HS6ST2;NDST4;NDST3;HS3ST1
prerank,ligand-gated anion channel activity (GO:0099095),0.7839752955034864,2.1387710824705186,0.0,0.0003229121817752531,0.006,10/17,8.86%,GABRB3;GABRB1;GABRG3;GLRA1;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GLRA2
prerank,sodium channel activity (GO:0005272),0.6391878559949774,2.137827642593669,0.0,0.00030391734755317944,0.006,12/37,10.58%,ASIC2;GRIK5;GRIK2;GRIK1;SCN2A;SCN1A;GRIK4;SCN3A;SCN9A;HCN2;SLC4A11;HCN1
prerank,GABA-A receptor activity (GO:0004890),0.7462735891977709,2.094653981047755,0.0,0.0008610991514006749,0.017,8/18,7.52%,GABRB3;GABRB1;GABRG3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.827069392292495,2.0763319177706117,0.0,0.0012236672151483277,0.025,8/12,7.52%,GABRB3;GABRB1;GABRG3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.739813317588908,-1.985607094770115,0.0,0.03957359378256856,0.034,6/17,5.07%,ABCA1;ABCG1;PLTP;PITPNC1;PITPNA;PITPNM1
prerank,outward rectifier potassium channel activity (GO:0015271),0.7959171046686058,1.9830243598723323,0.0022471910112359553,0.004391605672143442,0.087,5/11,6.77%,KCND2;KCND3;KCNT2;KCNK2;KCNIP2
prerank,phosphatidylinositol binding (GO:0035091),-0.5302422558408277,-1.9813993649618917,0.0,0.021435696632224638,0.037,38/91,20.60%,DENND1A;SNX10;PITPNC1;SNX2;SNX9;PITPNA;ITPR1;SNX27;SNX8;MTM1;FES;SNX24;WDFY3;PITPNM1;SNX5;ANKFY1;FCHO2;ESYT1;PICALM;HIP1;EEA1;ESYT2;MYO1E;SESTD1;SNX13;NCF1;AIDA;CCDC88A;ITPR3;RNF34;SNX16;APPL2;WDFY1;SNX1;SNX4;DENND1B;APPL1;MPPE1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.611768514865424,-1.952406146373315,0.0016638935108153079,0.025283129361085472,0.062,17/35,20.12%,LYN;FGR;SYK;PEAK1;FES;ABL2;TEC;PTK2B;PKDCC;LCK;DYRK1A;ITK;FRK;TXK;ZAP70;HCK;SLA
prerank,voltage-gated calcium channel activity (GO:0005245),0.5822048865212073,1.9475401676696822,0.002457002457002457,0.006970802654195941,0.14,14/37,15.71%,CACNA2D3;CACNA1C;CACNA1E;CACNA2D1;CACNB2;NCS1;CACHD1;TMC1;CACNG4;CACNG2;RYR1;TMC2;CACNA1G;OPRM1
prerank,acetylcholine receptor activity (GO:0015464),0.6683829976234832,1.9415290818758628,0.0,0.007280201916387525,0.152,6/22,14.82%,CHRM2;CHRM3;HRH3;CHRNA5;CHRNA7;CHRFAM7A
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6692281208152051,1.8810397223013349,0.0,0.01564954109936879,0.304,6/21,14.82%,GRM5;GRM1;GRIA1;CHRNA5;CHRNA7;CHRFAM7A
prerank,cyclic nucleotide binding (GO:0030551),0.6508262921763834,1.8703861566092506,0.0022675736961451248,0.017257862159321864,0.338,8/21,10.71%,PDE4B;PDE10A;KCNH1;PDE4D;PDE11A;POPDC2;HCN1;RAPGEF4
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.7196839416480613,1.8555153285080883,0.012531328320802004,0.01942639685559923,0.386,7/13,8.86%,GABRG3;GLRA1;GABRA2;GABRA3;GABRA5;GABRG2;GLRA2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.6438174067611999,1.849015336613198,0.00228310502283105,0.02003711486913109,0.411,7/21,3.86%,PDE4B;PDE10A;PDE1A;PDE1C;PDE4D;PDE11A;PDE9A
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.6285468094289629,1.8474874036987619,0.002257336343115124,0.01967771023756357,0.418,7/23,3.86%,PDE4B;PDE10A;PDE1A;PDE1C;PDE4D;PDE11A;PDE9A
prerank,cholesterol transfer activity (GO:0120020),-0.7218864010482923,-1.834326667758227,0.0,0.1132244488779045,0.314,6/16,11.01%,ABCA1;ABCG1;PLTP;GRAMD1B;STARD5;NPC2
prerank,neuropeptide binding (GO:0042923),0.6538695799192853,1.831581195650625,0.002325581395348837,0.023218923546696774,0.482,8/18,23.27%,GPR37;OPRD1;GPR149;OPRK1;OPRL1;OPRM1;SORL1;MC4R
prerank,sterol transfer activity (GO:0120015),-0.7068149004943134,-1.827792726974786,0.0,0.09871413115762934,0.335,6/17,11.01%,ABCA1;ABCG1;PLTP;GRAMD1B;STARD5;NPC2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.7871236365033354,-1.8271046398230206,0.0034071550255536627,0.08336104245865138,0.339,5/10,12.51%,CYBB;CYBA;NCF1;NCF4;NCF2
prerank,calcium channel activity (GO:0005262),0.461363578526966,1.812034384702508,0.0,0.027911489735056364,0.551,19/84,9.78%,CACNA2D3;CACNA1C;CACNA1E;TRPC5;RYR2;CACNA2D1;SLC24A4;SLC24A2;TRPC1;CACNB2;NCS1;SLC24A3;CACHD1;TMC1;CACNG4;CACNG2;PKD1L3;TRPM1;RYR1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5639510852631924,1.810922176737538,0.002232142857142857,0.027268139794354707,0.555,14/32,21.69%,KCNB2;KCNQ3;KCNQ5;KCNC2;KCNH1;KCNA1;KCNG1;KCNA2;KCNS3;KCNE4;KCNA6;KCNQ2;KCNG3;KCNA5
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.7311611397491992,-1.8010865485422303,0.0017825311942959,0.10050436516207888,0.424,7/14,12.51%,CYBB;CYBA;KMO;NCF1;NCF4;MICAL1;NCF2
prerank,chemorepellent activity (GO:0045499),0.5987993449747163,1.7937775353737817,0.0024390243902439024,0.03177733642588297,0.627,7/25,3.44%,NRG3;NRG1;SEMA6D;EPHA7;SEMA6A;SEMA3E;SEMA5A
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.7498894515594281,1.7900208476218973,0.015113350125944584,0.03180684990486243,0.636,5/10,7.52%,GABRG3;GABRA2;GABRA3;GABRA5;GABRG2
prerank,phosphotyrosine residue binding (GO:0001784),-0.5633779965531502,-1.7843094298305124,0.0,0.10841515796682846,0.485,19/37,18.46%,BCAR3;FGR;GRB2;SYK;PLCG2;VAV1;ABL2;SH3BP2;STAP1;VAV2;PTPN6;LCK;CRK;SAMSN1;RASA1;CRKL;ZAP70;HCK;PTPN11
prerank,calcium ion binding (GO:0005509),0.37751701232419493,1.7759637234675487,0.0,0.03595741304939789,0.698,90/323,14.59%,KCNIP4;NRXN1;ADGRL3;ASTN2;CDH18;SPOCK1;CDH8;RYR3;RYR2;CDH10;SYT1;EML1;CDH2;SLIT3;SLIT2;CDH20;CDH11;PCLO;KCNIP1;SYT10;ENPP2;NCS1;CDH13;TUBB4A;PAM;TESC;MMP12;SYT2;CDH12;PITPNM3;CDH22;SCUBE1;SLIT1;CDH19;CDH7;PDCD6;SPARCL1;SLC25A23;CASQ2;DCHS1;PRNP;SYT5;PLA2G4E;ENPP3;KCNIP2;GLCE;ADGRV1;CDH6;PCDHB6;CALR3;LETM1;CCDC47;SYT11;SYT12;CETN3;CDH17;PLA2G10;CRP;RYR1;PCDHA4;MMP13;DSC3;DSC2;CABCOCO1;DNER;CDHR3;SMOC2;GSN;TTN;CDH9;CDK5R1;CAPN3;AMY1B;AMY1C;AMY1A;DYSF;NDUFAB1;RET;CALM1;F9;CALM3;SYT7;CALM2;MICU3;CDH1;NOL3;CDH5;CLEC3B;ATP2A1;MCTP2
prerank,thioesterase binding (GO:0031996),-0.7365913304060799,-1.7739756836356633,0.0017452006980802793,0.1093159457882681,0.526,7/11,13.07%,RAC1;TRAF5;CDC42;TRAF3;TRAF1;HAUS7;TRAF2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.7035045483132314,1.7708769271754143,0.0045662100456621,0.03674867260830528,0.72,5/12,9.79%,OPN3;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,cell adhesion mediator activity (GO:0098631),0.5840597516937436,1.7637364522489947,0.004750593824228029,0.03833121365377862,0.738,8/24,13.05%,LRRC4C;CNTN6;CNTN4;DSCAM;NTNG1;DSCAML1;ROBO3;VSTM2L
prerank,androgen receptor binding (GO:0050681),-0.6005448712473563,-1.7616391341192956,0.0017985611510791368,0.11344430217669653,0.57,12/25,23.94%,FOXP1;PRKCB;KDM3A;PRMT2;DDX5;TGFB1I1;TRIM68;NSD1;ARID5A;KDM1A;ZBTB7A;PRPF6
prerank,GTPase regulator activity (GO:0030695),-0.41232801482827486,-1.7568956528009927,0.0,0.10902724953732905,0.593,69/212,16.66%,IQGAP2;ARHGAP15;IQGAP1;NRP1;VAV3;ABR;ARHGAP10;ARHGAP25;ASAP1;STARD8;ARHGAP22;MYO9B;JUN;ARHGAP30;ARHGAP24;ARHGAP19;ARHGAP17;IPO5;SIPA1;TBC1D15;SGSM2;RGS1;HTR2B;TBC1D2B;TBC1D9;RIN2;ARFGEF1;ARAP1;RAB3GAP1;RGS3;TBC1D5;ARHGAP18;TBC1D1;SIPA1L2;RIC8B;WASL;TBC1D22A;PREB;ARRB1;EIF5;SIPA1L3;TBC1D16;GPS1;ALS2;SIRPA;TBC1D22B;RGS11;SH3BP1;TBC1D8B;ITGB1BP1;TBC1D8;NCKAP1L;CDC42EP2;ADAP1;TBC1D17;FLCN;CCDC88A;RGS12;TBC1D10B;RACGAP1;RGS14;RASA1;RP2;RALGAPA2;TBC1D30;ACAP2;ARHGAP31;TBC1D7;BNIP2
prerank,histone methyltransferase activity (GO:0042054),-0.5630364723695609,-1.7538148675859528,0.0016750418760469012,0.10296462826760895,0.601,14/32,16.35%,NSD3;PRMT2;SMYD2;SMYD3;EZH2;KMT5B;EED;PRMT1;KMT2C;SMYD1;SETDB1;DOT1L;PRMT6;KMT5A
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.5402868412837789,-1.7507595307160237,0.006932409012131715,0.10020236887252937,0.621,21/42,18.46%,BCAR3;FGR;GRB2;SYK;PLCG2;VAV1;ABL2;SH3BP2;STAP1;YWHAE;VAV2;PTPN6;PIN1;LCK;CRK;SAMSN1;RASA1;CRKL;ZAP70;HCK;PTPN11
prerank,calcium-activated potassium channel activity (GO:0015269),0.7126533039507813,1.7477446906704186,0.002352941176470588,0.043987814984051146,0.789,3/11,2.07%,KCNN2;KCNMB3;KCNMB2
prerank,G protein-coupled receptor activity (GO:0004930),0.3867638202864571,1.7420010238391757,0.0,0.04531243372370579,0.807,71/239,19.86%,ADGRB3;ADGRL3;GRM5;GRM8;HCRTR2;LGR5;RORB;GRM1;GPR37;P2RY12;PAX8;GPR173;GPR45;OPRD1;ADRA1B;GRM3;GPR149;NTSR1;ADGRV1;GABBR1;GPR101;GPR85;TRHR;GPR22;PTH1R;CX3CR1;GPR183;ADGRL2;GPR156;OPN3;OXTR;OPN1MW;OPN1MW3;OPN5;OPN4;GPR143;LGR6;GPR3;AGTR1;ADRA2C;TAS1R1;GALR1;LPAR2;LGR4;FFAR1;TAPT1;F2RL2;ADRA1D;ADRA1A;ADRB1;ADGRG1;GPR26;OPRK1;ADGRB2;ADGRA1;OPRL1;OPRM1;GPR157;ADGRL4;CRHR1;LANCL1;GRM4;GPR61;ADGRB1;TM2D1;CELSR2;GPR34;NMBR;ADGRG2;GPR35;GABBR2
prerank,GTPase activator activity (GO:0005096),-0.3923419025817883,-1.7412445810294872,0.0,0.10395920271452534,0.669,95/313,16.66%,IQGAP2;ARHGAP15;DOCK2;IQGAP1;NRP1;VAV3;DENND1A;AKAP13;ABR;ARHGAP10;ARHGAP25;ASAP1;ITSN1;STARD8;RIN3;ARHGAP22;DENND4C;FGD6;MYO9B;JUN;ARHGAP30;ARHGAP24;ARHGAP19;ARHGAP17;DOCK10;SIPA1;ARHGEF2;CYTH1;TBC1D15;DOCK11;VAV1;SGSM2;RGS1;HTR2B;TBC1D2B;RASGRP4;RAP1A;TBC1D9;FGD4;RIN2;DOCK8;ARFGEF1;RGL2;ARAP1;RAB3GAP1;RGS3;TBC1D5;ARHGAP18;FGD3;TBC1D1;SIPA1L2;RIC8B;DOCK5;ARHGEF10;TBC1D22A;PREB;EIF2B3;ARRB1;ARHGEF18;DENND2D;SIPA1L3;TBC1D16;EEF1B2;ALS2;TBC1D22B;RGS11;SH3BP1;TBC1D8B;FNIP1;VAV2;TBC1D8;NCKAP1L;CDC42EP2;ADAP1;TBC1D17;FLCN;ARFGEF2;ARHGEF11;CCDC88A;DNMBP;TBC1D10B;SBF2;CYTH3;RACGAP1;DENND3;RGS14;RASA1;RP2;RALGAPA2;TBC1D30;ACAP2;ARHGEF5;ARHGAP31;TBC1D7;BNIP2
prerank,RNA binding (GO:0003723),-0.3521620950324361,-1.7375125064955317,0.0,0.1014256551760646,0.686,465/1321,25.29%,APOBEC1;RBM47;DIAPH1;MYO5A;RFTN1;FNDC3B;MBNL1;AHNAK;PTBP3;MSN;RBM39;GRB2;RBMS1;VIM;ZC3HAV1;TLR8;LRP1;SAMHD1;MYH9;CNOT4;JUN;YTHDF3;IREB2;DEK;AGO2;IPO5;ANXA11;DCP1A;MAP3K20;CANX;RPS18;MBNL2;FLNA;ANXA2;ERI3;SON;NFX1;TRA2B;DDX46;FARS2;TLR7;RPL7;RPS12;SRRM1;CDK13;UCHL5;RNASEL;RPS21;HNRNPA3;ADAT1;MKRN2;XPOT;BRCA1;ZCCHC9;RPS8;RPS24;GSPT1;TUT7;STAT3;DHX58;ANP32A;SEC63;CNOT1;HSPA9;ESF1;DHX9;AKAP8;RBPMS;CHD3;MPHOSPH10;RC3H1;NOC3L;NOA1;TEP1;DYNC1H1;TOP2A;NUP42;CCDC59;SARS1;FAM120A;RPL36;SF3B6;RPS6;MACF1;ELP5;TCF20;DHX40;BICC1;RPS20;EIF4G3;DDX60;PUS7;RPL11;DDX50;RPL10A;EIF4A2;ZC3H7B;DDX49;SNRNP35;RPL12;CRNKL1;RRBP1;YTHDC2;ERAL1;SNTB2;PUM3;EIF3A;CHTOP;PATL1;SRRT;FUS;SECISBP2;MRPL42;SRP14;SNRPG;ISG20L2;HNRNPH1;MBNL3;TUFM;RPS14;GRN;USP36;RBM18;EIF5;REXO4;HNRNPDL;RAE1;EDF1;NUFIP2;SNRPF;NOP14;ALKBH1;HNRNPL;NME1;EIF2AK2;PUM2;DALRD3;RPL32;ACIN1;CNBP;LARP4B;WDR36;DIMT1;CDC40;DCP2;RPS15A;NVL;RPS28;BST2;RPS13;NOL6;HELZ2;SPEN;PRMT1;ELP1;CAST;KMT2C;CWC22;AGFG1;RBM19;KHNYN;EXD1;YWHAE;KNOP1;DDX5;RALY;LARP4;FNDC3A;UBC;RPS27A;DARS1;RPL28;UBE2L3;PRPF8;RPS4X;SART1;FASTKD2;NUCKS1;ZC3H14;PUS1;DHX37;TPT1;TENT5A;SSBP1;KRR1;XPO5;APTX;CHCHD1;SF3B5;IBA57;DUSP11;MOV10;RPS23;EEF2;CSDE1;LRPPRC;GTPBP1;EIF3E;HSPE1;EIF4A1;XRCC6;KCTD12;PCBP2;ALYREF;ZYX;HNRNPUL1;MTPAP;TPR;PRDX1;IFIT1;NUDT21;HSP90B1;ZNF106;SNRPA;CELF1;LLPH;CCDC86;HNRNPLL;OASL;RPL22;GPATCH4;RPL14;RBM14;HSP90AB1;CPNE3;IFIT2;HMGB2;EEF1A1;PKM;CWC15;NYNRIN;ZBED4;LGALS1;OAS3;METTL14;RBM10;RPL34;WDR33;MKI67;UNK;RADX;MAP4;GTF2E2;MRPS11;DHX36;RPS11;YTHDC1;NIFK;POLR2A;ZNF326;RPL6;DUT;NGDN;CFAP20;MARK2;PSMA1;NOLC1;MANF;VIRMA;GAR1;RBMS2;NCBP1;PSPC1;EMG1;NGRN;FAU;SART3;DDX31;RAD51AP1;PPIL4;TFAM;SAMSN1;TMSB4X;NUSAP1;YY1;TRMT6;SNUPN;FASTKD3;PNISR;EIF4G1;RPS10;PPIG;CRKL;NCL;ANG;AATF;HLTF;THOC2;RPL18A;DAZAP1;KARS1;SF3A1;DDX1;OTUD4;DNAJC2;SRSF10;NUFIP1;EIF2A;ASS1;RPL37A;POLR2G;UTP6;UBE2I;MCAT;ZRANB2;G3BP1;ZCCHC3;DAP3;RBM4B;RPS9;SELENOH;HDLBP;MRPS15;MRPL21;HSPA1A;LSM6;RNPS1;TDRD7;RPS27;EIF3L;TWF2;WBP11;DNA2;GTPBP10;REPIN1;SNRNP70;TENT4B;ERH;ACAA2;SURF6;ABCF1;PPARGC1B;PDIA4;RPS3;NSRP1;MRPL45;MRPL22;CCT4;API5;HUWE1;HTATSF1;RPL23A;RPS16;HNRNPA1;WRAP53;HSPB1;TYW5;EXOSC10;MAGOH;DDX3X;PPIB;HMGB1;HMGB3;RPL9;AARS1;RBPMS2;RBM42;BUD13;EIF5B;PSMD4;C1QBP;CPSF3;ZNFX1;OAS2;DDX6;RTF1;SF3B1;RBM3;MRPL15;SMC1A;THUMPD1;S100A4;UBAP2;RBM11;GRSF1;MAZ;C1D;LSM5;DARS2;PTPN1;ZC3H12A;TSNAX;CPEB4;GDI2;TPD52L2;LSM14A;ATXN2L;HNRNPH2;TRIM25;LRRFIP1;DDX54;ANKHD1;KDM1A;RACK1;PCDHGA9;PNLDC1;HNRNPK;XRN2;ELAC2;NIP7;RBM38;EWSR1;SRPK1;EIF3H;DNTTIP2;RPL41;RPLP0;ANXA7;BRIX1;SUCLG1;SNU13;MEX3A;PRKDC;SYF2;CTNNA1;RPL7A;SRSF11;NONO;SMG1;MTREX;RRP8;TARDBP;PPP1CC;RPL19;MTDH;P4HB;PRRC2C;PUM1;MDH2;PABPC1L;RPS15;RPL39;PDIA3;RBM22;TES;EIF2S2;PRPF6;NQO1;DHX35;EIF1;DDX39B;PCBP4;UNC50;ARCN1;RPP40;GANAB;DHX38;DCN;GPATCH8;PTCD2;ASCC3;AKAP8L;DUSP14;PRR3;DSP;ESRP1;TRIM28;TSN;SND1;ACTN1;MRPS7;NHP2;GTF2F1;RBM15B;BUD23
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5524145973099072,-1.7373723896495639,0.0034129692832764505,0.09522396003930561,0.686,8/34,5.65%,IQGAP2;IQGAP1;GAB2;OGT;DAPP1;KIF16B;ARAP1;MYO1G
prerank,ATP binding (GO:0005524),-0.39824625677155434,-1.7325975479796931,0.0,0.09466624395045814,0.698,95/266,22.18%,ABCA1;MAP3K5;ABCG1;DAPK1;P2RX7;CDK6;MYH9;MYO9B;MTHFS;MAP4K3;PI4K2A;MYO1F;RUNX3;ERN1;MAP3K20;INSR;P2RX4;PEAK1;ABCD2;PRKAG2;MINK1;SMARCA5;TLK1;DYRK2;ERCC6;NLRC4;HSPA9;DHX9;ATP7A;PIM1;MTHFD1L;DAPK3;BLM;SMC4;STK3;ABCE1;RTEL1;CARS2;IRAK3;ABCF3;GUK1;NME1;MCM6;STK38;NVL;TGFBR1;TRIB1;NEK6;RAD51;SIK1;KIFC1;TAOK1;KIF14;TAP2;MTPAP;STK11;STK17B;CHD8;HSP90AB1;OAS3;KSR1;MKNK1;DHX36;MAST2;MARK2;ABCB8;PDXK;HSPA4;EIF4G1;MKNK2;LATS2;UBA2;ABCD3;HSPA1A;ZAP70;PGK1;TWF2;MLKL;ABCF1;PAPOLA;ENPP1;AARS1;HSPA2;CDC42BPG;OAS2;WNK1;VPS4A;DARS2;NOL9;HSPA13;PRKAG1;SRPK1;MAP4K4;PYGL;RPS6KA5
prerank,cation channel activity (GO:0005261),0.4347870661277524,1.7150309821055332,0.0,0.05721777256017643,0.88,22/94,11.28%,UNC80;TRPM3;CACNA1E;TRPC5;RYR2;KCNK10;SLC24A4;SLC24A2;NALCN;TRPC1;CACNB2;SLC24A3;KCNA1;PKD1L3;TRPM1;RYR1;SLC4A11;KCNF1;HCN1;TMEM175;KCNG1;PKD1
prerank,cAMP binding (GO:0030552),0.7096848734782155,1.7112666595077146,0.01312910284463895,0.057627404747583634,0.887,6/11,10.71%,PDE4B;PDE10A;PDE4D;POPDC2;HCN1;RAPGEF4
prerank,potassium channel regulator activity (GO:0015459),0.47798565420535594,1.7006341808675165,0.0024875621890547263,0.06204219385841863,0.903,6/49,2.07%,DPP10;KCNIP4;DPP6;KCNIP1;KCNMB3;KCNMB2
prerank,carboxylic acid binding (GO:0031406),0.5050761706945913,1.700411378900161,0.009259259259259259,0.06063398170960363,0.903,10/38,9.00%,GRM7;GRIN2B;GRIN3A;GLRA1;EPDR1;GLDC;SESN3;UBR1;GLRA2;CASTOR2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5796137659370414,-1.698107907977064,0.005042016806722689,0.13258375324375982,0.822,10/25,18.52%,GAB2;PLEK;DAPP1;KIF16B;MYO1G;HIP1;SESTD1;NCF1;PLEKHA2;PLEKHA4
prerank,manganese ion binding (GO:0030145),-0.4997683697691243,-1.6911858882875104,0.0033500837520938024,0.13584619620098098,0.846,24/48,20.60%,FAM20C;MGAT5;ABL2;DYRK2;GYG1;PIM1;PRIMPOL;GALNT3;GALNT1;IMPA1;XXYLT1;B4GALT7;WRN;MTPAP;XYLT2;FEN1;POMGNT1;LARGE1;ARG2;MGAT2;XPNPEP3;PAPOLA;B4GALT1;MPPE1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.4392144304041587,-1.6893858649382225,0.0,0.13103256608006034,0.853,28/100,14.90%,IQGAP2;IQGAP1;OSBPL8;DENND1A;SH3PXD2B;ZFYVE26;GAB2;SNX3;SNX27;OGT;DAPP1;TECPR1;SNX24;KIF16B;ARAP1;ANKFY1;MYO1G;GOLPH3L;HIP1;OSBPL5;SESTD1;SNX13;NCF4;CYTH3;PLA2G4A;RNF34;RACGAP1;MYO10
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.6217745532519015,1.6855061343343287,0.012531328320802004,0.06494289646493927,0.926,8/17,16.11%,EPHA6;EPHA7;EPHA5;EPHB1;EPHA10;EPHB4;EPHB3;EPHA3
prerank,ephrin receptor activity (GO:0005003),0.6217745532519015,1.6855061343343287,0.012531328320802004,0.06494289646493927,0.926,8/17,16.11%,EPHA6;EPHA7;EPHA5;EPHB1;EPHA10;EPHB4;EPHB3;EPHA3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.6227084047800195,-1.6835973841025194,0.005110732538330494,0.13322062986327643,0.869,6/18,10.17%,BIRC3;TNFAIP8;GAS6;SERPINB9;PRDX5;CD27
prerank,WW domain binding (GO:0050699),-0.5706837780776547,-1.6809818566327155,0.008960573476702509,0.13136234602824842,0.876,13/26,26.67%,LITAF;PMEPA1;KIF20B;NFE2;WBP11;NDFIP2;TCEAL5;CDC25C;SCNN1A;WBP1;TCEAL6;TCEAL3;RAPGEF2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.587220064083293,1.6784210551808467,0.004555808656036446,0.06471347318243768,0.936,7/22,14.96%,HTR2C;CHRM2;CHRM3;HRH3;HTR1B;HRH2;HTR7
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.587220064083293,1.6784210551808467,0.004555808656036446,0.06471347318243768,0.936,7/22,14.96%,HTR2C;CHRM2;CHRM3;HRH3;HTR1B;HRH2;HTR7
prerank,serotonin receptor activity (GO:0099589),0.587220064083293,1.6784210551808467,0.004555808656036446,0.06471347318243768,0.936,7/22,14.96%,HTR2C;CHRM2;CHRM3;HRH3;HTR1B;HRH2;HTR7
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.3675155843984079,-1.6770361278525934,0.0,0.13000021145964552,0.883,146/431,22.18%,ABCA1;MAP3K5;ABCG1;MFHAS1;DAPK1;P2RX7;CDK6;MYH9;MYO9B;RAB7A;MTHFS;RAC1;ARL8B;MAP4K3;RAP1B;DNM2;PI4K2A;MYO1F;RUNX3;ERN1;RHOA;ARL8A;RAP2B;MAP3K20;INSR;P2RX4;PEAK1;ABCD2;RAP2A;PRKAG2;RAB31;MINK1;SMARCA5;TLK1;RAP1A;DYRK2;ERCC6;CDC42;NLRC4;HSPA9;DHX9;ATP7A;PIM1;NOA1;MTHFD1L;DAPK3;BLM;SMC4;STK3;ARL11;ABCE1;RTEL1;RHOQ;RAB32;CARS2;IRAK3;ABCF3;GUK1;NME1;MCM6;GBP5;STK38;NVL;TGFBR1;RAB5A;TRIB1;NEK6;RAD51;ADSS1;RAB21;GBP2;SIK1;TGM2;KIFC1;TAOK1;KIF14;SEPHS1;TAP2;RRAGD;MTPAP;RAB11B;RAB29;STK11;STK17B;CHD8;HSP90AB1;EEF1A1;RAB10;OAS3;ARL5A;KSR1;MKNK1;ARL3;DHX36;TUBD1;MAST2;MARK2;GCH1;ANXA6;ABCB8;PDXK;HSPA4;EIF4G1;MKNK2;RAB13;LATS2;RND2;ARHGEF5;UBA2;RAB39A;ABCD3;HSPA1A;RALB;ZAP70;PGK1;TWF2;GTPBP10;KRAS;NRAS;MLKL;ARL1;ABCF1;ARFIP2;RHEB;GBP3;PAPOLA;ENPP1;AARS1;GBP7;HSPA2;RHOBTB1;GBP6;CDC42BPG;OAS2;WNK1;VPS4A;RHOF;DARS2;NOL9;HSPA13;PRKAG1;SRPK1;MAP4K4;PYGL;TUBA4A;RPS6KA5
prerank,single-stranded DNA binding (GO:0003697),-0.43868216070759425,-1.6714010077479826,0.0,0.13200358481639188,0.902,40/93,23.35%,FAM111A;RBMS1;SAMHD1;TOP3A;RAD51B;DHX9;NABP1;BLM;WDR48;REXO4;POLR2H;MCM6;NEIL3;RAD51;NUCKS1;MCM9;SSBP1;APTX;MCM3;PCBP2;HMGB2;RADX;RPA3;DHX36;ERCC4;RAD51AP1;RAD52;MCM2;POLR2G;WBP11;RBBP8;HNRNPA1;NUP35;HMGB1;RTF1;DMC1;SMC6;CDC45;TWNK;MLH1
prerank,glycine binding (GO:0016594),0.6786106918950456,1.6666078045199038,0.024390243902439025,0.07015209895134435,0.945,6/11,14.35%,GRIN2B;GRIN3A;GLRA1;GLDC;GLRA2;GLRA3
prerank,adenylate cyclase binding (GO:0008179),0.6995349298047288,1.6629349364978478,0.022935779816513763,0.07053837215223863,0.95,6/10,13.07%,AKAP6;ADCY2;ADCY5;CALM1;CALM3;CALM2
prerank,low-density lipoprotein particle binding (GO:0030169),-0.643531060104037,-1.6590454262883099,0.012006861063464836,0.14413582268806638,0.932,4/16,1.52%,MSR1;STAB1;PLTP;CD36
prerank,amino acid binding (GO:0016597),0.5113140656004608,1.6527218662841026,0.011961722488038277,0.0746344509387483,0.963,7/31,9.00%,GRM7;GRIN2B;GRIN3A;GLRA1;GLDC;GLRA2;CASTOR2
prerank,double-stranded RNA binding (GO:0003725),-0.45920785414581106,-1.649173976345141,0.003401360544217687,0.1524598068161776,0.95,18/70,13.46%,RFTN1;MBNL1;MSN;VIM;TLR8;AGO2;TLR7;DHX58;DHX9;RC3H1;DDX60;EIF2AK2;APTX;EIF4A1;OASL;HSP90AB1;OAS3;DHX36
prerank,retinoic acid receptor binding (GO:0042974),-0.6272237439204333,-1.6444974696938175,0.007067137809187279,0.15377516843288214,0.959,9/17,18.21%,PPARG;CNOT1;RARG;PRMT2;ASXL1;NSD1;NRIP1;ARID5A;NCOA6
prerank,semaphorin receptor activity (GO:0017154),-0.7030411491885353,-1.6422728087177652,0.0017123287671232876,0.15130618099009843,0.963,5/11,7.14%,NRP1;PLXNC1;PLXNA1;PLXND1;NRP2
prerank,mannosyltransferase activity (GO:0000030),0.5607694415668787,1.6404623591804872,0.013452914798206279,0.08046110470687907,0.972,6/21,5.39%,TMTC2;TMTC1;DPY19L1;TMTC3;DPY19L2;POMT2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.6154642253700153,1.6319382286771367,0.01160092807424594,0.08268207813353019,0.977,8/16,8.63%,PTPRD;PTPRG;PTPRN2;PTPRR;PTPRT;PTPRK;PTPRB;PTPRZ1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.6154642253700153,1.6319382286771367,0.01160092807424594,0.08268207813353019,0.977,8/16,8.63%,PTPRD;PTPRG;PTPRN2;PTPRR;PTPRT;PTPRK;PTPRB;PTPRZ1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4959828498034368,1.6266348073529133,0.004728132387706856,0.08469641275946639,0.98,11/35,10.60%,PLCL1;MPPED2;APEX2;ENPP2;PDE11A;GDPD1;PLCE1;ENPP3;FAM83B;PLCXD3;ENPP6
prerank,Tat protein binding (GO:0030957),-0.7172351072452734,-1.6227714357213554,0.015901060070671377,0.17728515145696663,0.978,3/10,8.47%,MDFIC;ACTB;DNAJA1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.555889530647054,-1.6168019079144162,0.01565217391304348,0.18104919155525115,0.982,11/25,20.66%,ZC3HAV1;PARP11;PARP14;PARP4;TIPARP;PARP9;PARP8;SIRT3;TNKS2;PARP10;SIRT2
prerank,high voltage-gated calcium channel activity (GO:0008331),0.6690854714156568,1.61275858449527,0.028503562945368172,0.09253626621440958,0.984,2/10,2.57%,CACNA1C;CACNB2
prerank,inward rectifier potassium channel activity (GO:0005242),0.5377174629400084,1.611621339758272,0.029885057471264367,0.09169923145006825,0.986,7/24,13.04%,KCNN2;KCNJ3;KCNJ10;KCNJ6;KCNJ9;KCNJ16;KCNJ12
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.6451385222660472,-1.6088615565113662,0.023090586145648313,0.18900291654219575,0.987,7/13,21.49%,GEN1;DNASE1L1;EXO1;FEN1;SLX4;DNA2;FAN1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6008121874055488,-1.6085789237760304,0.020618556701030927,0.18347444825755096,0.987,9/18,23.14%,ANXA2;S100A11;ANXA1;BAIAP2;PPP1CA;RAB10;TRIM29;PDLIM5;PDLIM1
prerank,glutamate receptor binding (GO:0035254),0.5920484074991136,1.6047884839643287,0.020316027088036117,0.09476703696575642,0.989,11/17,23.92%,SHISA6;SYNDIG1;SHANK3;HOMER1;CAMK2A;HOMER3;SHANK2;NSF;HOMER2;SHANK1;SHISA7
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.5548583606519892,-1.601936239715867,0.008620689655172414,0.19000654792573324,0.991,11/22,27.48%,ATP6V0D2;ATP6V1E1;ATP6V1A;TCIRG1;ATP2A3;ATP6V0B;ATP6V0E1;ATP6V0D1;ATP5F1B;ATP6V0A1;ATP2C1
prerank,phosphatidate phosphatase activity (GO:0008195),0.6380870748906791,1.5973846218033743,0.02891566265060241,0.09789337721186621,0.992,3/13,2.69%,PLPP4;PLPPR1;PLPPR4
prerank,small GTPase binding (GO:0031267),-0.3830983595230896,-1.5950018845099845,0.0015337423312883436,0.1964453887441884,0.991,50/170,18.65%,IQGAP2;IQGAP1;MYO5A;ABCA1;AKAP13;RIN3;PAK2;FGD6;MYO9B;GOLGA5;EPS8;FLNA;OPTN;ARHGEF2;GOLGA4;SGSM2;IFT20;KIF3B;RNF41;GGA3;FGD4;TNFAIP1;RAB3GAP1;ANKFY1;DAPK3;FGD3;TRIOBP;AP1G1;CYRIB;PICALM;EXOC4;ALS2;AP3M1;CDC42EP2;XPO5;RAB29;CIB1;GCC1;EHD1;BRK1;TBC1D30;RABGGTA;TBC1D7;SPHK2;EXOC2;RAB34;PDE6D;RILP;ARFIP2;RCC1
prerank,monocarboxylic acid binding (GO:0033293),-0.5887948444079194,-1.5949742758112169,0.020560747663551402,0.19086407096561042,0.991,11/18,31.51%,PSAP;RXRA;RARA;CYP26C1;PYGL;NR1H4;UGT1A7;UGT1A6;UGT1A4;UGT1A8;UGT1A1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.38838180103822667,-1.5876656785227845,0.0016181229773462784,0.19857027806176186,0.992,38/147,12.01%,DOCK2;VAV3;DENND1A;AKAP13;ABR;ITSN1;RIN3;DENND4C;FGD6;DOCK10;ARHGEF2;CYTH1;DOCK11;VAV1;RASGRP4;RAP1A;FGD4;RIN2;DOCK8;ARFGEF1;RGL2;RAB3GAP1;FGD3;RIC8B;DOCK5;ARHGEF10;PREB;EIF2B3;ARHGEF18;DENND2D;EEF1B2;ALS2;FNIP1;VAV2;ARFGEF2;ARHGEF11;CCDC88A;DNMBP
prerank,DNA binding (GO:0003677),-0.3339746787926571,-1.5841461247926791,0.0,0.19950201370116205,0.993,234/694,25.03%,RBPJ;ZEB2;FLI1;FAM111A;TCF4;RBMS1;TLR8;BCL6;SAMHD1;JUN;TOP3A;DDB2;MEF2A;CREBBP;CGAS;NUPR1;PPARD;ARID5B;BPTF;DNMT3A;NFE2L2;RAD51B;IRF2;ZNF148;NFYA;RPL7;PPARG;SMARCA5;BRCA1;GTF2A1;ZNF3;STAT3;ERCC6;FOXO3;E2F2;IKZF1;LYL1;RFC1;DHX9;USF2;DCLRE1C;RYBP;CHD3;HHEX;ZBTB21;TOP2A;RARG;BCL2;IRF5;CRLF3;NABP1;AIM2;PARP4;BLM;NR1H2;CIITA;TSG101;CUX1;BATF;DDX60;RAD1;SRRT;TAF6;WDR48;AHR;REXO4;ATF6;NR2F1;POLR2H;MCM6;E2F1;CNBP;ARID1A;RNF4;THAP1;CEBPG;E2F3;NEIL3;CBFB;RAD51;HIF1A;SIRT3;NUCKS1;EGR1;ARNT;MCM9;SSBP1;HP1BP3;APTX;RELA;MCM3;IKZF3;APP;TIMELESS;XBP1;DCLRE1A;XRCC6;PCBP2;WRN;MAU2;DNASE1L1;PCNA;CUL4B;PRDM2;NFE2;KMT2D;EXO1;OASL;FOXJ1;ARID3B;CHD8;FEN1;HMGB2;SPTY2D1;WDR76;RADX;RPA3;XRCC4;DHX36;RXRA;FOXJ3;CALCOCO1;TFAP4;POLR2A;RPL6;KLF2;ERCC4;RAD51AP1;ZMYM6;TFAM;TCF3;MAP1S;YY1;INO80;RAD52;TAF4B;ANG;TFCP2;HMGN1;QRICH1;NUFIP1;MCM2;NR4A1;BRIP1;APLP2;POLR2G;SOX10;TAF9;ZCCHC3;CHTF18;RPS27;WBP11;JRK;DNA2;CSRNP1;ATF5;REPIN1;SNAPC3;GATA3;SURF6;ARID5A;RPS3;DNTTIP1;RBBP8;HUWE1;TRIM16;TAF4;HNRNPA1;ZDHHC1;NUP35;DDX3X;MEIS3;HMGB1;HMGB3;MBD6;MAX;KDM5B;LIN9;EHF;RTF1;GTF3C5;SMC1A;RFC3;RLF;C1D;PDS5B;TIPIN;ZFPL1;ZC3H12A;STAT1;TSNAX;DMC1;NBN;POU3F1;LRRFIP1;HOXB2;FAN1;CCDC25;NLRP3;ZBTB7A;TBX2;SMC6;SNAI2;CEBPB;EGR2;BARX2;MYRFL;TOPORS;MTF1;POLG2;NR1H4;PALB2;CDC45;TWNK;PRKDC;HES7;ESR2;TARDBP;MLH1;RPS15;RFX5;MAFF;ZNF395;PAX6;MCM5;DRAP1;MYC;RAD51C;GZF1;DNASE2;DDB1;POGK;TRIM28;TSN
prerank,damaged DNA binding (GO:0003684),-0.47164143899633454,-1.5835059135839555,0.007142857142857143,0.1951776588092033,0.993,23/44,27.60%,DDB2;CREBBP;DCLRE1C;RAD1;NEIL3;APTX;DCLRE1A;PCNA;CUL4B;FEN1;HMGB2;RPA3;ERCC4;RPS3;RBBP8;HMGB1;NBN;SMC6;DDB1;MPG;XRCC1;DCLRE1B;EP300
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.43419207059728243,1.5785250745740833,0.014742014742014743,0.1100128398599828,0.997,22/60,17.03%,ERBB4;NTRK3;EPHA6;NTRK2;EPHA7;EPHA5;BMPR1B;CSF1R;EPHB1;TIE1;ACVR1;ALK;EPHA10;ROS1;LTK;TYRO3;RET;EPHB4;EPHB3;ERBB3;EPHA3;ROR1
prerank,lipoprotein particle binding (GO:0071813),-0.5749262118747628,-1.5763515882335957,0.025817555938037865,0.20141944527794511,0.994,4/20,1.52%,MSR1;STAB1;PLTP;CD36
prerank,cysteine-type peptidase activity (GO:0008234),-0.43210750720488483,-1.5724813810133562,0.006462035541195477,0.20248488818747581,0.995,28/73,20.98%,CTSB;CTSZ;USP12;USP50;MALT1;USP18;USP8;USP36;USP9X;ATG4C;CTSC;CASP4;CTSH;OTULIN;CTSS;USP42;CASP7;CASP1;USP35;GGH;USP40;USP30;USP11;USP7;CASP8;CASP2;SFRP1;USP9Y
prerank,calcium:sodium antiporter activity (GO:0005432),0.6418542507974742,1.5724565229393632,0.035634743875278395,0.11259966022129166,0.998,5/10,8.85%,SLC24A4;SLC24A2;SLC8A3;SLC24A3;SLC8A2
prerank,voltage-gated sodium channel activity (GO:0005248),0.5305645955956688,1.56544653673989,0.03365384615384615,0.11573172594825071,0.998,9/22,15.85%,SCN2A;SCN2B;SCN1A;SCN3A;SCN9A;HCN2;HCN1;CACNA1G;SCN10A
prerank,adrenergic receptor binding (GO:0031690),0.5889116439989649,1.5595005621783915,0.047109207708779445,0.11870463547751271,0.998,5/16,13.09%,MAGI2;PDE4D;NEDD4;ADRA2C;ADRB1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6582414217787931,-1.5555040711211519,0.051094890510948905,0.23076552959794555,0.998,5/11,18.63%,MAP3K5;MAP3K1;MAP3K20;MAP3K15;TAOK2
prerank,cytokine receptor activity (GO:0004896),-0.41400021533879083,-1.555438151087478,0.009771986970684038,0.22540197728537065,0.998,26/83,18.72%,CD44;CD74;CCR2;CSF2RA;IL10RB;IL6R;CCR1;IFNAR2;IL17RA;IL18RAP;IFNGR2;IL2RG;IL7R;IL4R;IFNAR1;IL20RA;CSF2RB;CCRL2;CNTFR;IL31RA;IL27RA;IL2RB;IL18R1;CMKLR1;IL17RD;IL1R2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6777262201782609,1.5518615746745563,0.041379310344827586,0.12249829863474118,0.999,6/10,17.16%,DPYS;DPYSL5;DPYSL4;DPYSL3;DPYSL2;CAD
prerank,5'-3' exonuclease activity (GO:0008409),-0.6178924951319121,-1.550355974824234,0.02443280977312391,0.2296188755523455,0.998,10/14,26.18%,DCLRE1C;DCP2;DCLRE1A;EXO1;FEN1;CPSF3;FAN1;XRN2;MRE11;DCLRE1B
prerank,amino acid:sodium symporter activity (GO:0005283),0.6459047076681838,1.5486003865517108,0.050359712230215826,0.12324652457428391,0.999,7/11,18.00%,SLC1A2;SLC6A15;SLC1A1;SLC6A1;SLC6A13;SLC6A11;SLC38A1
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.3459105671200666,-1.5472284367624607,0.0,0.23082098040224175,0.998,111/346,22.42%,BIRC3;RNF213;WWP1;CBL;ZNRF3;CNOT4;RNF150;HECTD1;BFAR;BIRC6;DDB2;RNF149;RNF19A;FBXW8;NEURL3;RNF111;NFX1;MALT1;MKRN2;TRAF5;BRCA1;MYLIP;WWP2;RNF41;AMFR;AREL1;RNF166;PELI1;CDC42;TNFAIP1;RC3H1;RNF20;FBXW11;UBE2R2;RNF31;RBCK1;TRAF3;UHRF2;UBE3B;MGRN1;UBR2;KCTD10;CBLL1;RNF4;RNF38;TRIM47;RNF123;UBA7;RFWD3;ANKRD39;UBE2L3;RNF8;TRAF1;NEDD4L;SEL1L;CUL4B;TSPAN17;TRIM24;MAEA;UBE3A;RNF180;RNF128;FBXO10;TRIM68;UHRF1;TRAF2;UBE2H;FBXW2;RNF185;CUL2;TRIM11;ARIH1;KCMF1;RNF25;RNF34;CBLB;RNF43;KLHL42;UBE2G1;UBE2T;RNF216;CDC34;HLTF;BRAP;TRIM14;RNFT2;UBE2C;MIB1;ASB4;FBXO7;DTX1;RNF121;HUWE1;TRIM39;UBE2M;FBXL6;TRIP12;DTX3;UBE3C;FBXO22;VPS18;DTX3L;RNF125;TRIM25;NEURL1B;SMURF2;RNF135;HECTD3;RNF115;TOPORS;RSPRY1
prerank,death domain binding (GO:0070513),-0.6551454472863234,-1.544313686807663,0.03098106712564544,0.23167652063819769,0.998,4/11,5.01%,MCL1;CRADD;RIPK1;BCL2
prerank,translation initiation factor activity (GO:0003743),-0.4864213115464546,-1.5436258332960497,0.016863406408094434,0.22824118008291808,0.998,23/36,33.64%,AGO2;EIF4G3;EIF4A2;EIF2B3;EIF3A;EIF5;EIF3E;EIF4A1;EIF4G1;EIF2A;EIF3L;COPS5;EIF5B;EIF2B1;EIF3H;EIF2S2;EIF1;EIF1B;EIF2B2;EIF2B4;EIF4E;MTIF3;EIF2S1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6435392521930776,-1.5418716500171328,0.030965391621129327,0.22661261829746263,0.998,6/12,21.39%,KDM3A;JMJD1C;KDM7A;KDM3B;HR;KDM1A
prerank,MAP-kinase scaffold activity (GO:0005078),-0.6501321497265915,-1.539311617127667,0.030405405405405407,0.22672371437929906,0.998,5/11,17.54%,IQGAP1;AKAP13;MAP2K1;KSR1;SPAG9
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5763400255339555,-1.5316882446332762,0.02626970227670753,0.23110978769020038,0.998,8/16,26.79%,ATP6V0D2;ATP6V1A;TCIRG1;ATP6V0B;ATP6V0E1;ATP6V0D1;ATP5F1B;ATP6V0A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5763400255339555,-1.5316882446332762,0.02626970227670753,0.23110978769020038,0.998,8/16,26.79%,ATP6V0D2;ATP6V1A;TCIRG1;ATP6V0B;ATP6V0E1;ATP6V0D1;ATP5F1B;ATP6V0A1
prerank,GTPase binding (GO:0051020),-0.36150581116383257,-1.531257791861843,0.0015290519877675841,0.22737573028993233,0.998,54/195,18.65%,IQGAP2;IQGAP1;MYO5A;ABCA1;AKAP13;RIN3;GNB1;PAK2;FGD6;MYO9B;GOLGA5;EPS8;FLNA;OPTN;ARHGEF2;GOLGA4;SGSM2;IFT20;KIF3B;RNF41;GGA3;FGD4;TNFAIP1;RAB3GAP1;ANKFY1;DAPK3;FGD3;TRIOBP;AP1G1;CYRIB;PICALM;EXOC4;ALS2;LCP1;AP3M1;CDC42EP2;XPO5;RRAGD;RAB29;CIB1;GCC1;EHD1;RASA1;BRK1;TBC1D30;RABGGTA;TBC1D7;SPHK2;EXOC2;RAB34;PDE6D;RILP;ARFIP2;RCC1
prerank,ribonuclease activity (GO:0004540),-0.443476444488936,-1.5265327466899368,0.012216404886561954,0.23133217775782464,0.998,28/56,27.04%,SAMHD1;ERN1;AGO2;RNASEL;RNASE12;RNASE4;INTS11;RNASE7;EXOSC5;KHNYN;RNASE6;NYNRIN;ENDOG;ANG;EXOSC10;CPSF3;ZC3H12A;TSNAX;EXOSC4;ELAC2;YBEY;RPP40;SND1;RCL1;ZC3H12D;ERN2;LACTB2;EXOSC8
prerank,P-type ion transporter activity (GO:0015662),-0.6195051617740924,-1.5263315731482308,0.044444444444444446,0.2273407554773239,0.998,4/12,9.56%,ATP2B1;ATP6V1E1;ATP7A;ATP2A3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.3530111603609907,-1.524979153571561,0.0,0.2253903448356991,0.998,72/254,22.48%,RBPJ;MITF;ELF4;RUNX1;TCF4;RREB1;REL;LITAF;JUN;MEF2A;IRF2;NFIC;ATF3;ELF1;UBP1;ELK3;ETV1;STAT3;FOXO3;E2F2;STAT6;NFKB1;HHEX;SMARCD3;MLXIP;IRF5;MEF2B;KLF6;NR1H2;NRF1;NFATC3;ATF6;ATMIN;CEBPG;E2F3;HIF1A;MEF2C;TFEC;EGR1;RELA;ZNF319;KLF10;PRDM2;FOXJ1;FOSL2;FOXJ3;TFAP4;TCF3;YY1;TFCP2;NR4A1;SOX10;FOXJ2;NFATC1;ATF5;NR3C1;GATA3;MYB;TCF12;PLAG1;CASZ1;MEIS3;HOXD8;MDM4;EHF;RLF;ZSCAN21;HOXB2;EGR2;BARX2;MTF1;NR1H4
prerank,chloride channel activity (GO:0005254),0.4176857033351667,1.5230184853267574,0.013227513227513227,0.1437901036096721,1.0,13/59,8.86%,GABRB3;GABRB1;GABRG3;GLRA1;GABRA2;ANO4;GABRA3;GABRA5;GABRB2;ANO3;GABRG2;ANO5;GLRA2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5451534826654834,1.5225468917992209,0.03225806451612903,0.14202836926410212,1.0,5/19,3.32%,NRG3;NRG1;GRM5;EFNA5;EGF
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.45462814719887945,-1.5193869624313177,0.017421602787456445,0.231465550300973,0.999,18/44,18.49%,NSD3;ASH1L;SMYD2;SMYD3;EZH2;KMT5B;EED;WDR5;KMT2C;KMT5C;KMT2D;SMYD1;SETDB1;DOT1L;NSD1;KMT5A;KMT2A;CXXC1
prerank,rRNA binding (GO:0019843),-0.4614102283021034,-1.5190150197222936,0.02333931777378815,0.22790149990854217,0.999,18/42,25.76%,RPL11;RPL12;ERAL1;RPS14;RPS13;FASTKD2;MRPS6;MRPS11;EMG1;NGRN;ANG;RPS9;RPS3;GTF3A;RPLP0;MRPL18;MRPS7;RPL5
prerank,adenyl ribonucleotide binding (GO:0032559),-0.34481760648956916,-1.5173290866959088,0.0,0.22675746378920134,0.999,97/291,22.18%,ABCA1;MAP3K5;ABCG1;DAPK1;P2RX7;CDK6;MYH9;MYO9B;MTHFS;MAP4K3;PI4K2A;MYO1F;RUNX3;ERN1;MAP3K20;INSR;P2RX4;PEAK1;ABCD2;PRKAG2;MINK1;SMARCA5;TLK1;DYRK2;ERCC6;NLRC4;HSPA9;DHX9;ATP7A;PIM1;MTHFD1L;DAPK3;BLM;SMC4;STK3;ABCE1;RTEL1;CARS2;IRAK3;ABCF3;GUK1;NME1;MCM6;COQ8A;STK38;NVL;TGFBR1;TRIB1;NEK6;RAD51;SIK1;KIFC1;TAOK1;CNBD2;KIF14;TAP2;MTPAP;STK11;STK17B;CHD8;HSP90AB1;OAS3;KSR1;MKNK1;DHX36;MAST2;MARK2;ABCB8;PDXK;HSPA4;EIF4G1;MKNK2;LATS2;UBA2;ABCD3;HSPA1A;ZAP70;PGK1;TWF2;MLKL;ABCF1;PAPOLA;ENPP1;AARS1;HSPA2;CDC42BPG;OAS2;WNK1;VPS4A;DARS2;NOL9;HSPA13;PRKAG1;SRPK1;MAP4K4;PYGL;RPS6KA5
prerank,syntaxin-1 binding (GO:0017075),0.5329446257734769,1.5143544536417743,0.06746987951807229,0.14756108185366112,1.0,5/22,2.78%,SYT1;UNC13C;SNPH;SNAP25;CPLX1
prerank,neurexin family protein binding (GO:0042043),0.6328245405918214,1.512754753302333,0.04597701149425287,0.14684953587916585,1.0,4/10,14.13%,NLGN1;CPE;SYTL2;NLGN2
prerank,ligand-gated calcium channel activity (GO:0099604),0.5302232354536653,1.5114532305195176,0.05955334987593052,0.14614625450463514,1.0,4/19,1.30%,GRIN2A;RYR3;RYR2;GRIN2B
prerank,CARD domain binding (GO:0050700),-0.5966381820186061,-1.5113522045489178,0.04215851602023609,0.23374575293123473,1.0,10/14,31.13%,CARD11;CASP4;NOD1;CASP1;MAVS;NOD2;CARD10;CARD16;RIPK2;BCL10
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.48303721453267345,1.510381340882262,0.02122641509433962,0.14475201532023813,1.0,12/31,15.34%,KCNK10;SLC12A2;SLC12A8;SLC12A1;KCNA1;KCNF1;HCN1;TMEM175;KCNG1;SLC12A5;KCNA2;TMEM38A
prerank,retinoic acid binding (GO:0001972),-0.6190245559883374,-1.5083583708595774,0.047619047619047616,0.23457229082982026,1.0,8/12,31.51%,RXRA;RARA;CYP26C1;UGT1A7;UGT1A6;UGT1A4;UGT1A8;UGT1A1
prerank,SH3 domain binding (GO:0017124),-0.4313259217157317,-1.5008350900030085,0.018456375838926176,0.2440921249838708,1.0,20/62,14.50%,ABI1;GRB2;WIPF1;CYBA;CBL;DNM2;WASF2;SH3BP2;SYNJ1;PTPN12;PTPN22;ADAM9;AFAP1L2;NCF1;CRK;MICAL1;ZNF106;ADAM15;AFAP1L1;CBLB
prerank,histone acetyltransferase binding (GO:0035035),-0.5256811025315422,-1.4991771355731485,0.04060913705583756,0.2425594591590951,1.0,10/21,23.91%,MEF2A;HIF1A;EGR1;PCNA;TRIM68;SIRT2;STAT1;ZBTB7A;KANSL1;PAX6
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.6272762890615369,-1.4963824981394251,0.058823529411764705,0.2433456875742623,1.0,5/12,13.02%,APAF1;NOD1;CTSH;ATP2A3;CASP1
prerank,GTPase inhibitor activity (GO:0005095),-0.6160256590468735,-1.4938245814268671,0.05663430420711974,0.2437579828670559,1.0,4/13,7.69%,IQGAP2;IQGAP1;IPO5;GPS1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.5412778487174117,-1.480355659665738,0.04285714285714286,0.2666580049801983,1.0,11/20,26.01%,DCLRE1C;EXO1;FEN1;ENDOG;ERCC4;APLF;DNA2;RPS3;RBBP8;ZRANB3;MRE11
prerank,cholesterol binding (GO:0015485),-0.44490435085422836,-1.4778486720238917,0.03169014084507042,0.26767984717542526,1.0,12/47,15.20%,OSBPL8;ABCA1;ABCG1;OSBPL3;GRAMD1B;VDAC2;OSBPL5;ERLIN1;STARD5;NPC2;ANXA6;NPC1
prerank,lysine-acetylated histone binding (GO:0070577),-0.5364667284773658,-1.474147091889182,0.05140961857379768,0.26708894410714495,1.0,10/20,20.14%,BRD7;BRD4;PSME4;DPF2;ATAD2B;TRIM24;KMT2A;BRD2;ZMYND8;BRD9
prerank,acetylation-dependent protein binding (GO:0140033),-0.5364667284773658,-1.474147091889182,0.05140961857379768,0.26708894410714495,1.0,10/20,20.14%,BRD7;BRD4;PSME4;DPF2;ATAD2B;TRIM24;KMT2A;BRD2;ZMYND8;BRD9
prerank,four-way junction DNA binding (GO:0000400),-0.5561210418154565,-1.4736526042028448,0.04965753424657534,0.2643735917974372,1.0,9/17,19.44%,RAD51B;BLM;GEN1;WRN;HMGB2;YY1;XRCC3;HMGB1;HMGB3
prerank,cGMP binding (GO:0030553),0.5998364309168653,1.4734897175655033,0.07510729613733906,0.18001892830853536,1.0,2/11,3.70%,PDE10A;PDE11A
prerank,protein serine/threonine kinase activity (GO:0004674),-0.326029840691498,-1.4665708611257198,0.0,0.273860739582268,1.0,107/335,23.06%,PRKCH;MAP3K8;MAP3K5;TAOK3;PRKCB;MAPKAPK3;FAM20C;DAPK1;SYK;PAK2;CDK6;PRKCD;ROCK1;MAP4K3;CAMK1D;MAP3K1;ERN1;MAP3K20;CSNK2A1;BRD4;VRK2;CDK13;MINK1;RIPK1;ALPK1;IRAK2;TLK1;MAPKAPK2;SGK1;GRK3;DYRK2;RIOK3;PIM1;PTK2B;IRAK4;DAPK3;PHKG2;STK3;MAPK14;ULK2;IRAK3;GRK5;PLK2;VRK3;EIF2AK2;STK38;TGFBR1;CDK14;NEK6;MASTL;MAPK7;SIK1;TAOK1;CDK1;DYRK1A;MAP2K1;CAMKK1;STK11;HTATIP2;STK17B;PRKD3;CPNE3;MAP3K15;PLK3;STK24;MKNK1;ACVR2A;TGFBR2;MAST2;MARK2;TRIO;IKBKB;MAP3K10;TTK;MKNK2;LATS2;PNCK;CDKL4;AURKA;BRD2;PKN3;STK10;TAOK2;MAK;MOK;PAK6;ATM;STK16;CHEK1;BMPR2;CDC42BPG;CDK16;WNK1;GSK3B;CDK5;CSNK1G3;CCNK;GRK6;SRPK1;MAP4K4;MAST3;MAPK1;RPS6KA5;ILK;NEK3;PRKDC;SMG1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.5132296638933075,-1.4646751778617695,0.05123674911660778,0.27343468846908087,1.0,10/24,17.08%,MAPKAPK3;DAPK1;CAMK1D;MAPKAPK2;PTK2B;PHKG2;CAMKK1;MKNK1;MKNK2;PNCK
prerank,hyaluronic acid binding (GO:0005540),-0.6395770303524713,-1.4628887552014125,0.07042253521126761,0.2730361214223774,1.0,2/10,1.51%,CD44;LYVE1
prerank,PDZ domain binding (GO:0030165),0.39764311266332025,1.4597581913777364,0.03116883116883117,0.1927649283431314,1.0,18/61,16.83%,NLGN1;GRID2;SYNJ2;GRIA1;FZD8;TBC1D10A;TMEM88;TMEM88B;CLCN3;SDC2;ADRB1;PRKN;ATP2B4;ATP2B2;SLC22A5;ADAM17;TGFBR3;CIT
prerank,DNA secondary structure binding (GO:0000217),-0.4692580223210497,-1.4579505242724418,0.040955631399317405,0.2788319997110531,1.0,14/31,19.44%,RAD51B;BLM;NEIL3;MEF2C;GEN1;WRN;HMGB2;RAD51AP1;YY1;KMT2A;XRCC3;RBBP8;HMGB1;HMGB3
prerank,triglyceride lipase activity (GO:0004806),-0.5177870890489147,-1.4557074580717329,0.05892857142857143,0.27975579349031915,1.0,9/20,38.00%,DAGLB;LPL;ABHD5;LIPE;PLA2G15;LIPH;LCAT;PNPLA1;LIPG
prerank,store-operated calcium channel activity (GO:0015279),0.6162978318821501,1.4543726486598583,0.08009708737864078,0.19590005694365356,1.0,2/10,2.25%,TRPC5;TRPC1
prerank,RNA polymerase II complex binding (GO:0000993),-0.4752953984570255,-1.4540221785215537,0.03633217993079585,0.2793622389921112,1.0,11/32,16.97%,AGO2;BRD4;CTR9;DHX9;SMYD2;PCIF1;RPRD2;ELOF1;ZNF326;WAC;ELP4
prerank,Toll-like receptor binding (GO:0035325),-0.6176659967243339,-1.4534911871911442,0.055267702936096716,0.27647285167429286,1.0,3/11,8.18%,CD36;UNC93B1;MYD88
prerank,histone deacetylase binding (GO:0042826),-0.3848583540828633,-1.4529739589549364,0.01779935275080906,0.27391985345551295,1.0,25/88,18.64%,MEF2A;SPI1;AKAP8;NIPBL;TOP2A;MEF2B;YWHAE;MEF2D;MEF2C;SUDS3;HDAC10;RELA;IKZF3;NUDT21;HSP90AB1;MTA3;HDAC5;SP2;DHX36;TFAP4;ANKRA2;RBBP4;HSPA1A;RAD9A;MIER1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.45469583104876066,-1.4516273789041203,0.051194539249146756,0.27296071901973695,1.0,11/38,11.21%,DENND1A;SH3PXD2B;ZFYVE26;SNX3;SNX27;TECPR1;KIF16B;HIP1;SESTD1;SNX13;NCF4
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6315170702594117,1.4486918800854225,0.061465721040189124,0.20009349185218697,1.0,6/10,23.92%,SHISA6;SHANK3;SHANK2;NSF;SHANK1;SHISA7
prerank,phosphatidylglycerol binding (GO:1901611),-0.5825202793511179,-1.4478952908877307,0.07465277777777778,0.27683194539565326,1.0,4/13,8.96%,PLTP;PITPNC1;PITPNA;GSDME
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.3419093273748902,-1.4425677531842829,0.00641025641025641,0.28317939770360506,1.0,56/181,23.32%,RBPJ;MDFIC;RB1;JUN;MEF2A;CREBBP;PPARD;ANXA4;NFE2L2;PPARG;PIAS1;SPI1;WWP2;RERE;STAT3;DHX9;ACTB;SMARCD3;MAPK14;TAF6;CTNNB1;BHLHE40;FIZ1;ARID1A;DNAJA1;SPEN;PARP9;HIF1A;ARNT;RELA;MTA3;HDAC5;RXRA;SIN3A;ID2;RNF25;TCF3;TAF4B;HCLS1;FAF1;NRIP1;NFATC1;RBBP8;TAF4;MIER1;HSPB1;LMO2;GSK3B;DTX3L;STAT1;JUP;KDM1A;EGR2;NR1H4;MTDH;SETD6
prerank,phospholipase inhibitor activity (GO:0004859),-0.6397084708231269,-1.4418334035743232,0.0823327615780446,0.2810274791809348,1.0,4/10,5.43%,ANXA4;ANXA2;ANXA5;ANXA1
prerank,retinoid X receptor binding (GO:0046965),-0.6106991612761472,-1.439408448478449,0.06386861313868614,0.2822264939308285,1.0,6/11,18.21%,PPARG;RARG;NSD1;NRIP1;ARID5A;NCOA6
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.3410111490909508,-1.4377177580435296,0.0061823802163833074,0.28209591259030836,1.0,52/188,18.20%,FLI1;RUNX1;TFEB;JUN;ZNF568;ARID5B;NFE2L2;BRD7;NFYA;ATF3;PPARG;SPI1;BRCA1;STAT3;FOXO3;DHX9;CHD3;NFKB1;HHEX;CIITA;AHR;TBL1XR1;ATF6;CREB3L2;HNRNPL;ATMIN;MEF2C;EGR1;RELA;ZBTB20;XRCC6;KMT2D;FOXJ1;TCF7;HMGB2;ZBED4;HDAC5;DHX36;RXRA;CALCOCO1;TFAP4;PSPC1;TFAM;YY1;KLF11;SOX10;TAF9;ATF5;TFE3;GATA3;ARID5A;TCF12
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.576268575075815,1.437166073495648,0.0936768149882904,0.21066674374267322,1.0,2/12,3.01%,B3GALT1;B3GALT5
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5850667339322884,-1.4370982578947527,0.08394160583941605,0.2797567006255675,1.0,3/12,6.76%,IGF1;INSR;ARRB1
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.39232230222978287,-1.435940920076177,0.024429967426710098,0.27899121886593226,1.0,27/78,20.98%,CTSB;CTSZ;USP12;MALT1;USP18;CFLAR;USP8;USP36;USP9X;CTSC;CASP4;CTSH;CAPN15;CTSS;USP42;CASP7;CASP1;USP35;USP40;CAPNS1;USP30;USP11;USP7;CASP8;CASP2;SFRP1;USP9Y
prerank,single-stranded DNA helicase activity (GO:0017116),-0.519372810048494,-1.4326308201134605,0.06642066420664207,0.2821105799911603,1.0,9/19,24.40%,DHX9;MCM6;RAD51;RFC2;MCM2;CHTF18;DNA2;RFC3;MCM5
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.5984786336346495,-1.4326080439113136,0.08270676691729323,0.2788557887469366,1.0,6/12,21.54%,CNOT1;CNOT2;PAN3;CNOT6L;CNOT8;PNLDC1
prerank,GTP binding (GO:0005525),-0.34291348286885476,-1.4314661323131337,0.006745362563237774,0.2780259762425411,1.0,66/172,26.03%,MFHAS1;RAB7A;RAC1;ARL8B;RAP1B;DNM2;RHOA;ARL8A;RAP2B;INSR;RAP2A;RAB31;RAP1A;CDC42;NOA1;ARL11;RHOQ;RAB32;NME1;GBP5;RAB5A;ADSS1;RAB21;GBP2;TGM2;SEPHS1;RRAGD;RAB11B;RAB29;EEF1A1;RAB10;ARL5A;ARL3;TUBD1;GCH1;ANXA6;RAB13;RND2;ARHGEF5;RAB39A;RALB;GTPBP10;KRAS;NRAS;ARL1;ARFIP2;RHEB;GBP3;GBP7;RHOBTB1;GBP6;RHOF;TUBA4A;TUBB1;TUBA8;RABL3;RND1;RAB26;RAB4A;GBP4;RAB1B;RAB35;REM1;ARL4A;RND3;NUDT16
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.5802644163173813,-1.4299612730844224,0.08361774744027303,0.2778396063484501,1.0,8/12,29.29%,GAB2;BLNK;STAP1;FRS2;TRADD;SHC1;SH2B1;TRAT1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.5479747447866234,-1.4289235156954305,0.09106529209621993,0.276755778990641,1.0,6/16,9.62%,MTM1;MTMR10;SYNJ1;MTMR3;MTMR14;MTMR6
prerank,phosphatidic acid binding (GO:0070300),-0.5143164426013785,-1.427731918023285,0.06518010291595197,0.2758914618397095,1.0,6/19,10.92%,PLTP;PITPNC1;GRAMD1B;PITPNM1;PACSIN2;SESTD1
prerank,bHLH transcription factor binding (GO:0043425),-0.5246929147102394,-1.4253573104366462,0.06060606060606061,0.27724467365803757,1.0,8/19,21.39%,CREBBP;USF2;BHLHE40;TCF3;MAP3K10;TCF12;LMO2;KDM1A
prerank,DNA-binding transcription factor binding (GO:0140297),-0.3362430713288627,-1.4240248413668923,0.007763975155279503,0.27664475146371076,1.0,55/189,21.99%,RBPJ;RB1;JUN;MEF2A;CREBBP;PPARD;NFE2L2;PPARG;PIAS1;SPI1;WWP2;RERE;STAT3;DHX9;USF2;HHEX;BCL2;DAPK3;CIITA;CTNNB1;SKI;BHLHE40;FIZ1;SPEN;NEK6;MEF2D;TLE3;MEF2C;SIK1;RELA;MTA3;HDAC5;SIN3A;CRTC3;ID2;TCF3;MAP3K10;HCLS1;TLE4;TAF9;NFATC1;TCF12;ZMYND8;RBBP8;MIER1;HSPB1;LMO2;HMGB1;GSK3B;STAT1;NBN;KDM1A;NLRP3;ZBTB7A;EGR2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.5696978332422968,-1.421490830837968,0.060714285714285714,0.2782208036003879,1.0,4/14,29.02%,DHRS3;AKR1A1;RDH12;RDH10
prerank,dipeptidyl-peptidase activity (GO:0008239),0.5976189784347548,1.4185695448319424,0.0979498861047836,0.2303956889487646,1.0,2/10,0.18%,DPP10;DPP6
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.5681164364382961,-1.4183941616874918,0.10288808664259928,0.28101461542409056,1.0,6/14,13.02%,APAF1;NOD1;CTSH;ATP2A3;EBAG9;CASP1
prerank,neuropeptide hormone activity (GO:0005184),0.47497604072223515,1.418240481494801,0.09302325581395349,0.22785136756141544,1.0,8/22,18.75%,PNOC;SPX;CORT;GHRH;CALCB;PENK;GRP;CRH
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.5701026092493868,-1.4168888052648956,0.09911504424778761,0.2809725158562368,1.0,6/14,9.62%,MTM1;MTMR10;SYNJ1;MTMR3;MTMR14;MTMR6
prerank,CCR chemokine receptor binding (GO:0048020),-0.4674486153440532,-1.41275135546449,0.07092198581560284,0.28562607734733514,1.0,13/28,39.74%,CCR2;NES;CCL5;CCRL2;CCL7;CCL24;CCL4;CCL25;CCL19;CCL8;CNIH4;MSMP;CCL14
prerank,nuclease activity (GO:0004518),-0.4156327187453698,-1.4115777711067838,0.03395585738539898,0.2848913442439837,1.0,25/52,26.18%,SAMHD1;RNASEL;RNASE12;REXO5;RNASE4;ISG20L2;REXO4;RNASE7;NME1;WRN;DNASE1L1;RNASE6;EXO1;FEN1;ENDOG;MAP1S;ANG;DDX1;DNA2;ENPP1;ZC3H12A;XRN2;SND1;MRE11;ERN2
prerank,growth factor activity (GO:0008083),0.37150472263384354,1.4076914854230052,0.03968253968253968,0.2387704932669586,1.0,16/74,14.63%,NRG3;NRG1;TGFA;EGF;PTN;GDNF;VEGFD;PGF;FGF10;BDNF;AMELX;AREG;CLEC11A;ANGPTL3;IGF2;INHBA
prerank,cadherin binding (GO:0045296),-0.31775146966667295,-1.4059703916256052,0.0,0.29268531251943347,1.0,132/315,26.01%,IQGAP1;AHNAK;ABI1;ASAP1;ZC3HAV1;PAK2;MYH9;SWAP70;CBL;SNX2;NIBAN2;PTPRJ;SNX9;IDH1;RARS1;FLNA;ANXA2;P2RX4;CAPZB;EHD4;WASF2;TAGLN2;FXYD5;S100A11;CHMP5;RAB1A;ITGB1;USP8;SNX5;ANXA1;TLN1;ARHGAP18;MACF1;CAPG;PICALM;GOLGA3;CTNNB1;ABCF3;EIF5;EPS15;BAIAP2;PPP1CA;STK38;CKAP5;CAST;YWHAE;ESYT2;LIMA1;MRTFB;DIAPH3;PACSIN2;SCRIB;EEF2;EIF3E;RAB11B;PRDX1;FMNL2;CD46;TMPO;RPL14;CLINT1;STX5;HSP90AB1;PKM;CAPZA1;RAB10;STK24;RPL34;PLCB3;SH3GLB1;TJP2;RPL6;SH3GL1;MARK2;EHD1;CRKL;BAG3;CDH24;EIF2A;VAPB;VASN;HDLBP;HSPA1A;TWF2;PTPRO;SNX1;EFHD2;PTPN11;ARFIP2;RPL23A;CLIC1;DDX3X;PAK6;TRIM29;BMPR2;DDX6;UBAP2;PTPN1;STAT1;JUP;ATXN2L;KDR;TRIM25;LRRFIP1;RACK1;HNRNPK;PDLIM5;SFN;RANBP1;CHMP4B;PPFIBP1;CNN2;CTNNA1;RPL7A;MPRIP;PDLIM1;SPTAN1;PPL;TES;MICALL1;AHSA1;ARGLU1;LASP1;CCNB2;CHMP2B;SND1;ATIC;NUDC;EEF1D;NCK1;PFN1;MRE11
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.5453996177522085,-1.4048401955696697,0.07796610169491526,0.29181639118958597,1.0,9/15,19.63%,PI4K2A;PI4K2B;PIK3CB;PIK3CG;PI4KB;PIK3CA;PIK3CD;PIK3C2A;ATM
prerank,chemokine activity (GO:0008009),-0.45509795587801327,-1.4044993716241088,0.07692307692307693,0.28960175783382464,1.0,15/31,44.64%,CKLF;PF4;CXCL16;CCL5;CCL7;CCL24;CCL4;CCL25;CCL19;CCL8;CXCL9;CXCL1;CCL14;CXCL10;CCL3
prerank,ubiquitin protein ligase binding (GO:0031625),-0.3237987961294425,-1.4038952357324859,0.0061823802163833074,0.28795340228421795,1.0,72/254,18.13%,MFHAS1;RB1;JUN;SNX9;TNFRSF1B;RIPK1;TRAF5;BRCA1;ARRB2;HSPA9;RNF20;BCL2;UBXN7;PTPN22;RNF31;TSG101;AXIN1;RPL11;TRIOBP;TRAF3;ARRB1;WFS1;DET1;SKI;ATXN3;LAPTM5;DNAJA1;TRIB1;JAK1;NEK6;YWHAE;HIF1A;UBC;RPS27A;UBE2L3;TRIB2;RNF8;RELA;TRAF1;DERL1;LRPPRC;PCBP2;CUL4B;TMBIM6;TPI1;HSP90AB1;TRAF2;POLR2A;CUL2;CD40;ARIH1;ARRDC1;ANKRA2;RNF34;GABARAP;UBE2G1;UBE2T;HLTF;CXCR4;HM13;FAF1;USP7;UQCRC1;ISG15;ASB4;CASP8;HSPA1A;RALB;SMAD7;FBXO7;LAPTM4B;DTX1
prerank,SUMO transferase activity (GO:0019789),-0.5356859799593283,-1.3950511697190782,0.08576329331046312,0.3018779780619629,1.0,8/16,28.82%,NSMCE2;PIAS1;UBE2I;EGR2;TOPORS;RANBP2;TRIM28;PIAS2
prerank,thyroid hormone receptor binding (GO:0046966),-0.46072133470456417,-1.3948652586777992,0.07334525939177101,0.2992886435934655,1.0,11/28,25.17%,JMJD1C;PRMT2;MED24;MED4;OASL;NSD1;ARID5A;NCOA6;TRIP12;GAS2L1;NCOR1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5376890998764641,1.3890215937859791,0.07673267326732673,0.2603831357043118,1.0,4/14,7.65%,SPOCK1;SPOCK3;TIMP3;COL4A3
prerank,1-phosphatidylinositol binding (GO:0005545),-0.5393049531168151,-1.3888352448092134,0.09059233449477352,0.3083548214259809,1.0,6/15,10.92%,SNX10;SNX9;WDFY3;PICALM;EEA1;SESTD1
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.45135692301914293,-1.3883435426058304,0.0707070707070707,0.3064440909020012,1.0,11/33,16.97%,AGO2;CTR9;DHX9;SMYD2;MAF1;RPRD2;SPTY2D1;ELOF1;ZNF326;WAC;ELP4
prerank,nuclear receptor binding (GO:0016922),-0.350938219020086,-1.388243449437882,0.02456140350877193,0.30377088812342723,1.0,40/111,25.17%,FOXP1;PRKCB;KDM3A;JMJD1C;CNOT1;SMARCD3;PRMT2;MED24;CTNNB1;STAT5B;ARID1A;WBP2;DDX5;TGFB1I1;HIF1A;ASXL1;STRN;MED4;OASL;TRIM68;RXRA;NSD1;NR4A1;NRIP1;PPARGC1B;ARID5A;NCOA6;TRIP12;MMS19;STAT1;JUP;GAS2L1;DDX54;KDM1A;ZBTB7A;NR1H4;PRPF6;DCAF1;TADA3;NCOR1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.3177168963524718,-1.3876916802840769,0.0061633281972265025,0.3020414478731868,1.0,100/269,27.06%,MFHAS1;RB1;JUN;SNX9;TNFRSF1B;RIPK1;TRAF5;BRCA1;ARRB2;HSPA9;RNF20;BCL2;UBXN7;PTPN22;RNF31;TSG101;AXIN1;RPL11;TRIOBP;TRAF3;ARRB1;WFS1;DET1;SKI;ATXN3;LAPTM5;DNAJA1;TRIB1;JAK1;NEK6;YWHAE;PARP9;HIF1A;UBC;RPS27A;UBE2L3;TRIB2;RNF8;RELA;TRAF1;DERL1;LRPPRC;PCBP2;CUL4B;TMBIM6;TPI1;HSP90AB1;TRAF2;POLR2A;CUL2;CD40;ARIH1;ARRDC1;ANKRA2;RNF34;GABARAP;UBE2G1;UBE2T;HLTF;CXCR4;HM13;FAF1;USP7;UQCRC1;UBE2C;ISG15;ASB4;CASP8;HSPA1A;RALB;SMAD7;FBXO7;LAPTM4B;DTX1;WRAP53;UBXN1;GSK3B;TXNIP;DTX3L;STAT1;BLZF1;FAF2;BAG6;SMC6;EGR2;BECN1;SUMO3;CCNB1;SLC22A18;STAT2;TRIM28;SPOP;MID1;UBE2N;RNF40;RPL5;PML;VCP;HSPA8;CUL3
prerank,anion channel activity (GO:0005253),0.37546047686173845,1.3875370346447606,0.03826530612244898,0.25895104480792197,1.0,13/61,8.86%,GABRB3;GABRB1;GABRG3;GLRA1;GABRA2;ANO4;GABRA3;GABRA5;GABRB2;ANO3;GABRG2;ANO5;GLRA2
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.32110703222193593,-1.38413855021866,0.010769230769230769,0.30604393463330026,1.0,94/232,31.06%,NSMCE2;BIRC3;WWP1;CBL;ZNRF3;RNF150;HECTD1;BFAR;RNF149;RNF19A;NEURL3;RNF111;NFX1;MKRN2;PIAS1;MYLIP;WWP2;RNF41;AMFR;AREL1;RNF166;PELI1;CDC42;RC3H1;UHRF2;UBE3B;MGRN1;UBR2;CBLL1;RNF38;RFWD3;RNF8;NEDD4L;TRIM24;UBE3A;RNF180;RNF128;TRIM68;UHRF1;RNF185;TRIM11;ARIH1;KCMF1;RNF25;RNF34;CBLB;RNF43;RNF216;HLTF;BRAP;TRIM14;RNFT2;DTX1;RNF121;HUWE1;TRIM39;TRIP12;DTX3;UBE3C;VPS18;DTX3L;RNF125;TRIM25;NEURL1B;SMURF2;RNF135;EGR2;RNF115;TOPORS;MEFV;TRIM72;ZNRF1;TRIM69;RNF187;RNF19B;VPS11;LRSAM1;SIAH2;SMURF1;CUL3;COP1;RNF2;RNF26;PIAS2;HACE1;RNF167;GID4;RBBP6;TRIM41;MKRN3;RNF10;TRIM55;TRAF6;XIAP
prerank,endopeptidase activator activity (GO:0061133),-0.6016071240366754,-1.382608680738319,0.09982788296041308,0.3056666804168885,1.0,3/10,11.38%,PSME3;NLRC4;PSENEN
prerank,ferrous iron binding (GO:0008198),-0.48962992906024677,-1.3824844857260359,0.08226691042047532,0.3031677057024703,1.0,7/21,15.22%,FTL;CDO1;ALKBH1;EGLN1;FTO;TET2;ACP5
prerank,heme binding (GO:0020037),-0.3782501181674083,-1.3810729310892318,0.048576214405360134,0.30322919620332006,1.0,20/65,25.42%,CYBB;TBXAS1;HEBP1;BACH1;CYP27A1;EIF2AK1;HMOX2;FLVCR1;RSAD1;CYB5B;CYP46A1;PGRMC1;CYP2R1;CYB5R4;CAT;PXDNL;HMOX1;CYP1B1;CYCS;CYB5A
prerank,endoribonuclease activity (GO:0004521),-0.44975215427195714,-1.3800406921019477,0.07142857142857142,0.3023866197537586,1.0,17/32,28.81%,ERN1;AGO2;RNASEL;INTS11;KHNYN;NYNRIN;ENDOG;CPSF3;ZC3H12A;TSNAX;YBEY;SND1;RCL1;ZC3H12D;ERN2;LACTB2;ZC3H12C
prerank,voltage-gated ion channel activity (GO:0005244),0.5365259368892963,1.3800033448557754,0.10096153846153846,0.26626262135248124,1.0,2/14,0.88%,KCND2;CACNA1E
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.44888684681606783,-1.3786213173024893,0.08020477815699659,0.30227882979492454,1.0,11/32,19.25%,SLC38A6;SLC6A6;MFSD12;SLC43A2;SLC38A7;SLC36A4;SFXN2;SLC7A5;SFXN1;SLC6A9;SLC38A2
prerank,pentosyltransferase activity (GO:0016763),-0.4324349775782873,-1.3773711700154128,0.06949152542372881,0.3018740075431509,1.0,12/36,17.36%,ZC3HAV1;PARP11;PARP14;PARP4;TIPARP;PARP9;PARP8;SIRT3;QTRT1;TNKS2;LARGE1;PARP10
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.5714882490210484,-1.3760059856831086,0.09302325581395349,0.30171519665531255,1.0,6/12,16.56%,GNS;GALNS;ARSA;SULF2;ARSK;ARSJ
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3944090011949274,1.3745282488299233,0.057356608478802994,0.2707891059812098,1.0,9/48,10.80%,UNC80;TRPM3;SLC12A2;NALCN;TRPC1;PKD1L3;TRPM1;SLC4A11;MMGT1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5396705763594504,1.373885531923986,0.1347517730496454,0.2685159183087227,1.0,8/13,25.44%,RYR2;SOX9;PKIA;PJA2;PRKAR1A;PRKAR2B;PRKAR1B;KCNQ1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.36518811441870735,1.372278677913591,0.04899777282850779,0.26766696513418575,1.0,13/73,11.47%,SORCS1;HCRTR2;LGR5;SORCS3;GPR37;OPRD1;PTH1R;CX3CR1;CCKBR;OXTR;NPSR1;GALR1;LGR4
prerank,histone demethylase activity (GO:0032452),-0.45529207888775997,-1.3704536618412246,0.08747855917667238,0.30953828240273457,1.0,13/27,30.88%,KDM3A;JMJD1C;KDM7A;KDM3B;JARID2;KDM2A;HR;KDM5B;KDM1A;FBXL19;KDM2B;KDM6A;RIOX2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5597695999669344,-1.3692755125945621,0.1138353765323993,0.30902542096449725,1.0,6/12,22.16%,CDK6;BRD4;CDK13;CDK1;CCNK;MAPK1
prerank,chemokine binding (GO:0019956),-0.4470052613657149,-1.3686332900872078,0.0913978494623656,0.3076083019539581,1.0,5/30,4.91%,ITGA4;CCR2;CCR1;ITGB1;ITGAV
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.42810232067263726,-1.3664744006685867,0.0763888888888889,0.3091248231418941,1.0,13/34,21.68%,ERI3;CNOT1;CNOT2;EXOSC5;ERI2;PAN3;CNOT6L;ANGEL1;EXOSC10;CNOT8;EXOSC4;PNLDC1;XRN2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.37650233808499994,1.361034655956853,0.05167958656330749,0.2809643516855917,1.0,17/55,14.99%,TRPC5;RYR2;SLC24A4;SLC24A2;TRPC1;CACNB2;SLC24A3;PKD1L3;TRPM1;SLC8A2;RYR1;PKD1;ATP2B4;ATP2B2;ATP2A1;CHRNA7;TRPV3
prerank,RNA polymerase binding (GO:0070063),-0.5009111080094077,-1.360127881962207,0.08919382504288165,0.31880560435670163,1.0,6/18,10.42%,BRCA1;DHX9;ANP32B;STOM;YTHDC2;PHRF1
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5464989911849161,-1.3551261550093034,0.11224489795918367,0.3263367911532703,1.0,11/13,40.13%,EIF5;ITGB1BP1;CCDC88A;RGS14;GDI2;RANBP1;GDI1;ARHGDIB;SH3BP4;ARHGDIA;ARHGDIG
prerank,calcium activated cation channel activity (GO:0005227),0.49745108401545307,1.3548890302938925,0.1380952380952381,0.2865535364296411,1.0,3/17,2.07%,KCNN2;KCNMB3;KCNMB2
prerank,ubiquitin protein ligase activity (GO:0061630),-0.31422677085016576,-1.3525387512522133,0.010719754977029096,0.32882484779167964,1.0,92/228,31.06%,BIRC3;WWP1;CBL;ZNRF3;RNF150;HECTD1;BFAR;RNF149;RNF19A;NEURL3;RNF111;NFX1;MKRN2;MYLIP;WWP2;RNF41;AMFR;AREL1;RNF166;PELI1;CDC42;RC3H1;UHRF2;UBE3B;MGRN1;UBR2;CBLL1;RNF38;RFWD3;RNF8;UBE4B;NEDD4L;TRIM24;UBE3A;RNF180;RNF128;TRIM68;UHRF1;RNF185;TRIM11;ARIH1;KCMF1;RNF25;RNF34;CBLB;RNF43;RNF216;HLTF;BRAP;TRIM14;RNFT2;DTX1;RNF121;HUWE1;TRIM39;TRIP12;DTX3;UBE3C;VPS18;DTX3L;RNF125;TRIM25;NEURL1B;SMURF2;RNF135;RNF115;TOPORS;MEFV;TRIM72;ZNRF1;TRIM69;RNF187;RNF19B;VPS11;LRSAM1;SIAH2;SMURF1;CUL3;COP1;UBE4A;RNF2;RNF26;HACE1;RNF167;GID4;RBBP6;TRIM41;MKRN3;RNF10;TRIM55;TRAF6;XIAP
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.45828809421116945,-1.3465481803320611,0.11033274956217162,0.3375463106535303,1.0,8/25,14.91%,POR;CYP27A1;KMO;MICAL1;MICAL2;CH25H;FMO5;CYP46A1
prerank,clathrin adaptor activity (GO:0035615),-0.5141103920047394,-1.3449962304913738,0.11187607573149742,0.33782055068824823,1.0,4/15,7.99%,DAB2;AP1G1;HIP1;AP2A2
prerank,MHC protein binding (GO:0042287),-0.4922499427843222,-1.3421231066323003,0.1218274111675127,0.34060552462059174,1.0,12/20,33.06%,CD74;LILRB1;TAPBP;DERL1;TAP2;PILRA;ATP5F1B;KIR3DL2;CD8B;CD4;ATP5F1A;CD8A
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.43801857934806854,-1.3390813555359156,0.085667215815486,0.3443234183899104,1.0,10/30,15.44%,BIRC3;TNFAIP8;BIRC6;GAS6;CAST;SERPINB9;PRDX5;CD27;CST7;CST3
prerank,ADP binding (GO:0043531),-0.4640987557749329,-1.337514353437525,0.08970099667774087,0.34476286394433253,1.0,6/25,7.94%,ABCG1;MYH9;MYO9B;ERN1;PRKAG2;COQ8A
prerank,nuclear localization sequence binding (GO:0008139),-0.5084006130707499,-1.3362786694053121,0.1152542372881356,0.34443110942788513,1.0,5/18,18.34%,KPNA4;IPO5;KPNA3;BRAP;NUP153
prerank,metal ion binding (GO:0046872),0.27411948452162826,1.3342108993021324,0.006389776357827476,0.3145915609053233,1.0,107/477,14.76%,KCNIP4;NRXN1;ADGRL3;ASTN2;CDH18;SPOCK1;CDH8;RYR3;RYR2;CDH10;SYT1;ADCY2;EML1;CDH2;SLIT3;SLIT2;CDH20;CDH11;PCLO;KCNIP1;SYT10;ENPP2;CDC42BPA;NCS1;CDH13;TUBB4A;PAM;TESC;MMP12;SYT2;RAN;CDH12;PITPNM3;CDH22;SCUBE1;SLIT1;EYA2;CDH19;CDH7;ACVR1C;PDCD6;MARK1;SPARCL1;SLC25A23;CASQ2;MAP2K7;DCHS1;GNAI1;PRNP;GSS;SYT5;YDJC;PLA2G4E;ENPP3;KCNIP2;GLCE;HMGCLL1;ADGRV1;CDH6;PCDHB6;CALR3;LETM1;CCDC47;SYT11;SYT12;CETN3;CDH17;PLA2G10;CRP;RYR1;PCDHA4;MMP13;THTPA;DSC3;DSC2;CABCOCO1;DNER;CDHR3;SMOC2;GSN;TTN;CDH9;CDK5R1;CAPN3;AMY1B;AMY1C;AMY1A;DYSF;NDUFAB1;BRSK1;RET;CALM1;F9;CALM3;SYT7;CALM2;PRKACB;MICU3;CDH1;DYRK3;NOL3;CDH5;CLEC3B;MVK;ATP2A1;MCTP2;IDH3A
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.36274733354501215,1.333626894409686,0.07524271844660194,0.31182676741239385,1.0,20/60,17.03%,ERBB4;NTRK3;EPHA6;NTRK2;EPHA7;EPHA5;CSF1R;EPHB1;TIE1;ALK;EPHA10;ROS1;LTK;TYRO3;RET;EPHB4;EPHB3;ERBB3;EPHA3;ROR1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5310972122190388,-1.332195524048556,0.13703703703703704,0.34989056001556096,1.0,7/12,41.98%,SLC25A42;ENTPD6;ENTPD3;NUDT15;ENTPD7;NUDT5;ENTPD1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.5162552071247727,1.3302498447566424,0.14074074074074075,0.3140957006910257,1.0,4/13,15.44%,BMP7;BMP3;CDH5;GDF15
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5815769334193299,-1.3279946371309894,0.12152777777777778,0.3562469030041909,1.0,6/10,18.91%,CFLAR;CASP4;CASP7;CASP1;CASP8;CASP2
prerank,transition metal ion binding (GO:0046914),-0.2942720675484386,-1.3272025621639014,0.0030349013657056147,0.35517216506382465,1.0,112/397,20.93%,ADAM33;GDA;FAM20C;LITAF;TET3;SAMHD1;FTL;ANPEP;SLC30A5;ACER3;MGAT5;ETHE1;P2RX4;ARHGEF2;PPARG;KDM3A;ABL2;ZNF3;DHX58;DYRK2;TAB2;GYG1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;CHD3;ATP7A;PIM1;RC3H1;LNPEP;BLM;GALT;ABCE1;PRIMPOL;KDM7A;PITRM1;CRIP1;GALNT3;KDM2A;SKI;EEA1;TIMP2;QPCTL;THAP1;GALNT1;IMPA1;ATAD3A;XXYLT1;AGMO;POLR2L;SIRT3;ADAM8;MSRB1;EGR1;RNF8;HDAC10;B4GALT7;SEC24A;WRN;CHMP1A;MTPAP;SEC24D;PRDM2;TRIM24;XYLT2;FEN1;POMGNT1;UHRF1;MT2A;RXRA;TET2;AOC2;SORD;MOXD1;GCH1;ARIH1;CBLB;LARGE1;PDXK;NSD1;ANG;ARG2;CYP2R1;IKZF4;TNFSF10;KMT2A;RPS27;LIMS1;WDFY1;ZMYND8;MMP8;MGAT2;XPNPEP3;TYW5;PAPOLA;MDM4;B4GALT1;ENPP1;RABGGTB;SLU7;SLC11A2;KDM5B;MPPE1;SIRT2;PTPN1;ZFPL1;RNF125
prerank,SH2 domain binding (GO:0042169),-0.4321353193783057,-1.3266012596928758,0.09726962457337884,0.35386387773756384,1.0,11/31,21.45%,SH3PXD2B;LILRB1;BLNK;AFAP1L2;LCK;CRK;CCDC88A;LAT2;LAX1;RACK1;NUP62
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.3861127809779614,-1.3254603519425432,0.08844765342960288,0.3534513710354557,1.0,21/53,24.95%,CYBB;XDH;POR;CYB5R1;GSR;CYB5R3;KMO;GFER;MICAL1;MICAL2;ACOX1;DLD;PPOX;FOXRED2;MTHFR;KDM1A;ACADVL;NQO2;ACOXL;QSOX1;CYB5R2
prerank,protein homodimerization activity (GO:0042803),-0.2810995796282757,-1.3212799057658966,0.005641748942172073,0.35906637642268363,1.0,172/590,22.39%,EXT1;APOE;MAP3K5;ABCG1;LILRB1;PSAP;XDH;TPD52;MCL1;PLEK;MYH9;MYO9B;SNX2;GOLGA5;SNX9;IDH1;ERN1;PDCD6IP;ABCB7;FLNA;PIP4K2A;ATF3;ABCD2;KYNU;RIPK1;IRAK2;IL6R;S100A11;STAT3;GYG1;ATG7;NLRC4;USF2;RBPMS;SNX6;DPP4;HHEX;TOP2A;PRMT2;BCL2;CENPF;SARS1;MTHFD1L;KIF20B;TPST1;DAPK3;BLM;TSG101;AXIN1;NRF1;TBC1D22A;TPM4;LRP6;AHR;IRAK3;DGKD;CEP57;HIP1;ALS2;MFSD1;VEGFA;EEA1;EIF2AK1;BHLHE40;GBP5;DCK;BST2;B2M;THAP1;IMPA1;EXD1;NOD1;JAML;ST6GAL1;LPL;GBP2;RPE;ARNT;RNF8;SSBP1;RELA;AGXT;IKZF3;ZDHHC2;GEN1;MYOM1;RABEP1;CLN6;WRN;CHMP1A;MTPAP;TPR;CCDC88A;NUDT21;FAP;GADD45A;CPQ;QTRT1;KYAT1;TPI1;PPCS;CCL5;HSP90AB1;TRIM68;DEFA6;SH3GLB1;TFAP4;KNSTRN;CST7;GREM1;GCH1;S100A6;TKT;PDXK;TCF3;IKBKB;PGRMC1;MAP3K10;NADK2;ANG;KARS1;TARS2;PEX7;PAPSS1;TRIM14;HM13;CYP2R1;VAPB;APPL2;ABCD3;GALE;GALM;ACOX1;KMT2A;BNIP3L;MIGA2;PTPRO;SNX1;DNTTIP1;STK10;MGAT2;XPNPEP3;ADRB2;HSPB1;GBP3;TYW5;MMUT;ENPP1;SLC8B1;RBPMS2;PLN;CARNMT1;CSF1;CAT;RBM11;APPL1;DARS2;PNPO;STAT1;JUP;LRRFIP1;PDGFA;RACK1;BCL2L2;CEBPB;MASP1;SHMT1;GTF2A2;HPS4;PHETA1;CHMP4B;CHMP4A
prerank,phospholipid transfer activity (GO:0120014),-0.4804902507686162,-1.3193037517020672,0.1226890756302521,0.36025812957246517,1.0,6/21,9.89%,PLTP;PITPNC1;PITPNA;PITPNM1;GLTP;PRELID2
prerank,transcription cis-regulatory region binding (GO:0000976),-0.28931114405895186,-1.318967446136691,0.0113314447592068,0.3582073030355578,1.0,97/406,18.74%,FLI1;FOXP1;RUNX1;TRPS1;TFEB;RREB1;RB1;JUN;ZNF568;MEF2A;ETV6;RUNX3;AGO2;ARID5B;NFE2L2;BRD7;IRF2;NFX1;NFYA;ATF3;PPARG;ELK3;SPI1;BRCA1;FOXN2;ZNF3;STAT3;FOXO3;E2F2;STAT6;CHD3;NFKB1;HHEX;MLXIP;TIPARP;CIITA;CUX1;AHR;TBL1XR1;ATF6;CREB3L2;HNRNPL;E2F1;ATMIN;E2F3;MEF2D;HIF1A;MEF2C;FOXN3;PRDX5;EGR1;ARNT;RELA;ZBTB20;XBP1;XRCC6;OSR1;KLF10;PRDM2;NFE2;KMT2D;FOXJ1;ZFP57;FOSL2;TCF7;HMGB2;ZFP41;UHRF1;ZBED4;HDAC5;DHX36;RXRA;CALCOCO1;E2F8;TFAP4;DR1;PSPC1;ZBTB46;TFAM;TCF3;YY1;TFCP2;ZNF177;KLF11;SOX10;TAF9;RARA;ATF5;SNAPC3;NR3C1;TFE3;GATA3;ARID5A;RPS3;TCF12;TAF4;CASZ1
prerank,protease binding (GO:0002020),-0.3444049343311313,-1.318705112561961,0.06320907617504051,0.3561543202000954,1.0,23/99,12.79%,PSAP;CRADD;BFAR;ANXA2;AMFR;RIOK3;CFLAR;NLRC4;RHBDD2;ITGB1;DPP4;ITGAV;BCL2;FN1;TIMP2;CD28;SERPINB9;SELENOS;UBC;DERL1;FAP;ITGA3;SERPINE1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5181993677918462,-1.3176122178123975,0.13644214162348878,0.35581981897615844,1.0,4/14,10.38%,IREB2;CIAO3;RSAD2;RSAD1
prerank,sodium channel regulator activity (GO:0017080),0.39607023899900484,1.3173878826805598,0.1,0.3316876529024487,1.0,6/37,8.69%,FGF14;FGF12;SCN2B;PTPN3;NEDD4;FXYD6
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.43266022870989995,-1.3169260767795952,0.10942760942760943,0.35452530689024103,1.0,12/29,20.82%,MAPKAPK3;PTPRJ;MAPKAPK2;MAPK14;PRMT1;MAPK7;DUSP6;TPR;GCH1;NFATC1;DUSP5;ATF7
prerank,magnesium ion binding (GO:0000287),-0.32565059453799305,-1.3162608516616146,0.037037037037037035,0.3533906220976316,1.0,32/135,15.31%,MAP3K5;PI4K2A;IDH1;ERN1;MAP3K20;RAP2A;ABL2;DYRK2;NLRC4;TOP2A;STK3;IRAK3;NME1;STK38;HPRT1;NEK6;IMPA1;XXYLT1;SIK1;GEN1;WRN;MTPAP;STK11;XYLT2;FEN1;DHX36;MAST2;DUT;MARK2;TKT;PDXK;RP2
prerank,kinase binding (GO:0019900),-0.28510767413307403,-1.3134544344995422,0.0043859649122807015,0.35661452458673193,1.0,132/435,21.22%,IQGAP1;SASH1;PTPRC;LYST;MSN;BCAR3;FGR;SP100;GRB2;PLCG2;PAK2;PRKCD;RB1;RAC1;ITGB2;PTPRJ;MAP3K1;RHOA;KIF13B;FLNA;IBTK;CENPJ;PRKAG2;VRK2;MAML1;KIF11;STAT3;FOXO3;CDC42;CCND3;BLNK;STAP1;ADIPOR1;ACTB;IRF5;IFNAR2;IRAK4;PTPN22;RPS6;DUSP3;AXIN1;MVP;CAB39;UTRN;IRAK3;CTNNB1;DGKD;SKI;AP2A2;NEK6;HIF1A;SLC12A7;PTPN6;SIK1;SPRED1;TPX2;SPRY2;TNIP2;RELA;KIF14;LCK;CDK5RAP1;EEF2;CDC25A;MYOM1;DCTN1;SPRED2;CRK;TICAM1;GADD45A;HSP90AB1;CACUL1;TRIM68;EEF1A1;CASP1;STK11IP;TRAF2;RB1CC1;POLR2A;PPP1R12A;BTG1;ANKRA2;RACGAP1;IKBKB;RELB;MAVS;CSPG4;IL31RA;TRIM14;SGO1;RND2;HCLS1;FAF1;KIF20A;STRADA;GPRC5B;DNAJC3;CD226;EXOC2;AURKA;MAP2K3;RAD9A;ATF5;LIMS1;FBXO7;NR3C1;CDKN2C;LAPTM4B;RPS3;NISCH;FAM83D;PTPN11;PDGFRB;TRADD;HSPB1;JTB;NOD2;RHOBTB1;PRAM1;GDF3;SUFU;PIP5K1A;WNK1;PRC1;GSK3B;RHOF;MIDN;PTPN1;CEP192;MOB1B;CDC25C;LAX1
prerank,GABA receptor binding (GO:0050811),-0.5580358956877209,-1.3131679680323112,0.14853195164075994,0.3547069771356204,1.0,4/11,14.52%,TRAK1;PLCL2;ARFGEF2;GABARAP
prerank,deubiquitinase activity (GO:0101005),-0.3506646790573073,-1.3129535570642412,0.06280193236714976,0.35272617535220635,1.0,36/88,28.84%,USP12;USP50;OTUD5;UCHL5;USP18;USP8;MINDY2;USP36;USP9X;USP3;ATXN3;OTULIN;USP42;USP35;USP40;JOSD1;USP30;OTUD4;USP11;USP7;STAMBPL1;MINDY1;BRCC3;COPS5;BAP1;ZC3H12A;USP9Y;ZRANB1;EIF3H;MINDY3;USP34;USP16;STAMBP;USP28;JOSD2;USP51
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.5169685528597671,1.3124012988699165,0.14989293361884368,0.3363070574637081,1.0,4/14,7.87%,SLC1A2;SLC17A6;SLC1A6;SLC1A1
prerank,semaphorin receptor binding (GO:0030215),0.4432061147981368,1.30885584694754,0.13752913752913754,0.3388850979023338,1.0,7/23,11.05%,RIT2;SEMA6D;SEMA6A;SEMA3E;SEMA5A;SEMA3F;SEMA5B
prerank,endonuclease activity (GO:0004519),-0.3927233871189526,-1.30810414011447,0.08135593220338982,0.359994509181784,1.0,24/49,26.52%,ERN1;AGO2;RNASEL;INTS11;REXO4;KHNYN;FEN1;NYNRIN;ENDOG;ERCC4;APLF;ANG;RPS3;CPSF3;ZC3H12A;TSNAX;YBEY;ZRANB3;SND1;RCL1;MRE11;ZC3H12D;ERN2;LACTB2
prerank,transcription coactivator binding (GO:0001223),0.45787719849130615,1.3076840622006698,0.1310344827586207,0.33719519596044256,1.0,3/20,2.48%,RORA;PGR;THRB
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.5020595137214424,1.3045606339222975,0.14248704663212436,0.33847678041508683,1.0,7/15,25.40%,ALDH1A1;ALDH1A3;ALDH7A1;ALDH1L1;ALDH9A1;ALDH3A2;ALDH2
prerank,myosin binding (GO:0017022),0.3689993809175421,1.3015381598003124,0.08908685968819599,0.3401341648032666,1.0,19/55,17.62%,DMD;STXBP5L;RAB3C;RAB6B;SHROOM4;RAB27B;RAB6A;ACTA1;SHROOM1;MLPH;NKD2;GSN;CALD1;LARP6;USH2A;MYRIP;RAB3A;RAB3B;HAP1
prerank,carbohydrate kinase activity (GO:0019200),-0.554929131747053,-1.3009637607785445,0.15437392795883362,0.37232535207844963,1.0,6/11,29.55%,FGGY;POMK;HK3;GALK2;GALK1;GNE
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5548589852881809,-1.3007355312063424,0.13612565445026178,0.37024951945544315,1.0,6/11,18.91%,CFLAR;CASP4;CASP7;CASP1;CASP8;CASP2
prerank,beta-tubulin binding (GO:0048487),-0.41437707006914165,-1.3000996913697864,0.11647254575707154,0.3690245098227879,1.0,13/31,20.56%,ARL8B;PEX14;ARL8A;EML4;TAOK1;LRPPRC;GABARAP;RACGAP1;MAP1S;VAPB;UXT;PDCD5;APPL1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.37683625230514806,1.2996486607426485,0.09725685785536159,0.33969001892517575,1.0,7/42,7.78%,LRRC4C;CNTN6;CNTN4;DSCAM;NTNG1;DSCAML1;CD200
prerank,iron ion binding (GO:0005506),-0.3843293190804124,-1.2986393808852466,0.09515859766277128,0.3694946640205402,1.0,19/48,26.99%,FTL;CDO1;ETHE1;KDM3A;ABCE1;KDM7A;ALKBH1;EGLN1;AGMO;FTO;TET2;ACP5;CYP2R1;TYW5;ALKBH3;FTH1;FDX1;ALOX15;LCN2
prerank,deoxyribonuclease activity (GO:0004536),-0.52060908140065,-1.298357114608365,0.15789473684210525,0.3675238903565316,1.0,8/14,26.01%,NME1;DNASE1L1;ERCC4;APLF;MAP1S;RPS3;ZRANB3;MRE11
prerank,protein kinase binding (GO:0019901),-0.27975492433723786,-1.2972648814580066,0.007429420505200594,0.36720630808577087,1.0,146/480,21.66%,IQGAP1;SASH1;PTPRC;NEDD9;BANK1;PRKCB;LYST;MSN;FGR;GRB2;MAPKAPK3;PLCG2;PAK2;PLEK;PRKCD;RAC1;ITGB2;PTPRJ;MAP3K1;RHOA;KIF13B;IBTK;CENPJ;PRKAG2;VRK2;MAML1;MAPKAPK2;KIF11;STAT3;FOXO3;CDC42;ITGB1;CCND3;BLNK;STAP1;ADIPOR1;ACTB;TOP2A;ITGAV;IRF5;IFNAR2;IRAK4;ADAM9;RPS6;DUSP3;AXIN1;MVP;UTRN;IRAK3;GRK5;SKI;SIRPA;AP2A2;STK38;TRIB1;NEK6;HIF1A;SLC12A7;PTPN6;MAPK7;SIK1;TRIB2;SPRED1;TPX2;SPRY2;TNIP2;RELA;PIN1;KIF14;LCK;CDK5RAP1;EEF2;DUSP6;CDC25A;DCTN1;SPRED2;TPR;CRK;CCDC88A;TICAM1;CACUL1;TRIM68;EEF1A1;STK11IP;TRAF2;HDAC5;RB1CC1;TJP2;GCH1;PPP1R12A;ANKRA2;TCF3;RACGAP1;IKBKB;RELB;MAVS;CSPG4;IL31RA;TRIM14;RND2;HCLS1;FAF1;KIF20A;GPRC5B;DNAJC3;CD226;EXOC2;AURKA;MAP2K3;SPAG9;RARA;TWF2;RAD9A;LIMS1;FBXO7;NR3C1;CDKN2C;RPS3;NISCH;FAM83D;PTPN11;PDGFRB;TAOK2;DUSP5;HSPB1;JTB;NOD2;RHOBTB1;PRAM1;GDF3;SUFU;BMPR2;WNK1;PRC1;GSK3B;APPL1;RHOF;PTPN1;ATF7;CEP192;CDC25C;LAX1;RACK1;PDLIM5;CCNK;PRKAG1
prerank,ribosomal small subunit binding (GO:0043024),-0.48427840522698706,-1.2952406599888449,0.13644214162348878,0.3688148285894939,1.0,9/17,33.45%,PIM1;ABCE1;ERAL1;NME1;DDX3X;EIF1;EIF1B;MTIF3;EIF4H
prerank,cation:chloride symporter activity (GO:0015377),0.567879088596091,1.2948921684729595,0.16473317865429235,0.34374001749975697,1.0,5/10,11.73%,SLC12A2;SLC12A8;SLC12A1;SLC6A1;SLC12A5
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.3114516164496403,-1.2948012234082897,0.03715170278637771,0.3671984010811652,1.0,43/173,17.97%,MITF;ZEB2;FOXP1;TRPS1;BCL6;JUN;ETV6;PPARD;ZBTB34;BACH1;ZNF148;NFX1;ATF3;PPARG;ELK3;ZNF3;FOXO3;NFKB1;HHEX;ZBTB21;NFATC3;ZBTB2;NR2F1;SKI;BHLHE40;THAP1;TFEC;RELA;ZBTB20;PRDM2;ZFP57;TGIF1;SP2;E2F8;BATF3;TCF3;YY1;KLF8;ZNF177;ZBTB12;ZBTB25;NR3C1;GATA3
prerank,protein heterodimerization activity (GO:0046982),-0.31075529431000287,-1.2930051436490975,0.04573170731707317,0.3687643926078638,1.0,56/178,22.46%,EXT1;CYBB;ABCG1;TCF4;HEXA;SDCBP;CYBA;MCL1;SNX2;MEF2A;ATF3;IRAK2;GTF2A1;TLR4;USF2;ITGB1;TOP2A;BCL2;TPM4;AHR;IRAK3;DGKD;ATF6;HIP1;BHLHE40;YWHAE;HIF1A;MEF2C;ARNT;XBP1;RRAGD;GADD45A;ITGA3;QTRT1;NOLC1;TCF3;IKBKB;RALGAPA2;NR4A1;VAPB;UBA2;AURKA;LSM6;MIGA2;FBXO7;SNX1;RCC1;PAFAH1B1;SMC1A;LSM5;PDGFA;KCNB1;BCL2L2;GTF2A2;CD3E;SRI
prerank,ribonuclease P RNA binding (GO:0033204),0.5528831780090634,1.2920289527701552,0.1718377088305489,0.3451054588732087,1.0,6/10,21.45%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,peptidase activator activity (GO:0016504),-0.4584321311275581,-1.2909449934574286,0.14013840830449828,0.3706241227233991,1.0,5/22,11.38%,PSME4;PSME3;NLRC4;EBAG9;PSENEN
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.4187548420284283,-1.288214578781548,0.10186757215619695,0.37353075464768876,1.0,13/33,25.43%,AGO2;CTR9;DHX9;SMYD2;RPRD2;LLPH;ELOF1;ZNF326;WAC;ELP4;URI1;DRAP1;RECQL5
prerank,BMP receptor binding (GO:0070700),0.5162648911385179,1.2879129469066841,0.16584158415841585,0.3482706731113996,1.0,4/12,15.44%,BMP7;BMP3;CDH5;GDF15
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.45700567667209685,1.2862076526125927,0.1607565011820331,0.34751004440314315,1.0,7/18,25.40%,FAR2;ALDH18A1;ALDH1A1;ALDH1A3;ALDH9A1;ALDH3A2;ALDH2
prerank,tubulin binding (GO:0015631),0.276600175847811,1.285844974163079,0.028089887640449437,0.3446721573311482,1.0,80/296,17.65%,UNC5C;NAV3;MAP2;DNM3;AGBL4;KIF5C;SGIP1;TTLL11;MAP1B;MTUS2;EML1;NCALD;SNPH;MAPRE3;TTLL7;EML5;ARHGEF7;NEFH;KIFC2;IFT81;DST;KIF1B;KIF26B;CLASP2;KIF21A;DLEC1;PPP1R42;DYNC1I1;TTLL5;APC2;KIF5A;DNM1;PRNP;SYBU;KIF2A;HOOK3;MAP7D3;FYN;REEP1;KIF6;HOOK1;FMR1;MTCL1;FAM161A;MAP6D1;AGBL1;PACRG;MACO1;CETN3;EML2;MAP9;CDK5R1;FSD1;FNTA;BRSK1;GAS8;GAS2L2;CDK5RAP2;GOLGA2;PRKN;EML6;TTLL9;KIF3A;NDRG1;TUBGCP5;HDGFL3;CAPN6;RAD51D;CCDC170;SNCA;KIF3C;MTUS1;TUBGCP3;GABARAPL2;PRUNE1;MAP1A;TERF1;DIXDC1;NEFM;MAP1LC3A
prerank,protein phosphatase binding (GO:0019903),-0.324805765415753,-1.2851806451777719,0.06951026856240126,0.377097733488988,1.0,26/117,13.07%,IQGAP1;MAP3K5;MFHAS1;LILRB1;SNX3;STAT3;CD22;STAT6;MTMR3;MAPK14;TRAF3;MVP;CTNNB1;VRK3;SIRPA;JAK1;SLC9A1;MASTL;AKAP11;STYXL1;LCK;STRN;PPP6R3;HSP90B1;PPP1R3E;TRAF2
prerank,solute:sodium symporter activity (GO:0015370),0.424989819490609,1.2849573473669111,0.14523809523809525,0.34263220491574575,1.0,5/27,10.00%,SLC4A10;SLC4A4;SLC5A7;SLC13A5;SLC5A10
prerank,MHC class I protein binding (GO:0042288),-0.5273098798219135,-1.2842751282799099,0.1646234676007005,0.37668431916284606,1.0,9/13,33.06%,LILRB1;TAPBP;DERL1;TAP2;PILRA;ATP5F1B;CD8B;ATP5F1A;CD8A
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.5386614462439425,-1.2842176787236297,0.17725752508361203,0.374383729787939,1.0,8/11,39.14%,PRMT2;PRMT1;PRMT3;PRMT6;NDUFAF7;CARM1;PRMT5;PRMT8
prerank,regulatory RNA binding (GO:0061980),-0.3959585887494193,-1.283930844513356,0.12241379310344827,0.37263751420102426,1.0,7/38,7.95%,AGO2;TLR7;TUT7;DHX9;RC3H1;ZC3H7B;PUM2
prerank,aspartic-type peptidase activity (GO:0070001),-0.5686050333935043,-1.2826982172304764,0.17060810810810811,0.3726238597901716,1.0,3/10,15.21%,CTSD;DDI2;CTSE
prerank,protein kinase activator activity (GO:0030295),-0.36237890583658916,-1.281635639503224,0.11608623548922056,0.3723782317645802,1.0,18/60,12.09%,IQGAP1;ABI1;PAK2;PRKAG2;ERCC6;INCENP;STK3;CAB39;GAS6;ALS2;NCKAP1L;TPX2;AFAP1L2;SPRY2;TAOK1;DBF4;MAP2K1;STK11
prerank,frizzled binding (GO:0005109),-0.40856426203306756,-1.2811362038838696,0.11619718309859155,0.37110422564620626,1.0,13/34,27.98%,SDCBP;ZNRF3;LRP6;RNF43;RYK;WNT3;SFRP1;DVL2;CCDC88C;WNT7B;FZD1;FZD7;WNT6
prerank,MHC class II protein complex binding (GO:0023026),-0.547517501801086,-1.2810128280815118,0.18150087260034903,0.36909052728803593,1.0,5/11,12.82%,CD74;ANXA11;YWHAE;HSP90AB1;PKM
prerank,guanyl ribonucleotide binding (GO:0032561),-0.2997715557669895,-1.278152965577902,0.04455445544554455,0.37213522242791736,1.0,72/196,26.83%,RAB8B;MFHAS1;RAB7A;RAC1;ARL8B;RAP1B;DNM2;RHOA;ARL8A;RAP2B;GNAI3;INSR;RAP2A;RAB31;RAP1A;CDC42;NOA1;ARL11;RHOQ;RAB32;NME1;GBP5;RAB5A;ADSS1;RAB21;GBP2;TGM2;SEPHS1;RRAGD;RAB11B;RAB29;EEF1A1;RAB10;ARL5A;ARL3;TUBD1;GCH1;ANXA6;RAB13;RND2;ARHGEF5;RAB39A;RALB;GTPBP10;KRAS;NRAS;ARL1;RAB12;ARFIP2;RHEB;GBP3;GBP7;RHOBTB1;GBP6;RHOF;TUBA4A;TUBB1;TUBA8;RABL3;RND1;RAB26;RAB4A;GBP4;RAB1B;RAB35;REM1;ARL4A;RND3;NUDT16;RAPGEF2;RAB22A;CNGB3
prerank,estrogen receptor binding (GO:0030331),-0.4087824105952178,-1.2759024670147725,0.14590747330960854,0.37421030120759147,1.0,16/32,30.05%,CNOT1;PRMT2;CTNNB1;WBP2;STRN;NSD1;NRIP1;PPARGC1B;ARID5A;NCOA6;MMS19;DDX54;DCAF1;ESR1;LEF1;PPID
prerank,I-SMAD binding (GO:0070411),-0.5200245968766656,-1.2741275843955866,0.16750418760469013,0.37560479239412464,1.0,9/13,33.27%,AXIN1;CTNNB1;TGFBR1;TGFB1I1;SMAD7;SMAD4;SMURF1;SMAD2;SMAD1
prerank,titin binding (GO:0031432),0.5055307033471755,1.2728714533199275,0.19230769230769232,0.3597621601660761,1.0,4/13,13.07%,CAPN3;CALM1;CALM3;CALM2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4867452802141574,1.2713730571165451,0.18693693693693694,0.35866033683728504,1.0,3/14,6.77%,KCND3;KCNJ3;KCNIP2
prerank,NAD+ binding (GO:0070403),-0.527087720950009,-1.2694899293860036,0.19107142857142856,0.38254473989816273,1.0,3/12,9.54%,ZC3HAV1;PARP9;SIRT3
prerank,E-box binding (GO:0070888),-0.4057175210488091,-1.2686077989273643,0.13921901528013583,0.382034366168824,1.0,14/34,28.00%,MITF;TCF4;PPARG;AHR;BHLHE40;CIART;TFAP4;TCF3;GATA3;MAX;SNAI2;MYC;CLOCK;SCRT2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.42880792029852094,-1.2679142078834384,0.15300546448087432,0.3811852919855137,1.0,11/27,21.09%,PRIMPOL;POLR2F;POLR2L;POLR2A;POLR3B;POLR2G;PRIM1;POLR1F;POLR3A;MED20;POLR2I
prerank,metalloendopeptidase activity (GO:0004222),0.33049721701867385,1.265760637406686,0.09438775510204081,0.3644436562312703,1.0,23/76,17.17%,OMA1;MMP16;ADAMTS17;MMP12;MME;ADAMTS16;ADAMTSL1;ECE2;IDE;MMP15;THSD4;MMEL1;MMP13;EEF1AKMT4-ECE2;PMPCB;ADAMTS5;ADAMTS12;TRABD2B;ADAMTS6;ECE1;ADAM17;ADAMTSL2;PHEX
prerank,receptor ligand activity (GO:0048018),0.27738573025140245,1.2650178168675354,0.037900874635568516,0.36216190119052577,1.0,35/245,12.73%,NRG3;NRG1;TAFA1;SEMA6D;TAFA2;EPHA7;SEMA6A;TGFA;SEMA3E;EGF;EDA;SEMA5A;WNT9A;PTN;GDNF;TAFA5;VEGFD;PGF;FGF10;APLN;BDNF;BMP7;SEMA3F;AMELX;AREG;BMP15;EDN1;CLEC11A;TGFB2;NBL1;SEMA5B;ANGPTL3;SCG2;NTS;BMP3
prerank,phospholipase C activity (GO:0004629),0.41833454643339046,1.2593473503598744,0.14150943396226415,0.3685179424918889,1.0,8/25,12.29%,PLCB1;PLCL1;CHRM3;PLCH2;PLCE1;PLCZ1;PLCD3;F2RL2
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.3398806653646233,-1.259172741180011,0.09516129032258064,0.39702272625096846,1.0,33/83,28.84%,USP12;USP50;OTUD5;UCHL5;USP18;USP8;USP36;USP9X;USP3;ATXN3;OTULIN;USP42;USP35;USP40;JOSD1;USP30;OTUD4;USP11;USP7;STAMBPL1;BRCC3;COPS5;BAP1;ZC3H12A;USP9Y;ZRANB1;MINDY3;USP34;USP16;STAMBP;USP28;JOSD2;USP51
prerank,ubiquitin-specific protease binding (GO:1990381),-0.460911467001471,-1.2564934952959548,0.1734860883797054,0.40038371370365783,1.0,5/19,14.40%,AMFR;RHBDD2;SELENOS;DERL1;SART3
prerank,acylglycerol lipase activity (GO:0047372),0.5222976296490985,1.25641636449912,0.19201995012468828,0.370184110890464,1.0,3/11,5.15%,ABHD16A;ABHD15;ABHD3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.49325988199510906,1.2529967845799397,0.19955156950672645,0.3730313416428887,1.0,4/15,7.87%,SLC1A2;SLC17A6;SLC1A6;SLC1A1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.28804939718057354,-1.25122243800274,0.050488599348534204,0.409125259365492,1.0,71/248,20.61%,ATP2B1;RAB8B;RNF213;GNB1;MYH9;RAB7A;RAC1;ARL8B;KLC1;RAP1B;DNM2;RHOA;ARL8A;RAP2B;GNAI3;ABCD2;RAP2A;RAB31;GNA12;RAP1A;RAB20;GSPT1;CDC42;DHX9;RAB1A;CHD3;KIF20B;KIF15;GNA15;RHOQ;RAB32;GNA11;GBP5;RAB5A;RAB21;GBP2;MYO1E;PIN1;KIF14;EFL1;GNA13;EEF2;GTPBP1;RAB24;RRAGD;RAB11B;SAR1A;RAB29;EEF1A1;GCH1;GNA14;RND2;TBC1D24;HSPA1A;RALB;DNA2;GTPBP10;KRAS;NRAS;KIF18B;ARL1;RHEB;GBP3;DDX3X;MMUT;GBP7;RHOBTB1;GBP6;ABCA4;RAB11A;RHOF
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.40535989695890556,1.2493067299996201,0.17757009345794392,0.3757789296759258,1.0,7/26,17.48%,B3GALT1;CHSY3;B3GALT5;B3GNT5;B4GALNT4;B4GALNT2;B3GALT4
prerank,tRNA binding (GO:0000049),-0.37564200220470106,-1.2484251317995574,0.13541666666666666,0.4125299340311013,1.0,14/43,20.70%,FARS2;XPOT;SARS1;ELP5;ALKBH1;DALRD3;ELP1;PUS1;EEF1A1;KARS1;EIF2A;TYW5;AARS1;DARS2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5068497061886209,1.245922886455097,0.206266318537859,0.37819474729517644,1.0,7/13,25.40%,ALDH1A1;ALDH1A3;ALDH7A1;ALDH1L1;ALDH9A1;ALDH3A2;ALDH2
prerank,sequence-specific DNA binding (GO:0043565),-0.2661797165090997,-1.2446667486091336,0.010043041606886656,0.4181319132342433,1.0,143/590,23.22%,RBPJ;ZEB2;FLI1;ELF4;FOXP1;BACH2;TFEB;TCF4;ELF2;BCL6;TET3;JUN;MEF2A;RUNX3;PPARD;BPTF;NFE2L2;MBNL2;IRF2;ZNF148;NFIC;ATF3;ELF1;UBP1;PPARG;ELK3;FOXN2;ETV1;KLF13;FOXO3;E2F2;USF2;HHEX;ZBTB21;RUNX2;RARG;BCL2;IRF5;MAF;MEF2B;KLF6;CUX1;BATF;TEF;ETV3;CHTOP;NFATC3;ZBTB2;AHR;KLF3;ATF6;NR2F1;KDM2A;BHLHE40;E2F1;PRMT1;THAP1;CEBPG;E2F3;CBFB;MEF2D;HIF1A;MEF2C;TFEC;SIRT3;OLIG2;EGR1;ARNT;IKZF3;UPF2;ZBTB20;XBP1;XRCC6;OSR1;KLF10;PRDM2;NFE2;TCF7;ZFP41;UHRF1;TGIF1;SP2;RXRA;FOXJ3;CALCOCO1;E2F8;TFAP4;BATF3;KLF2;TEN1;TFAM;YY1;NCL;TFCP2;ZNF177;NR4A1;ZBTB12;KLF11;IRX5;SOX10;FOXJ2;KMT2A;LRWD1;RARA;NFATC1;CSRNP1;ATF5;NR3C1;TFE3;GATA3;ERH;ARID5A;TCF12;GMEB2;CXXC1;MEIS3;HOXD8;WDR77;MAX;SP9;KDM5B;PKNOX1;ATF7;POU3F1;KDM1A;HOXB2;NLRP3;ZBTB7A;TBX2;SNAI2;CEBPB;EGR2;BBX;ZNF296;BARX2;MYRFL;MTF1;NR1H4;HOXD9;HES7;SOX7;SMG1;ZNF32
prerank,motor activity (GO:0003774),-0.3535686789500488,-1.2402993286392983,0.14904679376083188,0.4252779396605142,1.0,22/60,17.99%,MYH9;KLC1;KIF13B;KIF3B;KIF11;KIF16B;KIF20B;KIF23;KIF15;STARD9;KIF4A;CENPE;DNAH8;MYO1E;KIFC1;PIN1;KIF14;KIF21B;KIF2C;KIF20A;DNAH3;KIF18B
prerank,double-stranded DNA binding (GO:0003690),-0.2661961085956714,-1.240005477937017,0.011510791366906475,0.42349241679818167,1.0,132/531,23.22%,FLI1;ELF4;FOXP1;BACH2;TFEB;TCF4;RBMS1;ELF2;BCL6;JUN;CGAS;RUNX3;PPARD;MBNL2;RAD51B;IRF2;NFIC;ATF3;ELF1;UBP1;PPARG;ELK3;FOXN2;ETV1;KLF13;FOXO3;E2F2;DHX9;USF2;RUNX2;RARG;IRF5;MAF;MEF2B;AIM2;KLF6;CUX1;BATF;DDX60;TEF;ETV3;NFATC3;ZBTB2;WDR48;AHR;KLF3;REXO4;ATF6;NR2F1;BHLHE40;E2F1;CEBPG;E2F3;NEIL3;RAD51;MEF2D;MEF2C;TFEC;OLIG2;NUCKS1;EGR1;ARNT;APTX;ZBTB20;XBP1;XRCC6;OSR1;MAU2;KLF10;NFE2;FEN1;TCF7;HMGB2;ZFP41;UHRF1;TGIF1;SP2;RXRA;FOXJ3;E2F8;TFAP4;BATF3;KLF2;RAD51AP1;YY1;TFCP2;ZNF177;NR4A1;ZBTB12;KLF11;IRX5;SOX10;FOXJ2;ZCCHC3;RARA;NFATC1;NR3C1;TFE3;GATA3;RPS3;TCF12;RBBP8;GMEB2;MEIS3;HOXD8;HMGB1;HMGB3;MAX;SP9;KDM5B;PKNOX1;ATF7;STAT1;DMC1;POU3F1;HOXB2;ZBTB7A;TBX2;SNAI2;CEBPB;EGR2;BBX;ZNF296;BARX2;MTF1;POLG2;HOXD9;PRKDC;HES7;SOX7;TARDBP;ZNF32
prerank,kinase activator activity (GO:0019209),-0.40131587256696033,-1.2383452331601776,0.1710758377425044,0.4243976037557788,1.0,19/30,37.17%,PRKAG2;MALT1;CAB39;NCKAP1L;TPX2;STK11;MARK2;STRADA;GPRC5B;WNK1;MOB1B;MT3;GPRC5C;IL2;BCL10;FGF13;GPRC5A;GPRC5D;WNT11
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.260864216907362,-1.2267898604468566,0.012640449438202247,0.44653687141735365,1.0,121/597,18.20%,FLI1;ELF4;FOXP1;RUNX1;BACH2;TFEB;TCF4;ELF2;BCL6;JUN;ZNF568;RUNX3;PPARD;ARID5B;NFE2L2;BRD7;MBNL2;IRF2;NFIC;NFYA;ATF3;ELF1;UBP1;PPARG;ELK3;SPI1;BRCA1;FOXN2;ETV1;STAT3;KLF13;FOXO3;E2F2;DHX9;USF2;CHD3;NFKB1;HHEX;RUNX2;RARG;IRF5;MAF;MEF2B;KLF6;CIITA;CUX1;BATF;TEF;ETV3;NFATC3;ZBTB2;AHR;TBL1XR1;KLF3;ATF6;NR2F1;CREB3L2;HNRNPL;MCM6;BHLHE40;E2F1;ATMIN;CEBPG;E2F3;MEF2D;MEF2C;TFEC;OLIG2;EGR1;ARNT;MCM9;RELA;MCM3;ZBTB20;XBP1;XRCC6;OSR1;KLF10;NFE2;KMT2D;ORC5;FOXJ1;MLH3;KAT7;TCF7;HMGB2;ZFP41;ZBED4;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;E2F8;TFAP4;BATF3;PSPC1;KLF2;TFAM;YY1;KIF2C;TFCP2;ZNF177;MCM2;NR4A1;ZBTB12;KLF11;IRX5;SOX10;FOXJ2;TAF9;RARA;NFATC1;ATF5;NR3C1;TFE3;GATA3;ARID5A;TCF12
prerank,3'-5' exonuclease activity (GO:0008408),-0.36302115306874055,-1.2260756085903235,0.1797945205479452,0.4457433515704801,1.0,18/45,26.01%,ERI3;RAD1;REXO4;EXOSC5;ERI2;EXD1;WRN;APLF;CNOT6L;RAD9A;ANGEL1;EXOSC10;CNOT8;EXOSC4;PNLDC1;XRN2;ANGEL2;MRE11
prerank,alpha-actinin binding (GO:0051393),0.40215776162527,1.2250565324129914,0.18510158013544017,0.4108606599683113,1.0,8/24,17.40%,CACNA1C;KCNN2;PRICKLE4;SYNPO2;TTN;PDLIM4;MAGI1;PDLIM7
prerank,ubiquitin binding (GO:0043130),-0.3361662607380035,-1.2246750930780872,0.13573883161512026,0.4462899824757014,1.0,32/73,32.40%,GGA3;TOP2A;UBXN7;RNF31;TSG101;RBCK1;DDI2;UBAP1;WDR48;RAE1;MVB12B;RNF185;USPL1;CXCR4;FAF1;FBXO7;HSPB1;UBXN1;SIRT2;FAF2;NUP62;CKS2;RNF19B;UBE2N;USP16;ASCC2;MARK4;MVB12A;SQSTM1;AUP1;USP5;RNFT1
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.39007850220731505,-1.2232827018345425,0.1858108108108108,0.446879159624797,1.0,9/34,11.58%,IQGAP1;INCENP;STK3;CAB39;ALS2;SPRY2;TAOK1;DBF4;MAP2K1
prerank,actinin binding (GO:0042805),0.42281698811872803,1.2229297675145885,0.1925601750547046,0.41113640286742054,1.0,7/21,15.17%,CACNA1C;KCNN2;SYNPO2;CSRP1;TTN;PDLIM4;MAGI1
prerank,endopeptidase regulator activity (GO:0061135),-0.3792009934260526,-1.2215809738827048,0.1829059829059829,0.4481624936914816,1.0,9/40,15.44%,UCHL5;PSME3;NLRC4;TFPI;PROS1;CAST;PSENEN;CST7;CST3
prerank,GDP binding (GO:0019003),-0.34372998584288245,-1.2207307252202921,0.13982300884955753,0.4476357329503657,1.0,21/63,18.69%,RAB8B;RAB7A;ARL8B;RAP1B;RAP2B;GNAI3;RAP2A;RAB31;RAP1A;RAB5A;RAB21;RRAGD;RAB11B;RAB29;RAB10;ARL3;RALB;KRAS;NRAS;RAB12;RHEB
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.4085059487008636,-1.2204203080001685,0.1736842105263158,0.4458780230637741,1.0,11/28,22.30%,RIPK1;TRAF5;TRAF3;BABAM2;MYD88;TRAF1;TRAF2;BID;STAT1;FEM1B;TNFSF9
prerank,chemokine receptor binding (GO:0042379),-0.38579290176100367,-1.2170477090526535,0.20141342756183744,0.45053288705434136,1.0,14/35,39.74%,CKLF;PF4;CXCL16;CCL5;CCRL2;CCL7;CCL24;CCL4;CCL25;CCL19;CCL8;CXCL9;CXCL1;CCL14
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.3477680163375464,-1.216768276752971,0.1563573883161512,0.448802141316379,1.0,12/60,10.82%,PPM1H;PPP4C;CTDSPL2;MTMR3;LRRC39;PPM1B;LRRK1;PPP1CA;SSU72;MTMR6;LCK;CDKN3
prerank,transaminase activity (GO:0008483),0.5056853065411997,1.2151686325400493,0.2289156626506024,0.42168711275273585,1.0,5/11,18.41%,GOT1;BCAT1;ABAT;PSAT1;BCAT2
prerank,LRR domain binding (GO:0030275),0.466308230996446,1.2151514300011745,0.22566371681415928,0.41804853100237155,1.0,2/14,5.16%,ROBO1;MRTFA
prerank,omega peptidase activity (GO:0008242),-0.3228718334382646,-1.2139268602183437,0.12980769230769232,0.4525509681151279,1.0,34/89,28.84%,USP12;USP50;OTUD5;UCHL5;USP18;USP8;USP36;USP9X;USP3;ATXN3;OTULIN;USP42;USP35;GGH;USP40;JOSD1;USP30;OTUD4;USP11;USP7;STAMBPL1;BRCC3;COPS5;BAP1;ZC3H12A;USP9Y;ZRANB1;MINDY3;USP34;USP16;STAMBP;USP28;JOSD2;USP51
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.49563812594417755,-1.2120595254857987,0.23639455782312926,0.4539736733567705,1.0,5/12,13.07%,TRAF5;TRAF3;BABAM2;TRAF1;TRAF2
prerank,acid-thiol ligase activity (GO:0016878),0.47891240611874075,1.206308890902161,0.23146067415730337,0.43096889354797613,1.0,4/13,20.06%,SLC27A2;ACSS2;ACSM3;ACSS1
prerank,protein kinase C activity (GO:0004697),-0.47860698439863786,-1.2034812780519086,0.23752151462994836,0.4705035080894891,1.0,3/14,1.37%,PRKCH;PRKCB;PRKCD
prerank,amyloid-beta binding (GO:0001540),-0.32180042353249194,-1.2010386285949073,0.15384615384615385,0.4736045048899532,1.0,13/79,4.11%,APOE;MSR1;CD74;GSAP;LILRB1;LILRB3;LRP1;CD36;ITGB2;C1QA;INSR;APBB2;TLR4
prerank,poly(U) RNA binding (GO:0008266),-0.4264524874622414,-1.195337907674955,0.22920203735144312,0.48403408730389486,1.0,8/20,23.41%,RBMS1;PATL1;HNRNPH1;RBMS2;DAZAP1;ATXN1;RBM11;PABPC1L
prerank,GTPase activity (GO:0003924),-0.2789741981661662,-1.194399649700431,0.09047619047619047,0.4837058840741182,1.0,56/192,20.61%,RAB8B;GNB1;RAB7A;RAC1;ARL8B;RAP1B;DNM2;RHOA;ARL8A;RAP2B;GNAI3;RAP2A;RAB31;GNA12;RAP1A;RAB20;GSPT1;CDC42;RAB1A;GNA15;RHOQ;RAB32;GNA11;GBP5;RAB5A;RAB21;GBP2;EFL1;GNA13;EEF2;GTPBP1;RAB24;RRAGD;RAB11B;SAR1A;RAB29;EEF1A1;GCH1;GNA14;RND2;TBC1D24;RALB;GTPBP10;KRAS;NRAS;ARL1;RHEB;GBP3;DDX3X;MMUT;GBP7;RHOBTB1;GBP6;ABCA4;RAB11A;RHOF
prerank,lipid phosphatase activity (GO:0042577),0.4589484410806437,1.1942051000512024,0.2456575682382134,0.4505775542389498,1.0,2/14,2.69%,PLPPR1;PLPPR4
prerank,mRNA binding (GO:0003729),-0.27634680862807814,-1.1931193547677073,0.06763285024154589,0.48409304207856213,1.0,84/249,26.08%,RBM47;PTBP3;RBMS1;YTHDF3;IREB2;AGO2;DCP1A;TRA2B;RPL7;DHX9;RBPMS;RC3H1;RNF20;SF3B6;EIF4G3;SNRNP35;PUM3;EIF3A;SECISBP2;RPS14;HNRNPL;PUM2;CNBP;LARP4B;RPS13;KHNYN;DDX5;LARP4;XPO5;EIF4A1;PCBP2;TPR;NUDT21;CELF1;HNRNPLL;RBM14;PKM;NYNRIN;BOLL;METTL14;UNK;MRPS11;DHX36;YTHDC1;RBMS2;NCBP1;EIF4G1;NCL;THOC2;DAZAP1;EIF2A;G3BP1;RBM4B;HDLBP;RNPS1;TDRD7;SNRNP70;MARF1;RPS3;NSRP1;DDX3X;RBPMS2;C1QBP;DDX6;SF3B1;GRSF1;ZC3H12A;CPEB4;LSM14A;HNRNPK;SHMT1;RPL41;TARDBP;PUM1;PABPC1L;EIF2S2;PCBP4;ESRP1;MRPS7;RNF40;RPL5;ANGEL2;NUDT16;ZC3H12D
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.4934063282213701,1.1930612896919741,0.26741573033707866,0.448801933781309,1.0,2/11,5.21%,KCND3;KCNJ3
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.4698715490974924,-1.1926754155563106,0.2310405643738977,0.4827479805125589,1.0,8/16,36.18%,CDO1;ETHE1;BCO2;IDO2;ALOX15;HGD;HAAO;ALOX12
prerank,voltage-gated anion channel activity (GO:0008308),-0.4593187749631066,-1.1922742841885077,0.2171628721541156,0.4810897531336444,1.0,3/15,6.00%,ANO6;VDAC2;CLCN5
prerank,3'-5' DNA helicase activity (GO:0043138),-0.4449740456408448,-1.187691716099952,0.23752151462994836,0.4891960238223866,1.0,8/16,25.43%,DHX9;BLM;MCM6;WRN;MCM2;MCM5;ASCC3;RECQL5
prerank,potassium ion antiporter activity (GO:0022821),0.4422469450864584,1.1864761733209561,0.24824355971896955,0.458834493588719,1.0,4/15,5.38%,SLC24A4;SLC24A2;SLC24A3;SLC9A2
prerank,proton transmembrane transporter activity (GO:0015078),-0.36686323067413795,-1.1850377265292826,0.21731448763250882,0.49285641156872084,1.0,16/39,28.83%,CLCN5;SLC33A1;CTNS;SLC9A1;COX4I1;MFSD3;COX10;UQCRC1;COX8A;NNT;SLC11A2;NDUFA4;CYB5A;COX5A;COX6A2;UQCRQ
prerank,myosin II binding (GO:0045159),0.5104333657586202,1.184635624861104,0.26096491228070173,0.4586329858397158,1.0,4/10,10.85%,STXBP5L;SHROOM4;SHROOM1;GSN
prerank,metallopeptidase activity (GO:0008237),0.28579265230135403,1.1813388583290836,0.13333333333333333,0.4615276176719768,1.0,30/113,17.17%,OMA1;METAP2;ADAM12;MMP16;ADAMTS17;MMP12;MME;ADAMTS16;ADAMTSL1;ADAM23;ECE2;IDE;MMP15;THSD4;MMEL1;MMP13;BMP1;EEF1AKMT4-ECE2;PMPCB;ADAMTS5;ADAMTS12;TRABD2B;ADAMTS6;METAP1;ECE1;ADAM11;ADAM18;ADAM17;ADAMTSL2;PHEX
prerank,peptidoglycan binding (GO:0042834),-0.509930769213041,-1.1741859820136558,0.27228525121555913,0.515467156051678,1.0,5/10,28.99%,RNASE7;NOD1;NOD2;NLRP3;PGLYRP2
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3931335722000412,-1.1733826194308752,0.23316062176165803,0.5146445335492439,1.0,6/27,14.35%,APOE;LRP1;PICALM;DNAJA1;HSP90B1;ANKRA2
prerank,SUMO binding (GO:0032183),-0.47785871778710715,-1.1720461759387908,0.2755775577557756,0.5153965920257273,1.0,6/13,26.75%,RNF111;RNF4;USPL1;UBA2;SIMC1;PML
prerank,myosin V binding (GO:0031489),0.44690823323119155,1.169538623241094,0.2420091324200913,0.4808989682305836,1.0,4/15,5.97%,RAB3C;RAB6B;RAB27B;RAB6A
prerank,R-SMAD binding (GO:0070412),-0.43116283755995916,-1.1693515455040602,0.24041811846689895,0.5189358199622143,1.0,9/18,31.75%,JUN;PMEPA1;DDX5;LDLRAD4;PAX6;SMAD4;SMURF1;SMAD2;DROSHA
prerank,sterol binding (GO:0032934),-0.34217844443832274,-1.1673405498594345,0.2099644128113879,0.5210033409171247,1.0,11/56,11.01%,OSBPL8;ABCA1;ABCG1;OSBPL3;GRAMD1B;VDAC2;OSBPL5;ERLIN1;OSBPL11;STARD5;NPC2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4928657484716116,-1.1647193467633223,0.2862129144851658,0.5248862131013096,1.0,3/11,14.63%,SASH1;STK38;TCF3
prerank,metallocarboxypeptidase activity (GO:0004181),0.3820679395432283,1.1641655861123814,0.2379862700228833,0.48758680719598385,1.0,5/26,12.68%,AGBL4;AGBL1;CPE;CPA2;FOLH1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4865346468800533,-1.163786761600319,0.28295254833040423,0.5245818257525643,1.0,3/12,8.64%,SLC6A6;SLC38A7;SLC36A4
prerank,protein kinase regulator activity (GO:0019887),-0.3015125701364215,-1.1600992499410072,0.19547657512116318,0.5306186177723969,1.0,39/95,32.65%,TAOK3;CCNL1;PRKAG2;CCND3;CCNY;CAB39;TRIB1;NCKAP1L;TPX2;CCNL2;STK11;GMFG;MARK2;GMFB;CCNE1;FAF1;STRADA;GPRC5B;ELP4;DNAJC3;CNPPD1;SOCS3;WNK1;CCNK;PRKAG1;CCNF;CCNB1;ITPRIP;CCNB2;MT3;NCK1;SH3BP5;GPRC5C;ANKRD54;CSNK2B;FGF13;KIDINS220;CCNJL;GSKIP
prerank,lipase activity (GO:0016298),-0.35046205341018344,-1.1598715956902879,0.22259696458684655,0.5286084412218502,1.0,9/43,14.13%,LIPA;DDHD1;PLBD1;ABHD12;PLBD2;DAGLB;LPL;ABHD5;LDAH
prerank,RNA cap binding (GO:0000339),-0.4473286916601238,-1.1590716846117881,0.286231884057971,0.5278125415517004,1.0,4/16,14.94%,AGO2;EIF4A1;NCBP1;SNUPN
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4658778915027477,1.156813394588752,0.27740492170022374,0.4993044924963215,1.0,2/12,3.39%,PDE4B;PDE4D
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.36419367451498663,-1.1566586575199886,0.2508532423208191,0.5309932809983989,1.0,14/35,28.66%,FOXP1;AGO2;GTF2A1;RELA;KLF10;DR1;SNAPC3;NR3C1;TAF4;STAT1;DRAP1;MYC;UBTF;ZBTB17
prerank,hexosyltransferase activity (GO:0016758),0.2879798278195164,1.155531782160979,0.19664268585131894,0.49811113734531465,1.0,13/101,5.39%,MGAT4C;B3GALT1;TMTC2;TMTC1;FUT9;CHSY3;B3GALT5;HEXB;DPY19L1;B4GALT4;TMTC3;DPY19L2;POMT2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.5003281182603645,-1.1528725641944246,0.29464285714285715,0.5373256699664014,1.0,4/10,15.15%,NSD3;ASH1L;SMYD2;NSD1
prerank,ATPase regulator activity (GO:0060590),-0.35113180889940115,-1.1524773550983511,0.23035714285714284,0.5357406123374023,1.0,13/38,20.57%,FNIP2;DNAJC1;ATP1B3;SIL1;DNAJA1;FNIP1;TOR1AIP1;HSPH1;BAG3;GRPEL2;MYBPC3;PLN;DNAJB6
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.4453544291201186,-1.1501715545225444,0.2744755244755245,0.538562435133363,1.0,2/15,2.65%,P2RX7;P2RX4
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.3641481098109863,-1.1496688479862711,0.24567474048442905,0.5372250171685772,1.0,11/33,21.68%,ERI3;EXOSC5;ERI2;DCP2;CNOT6L;ANGEL1;EXOSC10;CNOT8;EXOSC4;PNLDC1;XRN2
prerank,syntaxin binding (GO:0019905),0.3140297373506255,1.1483097991919855,0.2141119221411192,0.509378036416161,1.0,16/61,14.32%,STXBP5L;SYT1;UNC13C;SYT10;SNPH;SNAP25;CPLX1;SYT2;SYT5;SYT12;PRRT2;NAPB;UNC13B;GOLGA2;SCFD1;VAMP8
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.41320874181609585,1.1450327387383805,0.2833333333333333,0.5118551043052092,1.0,5/17,15.01%,DPYD;PECR;DHCR24;DHCR7;DECR2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3307378296975534,-1.1445630045918629,0.24956672443674177,0.5467379957918012,1.0,14/55,20.26%,SLC16A7;SLC38A6;SLC6A6;SLC38A10;SLC38A7;SLC36A4;ABCC1;SLC7A5;SLC16A6;SLC23A1;SLC23A2;SLC38A2;SLC25A10;SLC16A1
prerank,mannose binding (GO:0005537),-0.469036599946635,-1.143761365435108,0.30442477876106194,0.5462173020339341,1.0,7/12,40.74%,CLEC4D;CLEC6A;LMAN2L;ACR;LMAN2;LMAN1L;CLN5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.4991729759476403,-1.1403481366540413,0.30427350427350425,0.5519749402556249,1.0,2/10,0.71%,APOBEC1;GDA
prerank,zinc ion binding (GO:0008270),-0.2578146226983136,-1.1348953227649303,0.13761467889908258,0.5627226609730157,1.0,77/293,20.93%,ADAM33;GDA;LITAF;TET3;SAMHD1;ANPEP;SLC30A5;ACER3;P2RX4;ARHGEF2;PPARG;ZNF3;DHX58;TAB2;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;CHD3;RC3H1;LNPEP;BLM;GALT;PRIMPOL;KDM7A;PITRM1;CRIP1;KDM2A;SKI;EEA1;TIMP2;QPCTL;THAP1;ATAD3A;POLR2L;SIRT3;ADAM8;MSRB1;EGR1;RNF8;HDAC10;SEC24A;CHMP1A;SEC24D;PRDM2;TRIM24;UHRF1;MT2A;RXRA;TET2;SORD;GCH1;ARIH1;CBLB;PDXK;NSD1;IKZF4;TNFSF10;KMT2A;RPS27;LIMS1;WDFY1;ZMYND8;MMP8;MDM4;ENPP1;RABGGTB;SLU7;KDM5B;SIRT2;PTPN1;ZFPL1;RNF125
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.310316810702023,-1.1332579482521234,0.25217391304347825,0.5642681820080042,1.0,32/74,30.91%,FAM20C;DGKZ;PANK2;NADK;PIK3CB;PIK3CG;DGKD;PI4KB;FGGY;POMK;HK3;PIK3CA;PKM;PIK3CD;PDXK;PIK3C2A;NADK2;DGKG;PAPSS1;SPHK2;GALK2;NMRK1;NOL9;PIK3C2G;FCSK;DGKA;GALK1;GK5;IDNK;GNE;TKFC;FAM20B
prerank,nuclear import signal receptor activity (GO:0061608),-0.4520709166871324,-1.1329065331345844,0.29441624365482233,0.562501724469048,1.0,4/15,20.46%,KPNA4;IPO5;KPNA3;TNPO3
prerank,microtubule binding (GO:0008017),0.25361730598907706,1.1327338328138183,0.13896457765667575,0.533732307086286,1.0,61/222,17.65%,NAV3;MAP2;DNM3;KIF5C;SGIP1;MAP1B;MTUS2;EML1;SNPH;MAPRE3;EML5;NEFH;KIFC2;DST;KIF1B;KIF26B;CLASP2;KIF21A;DYNC1I1;APC2;KIF5A;DNM1;PRNP;SYBU;KIF2A;CLIP4;HOOK3;MAP7D3;REEP1;KIF6;HOOK1;FMR1;MTCL1;FAM161A;MAP6D1;MACO1;CETN3;EML2;CEP290;MAP9;FSD1;FNTA;GAS8;GAS2L2;CDK5RAP2;GOLGA2;EML6;KIF3A;NDRG1;TUBGCP5;HDGFL3;CAPN6;CCDC170;KIF3C;MTUS1;TUBGCP3;GABARAPL2;MAP1A;TERF1;NEFM;MAP1LC3A
prerank,poly-pyrimidine tract binding (GO:0008187),-0.3928949104934599,-1.1322534226839829,0.29360967184801384,0.5616097303344072,1.0,9/23,26.35%,RBMS1;PATL1;HNRNPH1;RBMS2;DAZAP1;ATXN1;RBM11;PABPC1L;U2AF2
prerank,DNA polymerase binding (GO:0070182),-0.424480369987126,-1.131077830492852,0.3005181347150259,0.5619450317124736,1.0,10/18,32.44%,RTEL1;RAD51;PCNA;HSP90AB1;HMGB1;FANCD2;POLG2;CDK2AP1;LONP1;FANCI
prerank,voltage-gated chloride channel activity (GO:0005247),-0.49087016047525867,-1.1310756966619226,0.2931937172774869,0.5594072680689509,1.0,2/10,6.00%,ANO6;CLCN5
prerank,miRNA binding (GO:0035198),-0.3667234946545719,-1.1285119585036016,0.27692307692307694,0.563096785705695,1.0,9/30,23.35%,AGO2;TUT7;RC3H1;ZC3H7B;PUM2;RBM10;HNRNPA1;ZC3H12A;PUM1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.23673450300459487,-1.1268181831424926,0.08870967741935484,0.5645842571872105,1.0,140/731,18.47%,RBPJ;MITF;ZEB2;ELF4;FOXP1;RUNX1;BACH2;TFEB;TCF4;RREB1;REL;LITAF;BCL6;JUN;ZNF568;MEF2A;RUNX3;PPARD;BPTF;ZBTB34;BACH1;DNMT3A;NFE2L2;IRF2;ZNF148;NFIC;NFYA;ZSCAN12;ATF3;ELF1;UBP1;PPARG;ELK3;SPI1;FOXN2;ETV1;STAT3;KLF13;FOXO3;E2F2;IKZF1;LYL1;ZSCAN26;STAT6;DHX9;USF2;NFKB1;HHEX;NLRC5;RUNX2;RARG;MLXIP;IRF5;SARS1;MAF;MEF2B;KLF6;TIPARP;NR1H2;BATF;NRF1;TEF;NFATC3;ZBTB2;MYNN;AHR;KLF3;STAT5B;STAT4;ATF6;NR2F1;SKI;BHLHE40;E2F1;THAP1;WBP2;CEBPG;E2F3;MEF2D;HIF1A;MEF2C;TFEC;OLIG2;FOXN3;EGR1;ARNT;PROX2;CIART;RELA;ZNF569;IKZF3;ZBTB20;XBP1;ZNF319;KLF10;NFE2;SALL3;FOXJ1;FOSL2;TCF7;HMGB2;UHRF1;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;E2F8;TFAP4;BATF3;KLF2;TCF3;ZNF628;YY1;RELB;NSD1;TFCP2;KLF8;NR4A1;ZBTB12;NRIP1;KLF11;IRX5;IKZF4;SOX10;FOXJ2;ZBTB25;RARA;NFATC1;ZBTB24;SNAPC3;NR3C1;TFE3;GATA3;MYB;TCF12;PLAG1;GMEB2
prerank,ATP hydrolysis activity (GO:0140603),-0.3457433441722189,-1.1233616178388324,0.29180887372013653,0.5703328276565666,1.0,12/41,20.17%,ATP2B1;RNF213;ABCD2;DHX9;CHD3;KIF20B;MYO1E;KIF14;HSPA1A;DNA2;DDX3X;ABCA4
prerank,insulin-like growth factor binding (GO:0005520),-0.43478628222813376,-1.1212669052445816,0.3054545454545455,0.5725810457451467,1.0,5/15,12.21%,INSR;IGF1R;ITGAV;IGF2R;IGFBP3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.3770944167542555,1.1194534427060796,0.2786516853932584,0.5589004406188803,1.0,7/23,12.29%,PLCB1;CHRM3;PLCH2;PLCE1;PLCZ1;PLCD3;F2RL2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3650502881676664,-1.1185219799986312,0.30998248686514884,0.5769835810311739,1.0,10/32,21.08%,TET3;KDM7A;ALKBH1;KDM2A;EGLN1;FTO;TET2;TMLHE;TYW5;ALKBH3
prerank,transferrin receptor binding (GO:1990459),-0.49834339303316566,-1.11830637293789,0.3189102564102564,0.5749066911738566,1.0,4/10,18.23%,SNX2;IKBKB;SNX1;SNX4
prerank,retinoid binding (GO:0005501),-0.39194886756232317,-1.11825191887298,0.3177737881508079,0.5725298109266854,1.0,11/22,33.95%,RXRA;RARA;ABCA4;CYP26C1;RBP4;UGT1A7;UGT1A6;UGT1A4;UGT1A8;UGT1A1;RBP1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.43832690027667276,-1.1172895355352495,0.31866197183098594,0.5722906175106531,1.0,6/15,28.42%,CCR2;CCR1;CCRL2;CMKLR1;GPR17;XCR1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3850435222731661,-1.116381294313293,0.291958041958042,0.571919680290278,1.0,8/24,18.55%,OSBPL8;SNX3;GOLPH3L;OSBPL5;SESTD1;PLA2G4A;ARFIP1;ARFIP2
prerank,potassium:proton antiporter activity (GO:0015386),-0.4875723063137646,-1.1148044006666518,0.3394495412844037,0.5732984083414361,1.0,3/10,8.82%,SLC9A9;SLC9A8;SLC9A1
prerank,chloride channel regulator activity (GO:0017081),-0.44523312597671016,-1.1147488746229883,0.3190394511149228,0.5709789174770623,1.0,3/14,5.15%,STX7;SGK1;STX8
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.28441573421011773,1.1147221564311915,0.23113207547169812,0.5648743681316227,1.0,22/91,15.09%,FRMPD4;PLCB1;PLEKHA5;PARD3;SNAP91;CLVS1;KCNH1;SNX14;MARK1;TIRAP;PLA2G4E;SNX21;PLCZ1;PIRT;AMER2;GSN;GSDMD;SYT7;SYTL2;OSBPL2;MYO1B;RPH3A
prerank,endopeptidase activity (GO:0004175),-0.25503274705626827,-1.11428975033539,0.1935483870967742,0.5695946055034914,1.0,81/257,25.76%,CTSB;ADAM33;CTSZ;USP12;PLAU;MALT1;USP18;MBTPS2;PSMB7;DPP4;USP8;ADAM9;PREP;PSMB9;DDI2;HGF;PITRM1;PCSK7;USP36;USP9X;RHBDF1;TPP2;ADAMTS10;RHBDF2;CTSC;CASP4;CTSH;PSMA8;KLK3;PRSS36;F7;FAP;ADAMTS18;CTSS;USP42;HTRA3;CASP7;CASP1;USP35;PSMB10;USP40;PSMA1;CD5L;ADAMTSL5;CTSE;USP30;USP11;USP7;TPP1;PSMB8;ADAM19;CASP8;MMP8;MMP17;GZMM;CASP2;F10;PSMA5;MMP27;RHBDD3;PSMB3;ADAMTS1;MMP2;SFRP1;MMP1;USP9Y;HPR;HP;MASP1;ADAMTSL3;PDIA3;ADAMTS20;ADAMTS2;FURIN;PSMB1;RCE1;PSEN2;PRTN3;ZMPSTE24;USP34;USP16
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.4013541633683556,-1.112154420299782,0.3027027027027027,0.5696539303594799,1.0,12/21,35.21%,CDK6;CDK13;CDK14;CDK1;CDKL4;CDK5;CCNK;CDK20;CDKL1;CDK8;CDK12;CDK7
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.4013541633683556,-1.112154420299782,0.3027027027027027,0.5696539303594799,1.0,12/21,35.21%,CDK6;CDK13;CDK14;CDK1;CDKL4;CDK5;CCNK;CDK20;CDKL1;CDK8;CDK12;CDK7
prerank,methyl-CpG binding (GO:0008327),-0.39980669188318363,-1.111172840267106,0.3285968028419183,0.5694247017802759,1.0,8/22,19.57%,TET3;ZBTB21;CHTOP;PRMT1;UHRF1;LRWD1;ERH;WDR77
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4803078871579636,-1.110098660464872,0.35563380281690143,0.5696194888471006,1.0,5/10,16.94%,DSE;RPE;FUOM;GALE;GALM
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.30394447139344777,-1.10663402185019,0.28205128205128205,0.5755214347895606,1.0,29/75,37.00%,DHRS3;PGD;IMPDH2;ME2;NSDHL;CBR3;CBR1;ABCC4;HSD17B7;SORD;AKR1A1;KDSR;MDH1;MDH2;RDH12;DHRS4;KCNAB3;HSD17B10;RDH10;HSD3B2;SDR42E1;PTGR1;HADH;ADH5;CBR4;DHRS11;LDHAL6B;AKR1C1;MDH1B
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3275917762677507,-1.1064355553590806,0.2876480541455161,0.5735411433634048,1.0,20/49,22.94%,OPTN;TAB2;RNF169;MINDY2;ABRAXAS1;EPS15;BABAM2;ZFAND6;PRPF8;TNIP2;UBQLN4;TNIP3;MINDY1;PARP10;BRCC3;UBXN1;PSMD4;BAG6;ZRANB1;ZRANB3
prerank,Wnt-activated receptor activity (GO:0042813),0.41041068328617175,1.1048451241118695,0.3270588235294118,0.582381227611155,1.0,6/15,20.48%,FZD8;TSPAN12;PKD1;ROR1;FZD4;FZD10
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.4749081339877662,-1.1036712686398977,0.34024179620034545,0.5773027006885096,1.0,4/10,12.54%,DCLRE1C;DCLRE1A;EXO1;FEN1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.4219531752664515,-1.103099810116609,0.3380281690140845,0.5762573902384007,1.0,7/15,26.89%,WDR5;KMT2C;KMT2D;KMT2A;CXXC1;RBBP5;ASH2L
prerank,vitamin D receptor binding (GO:0042809),-0.4396573161176426,-1.0999744545417247,0.3381294964028777,0.5811167844579637,1.0,3/14,13.54%,MED24;MED4;RXRA
prerank,"DNA binding, bending (GO:0008301)",-0.43163595051699033,-1.0951381281769323,0.3448844884488449,0.59044634289991,1.0,6/14,19.44%,HHEX;TOP2A;HMGB2;TFAM;HMGB1;HMGB3
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.43974273987290086,-1.094165071249082,0.35951134380453753,0.5902655605417065,1.0,7/13,19.99%,PIP4K2A;PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;PIP5K1A
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.2288495664949965,-1.0895209271639328,0.1560379918588874,0.5985393889563091,1.0,137/730,18.47%,RBPJ;MITF;ZEB2;ELF4;FOXP1;RUNX1;BACH2;TFEB;TCF4;RREB1;REL;LITAF;BCL6;JUN;ZNF568;MEF2A;RUNX3;PPARD;BPTF;ZBTB34;BACH1;DNMT3A;NFE2L2;IRF2;ZNF148;NFIC;NFYA;ZSCAN12;ATF3;ELF1;UBP1;PPARG;ELK3;SPI1;ETV1;STAT3;KLF13;FOXO3;E2F2;IKZF1;LYL1;ZSCAN26;STAT6;DHX9;USF2;NFKB1;HHEX;NLRC5;RUNX2;RARG;MLXIP;IRF5;SARS1;MAF;MEF2B;KLF6;NR1H2;BATF;NRF1;TEF;NFATC3;ZBTB2;MYNN;AHR;KLF3;STAT5B;STAT4;ATF6;NR2F1;CREB3L2;SKI;BHLHE40;E2F1;THAP1;WBP2;CEBPG;E2F3;MEF2D;HIF1A;MEF2C;TFEC;OLIG2;EGR1;ARNT;PROX2;CIART;RELA;ZNF569;IKZF3;ZBTB20;XBP1;ZNF319;KLF10;NFE2;TRIM24;SALL3;FOXJ1;FOSL2;TCF7;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;E2F8;TFAP4;BATF3;KLF2;TCF3;ZNF628;YY1;RELB;NSD1;TFCP2;KLF8;NR4A1;ZBTB12;NRIP1;KLF11;IRX5;IKZF4;SOX10;FOXJ2;ZBTB25;RARA;NFATC1;ZBTB24;SNAPC3;NR3C1;TFE3;GATA3;MYB;TCF12;PLAG1;GMEB2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.45151645454429173,1.0893979350304155,0.34811529933481156,0.613983414776576,1.0,2/10,3.01%,B3GALT1;B3GALT5
prerank,epidermal growth factor receptor binding (GO:0005154),0.3621330899760977,1.0891230704915595,0.3340909090909091,0.6098865209363675,1.0,6/25,9.47%,ERBB4;LINGO1;TGFA;EGF;FAM83B;AREG
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.43980353687640633,-1.0875850737922472,0.35517241379310344,0.6004542137923539,1.0,7/13,31.32%,SLC7A7;SLC38A7;SLC66A1;SLC15A4;SLC7A2;SLC7A4;SLC7A1
prerank,poly-purine tract binding (GO:0070717),-0.3642674305653047,-1.0873651531065691,0.33772652388797364,0.5985750835553445,1.0,11/27,19.06%,RBMS1;RBPMS;PATL1;HNRNPDL;LARP4;ZC3H14;RBMS2;DAZAP1;DDX1;ATXN1;DDX3X
prerank,peptidase inhibitor activity (GO:0030414),-0.35279556955835706,-1.0868747432582258,0.34812286689419797,0.5972297131581231,1.0,11/33,27.58%,UCHL5;TFPI;PROS1;TIMP2;CAST;CST7;CST3;SPINT2;RENBP;SIMC1;A2M
prerank,microtubule motor activity (GO:0003777),-0.31613230737477094,-1.08612192241309,0.3287671232876712,0.5965926754791352,1.0,18/51,17.99%,KIF13B;KIF3B;KIF11;KIF16B;KIF20B;KIF23;KIF15;STARD9;KIF4A;CENPE;DNAH8;KIFC1;KIF14;KIF21B;KIF2C;KIF20A;DNAH3;KIF18B
prerank,calcium channel regulator activity (GO:0005246),0.3299388597146635,1.0834351098486774,0.3146341463414634,0.6180943811035207,1.0,5/37,7.24%,NRXN1;PRKG1;NRXN2;NPY2R;CACNG4
prerank,receptor antagonist activity (GO:0048019),-0.41552438940879877,-1.0822644876231122,0.34459459459459457,0.6035720553057599,1.0,7/17,33.02%,DKK2;CCL5;ESR2;WFIKKN1;DKK3;AGTR2;IL18BP
prerank,C-C chemokine receptor activity (GO:0016493),-0.3870315847263913,-1.0818582570705981,0.35221238938053095,0.6022359954221763,1.0,4/21,15.96%,CCR2;CCR1;CCRL2;CXCR4
prerank,exopeptidase activity (GO:0008238),0.3037621516214652,1.0809348499421576,0.34965034965034963,0.6191752726485764,1.0,5/50,4.07%,DPP10;DPP6;METAP2;MME;TRHDE
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.43605001814105276,-1.0805509986274997,0.3724137931034483,0.6030480018156075,1.0,4/13,7.83%,ITGA5;PTPRJ;ERN1;VEGFA
prerank,general transcription initiation factor binding (GO:0140296),-0.36467113589052724,-1.078081619808221,0.3637873754152824,0.6066691017872969,1.0,8/25,27.33%,GTF2A1;HHEX;AHR;RELA;DR1;GTF2A2;DRAP1;ESR1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3216666224200664,-1.0755859003384138,0.32996632996632996,0.610010675551927,1.0,10/47,14.69%,SLC38A6;SLC6A6;SLC43A2;SLC38A10;SLC7A7;SLC38A7;SLC36A4;SLC66A1;SLC7A5;SLC25A44
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.42131391062078244,-1.0753517890895536,0.3741258741258741,0.608148711250771,1.0,6/14,17.05%,OTUD5;MINDY2;USP9X;ATXN3;USP7;MINDY1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.4360754802674104,1.0745222324986627,0.3583535108958838,0.6298206763589189,1.0,2/11,1.17%,RYR3;RYR2
prerank,insulin-like growth factor I binding (GO:0031994),-0.4268779488585347,-1.07415219085809,0.362657091561939,0.6085985887577048,1.0,4/13,12.21%,INSR;IGF1R;ITGAV;IGFBP3
prerank,metalloexopeptidase activity (GO:0008235),0.3072260794547596,1.0727188001662762,0.32839506172839505,0.6297420705758172,1.0,11/51,14.94%,METAP2;AGBL4;MMP16;TRHDE;MMP15;AGBL1;CPE;CPA2;FOLH1;METAP1;LTA4H
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.35252677757483875,-1.071707332853921,0.351027397260274,0.6121845045975295,1.0,10/29,21.76%,PRKAG2;PKIB;INCA1;SPRED1;SPRY2;SPRED2;CIB1;CDKN2C;HSPB1;SFN
prerank,cytokine receptor binding (GO:0005126),-0.2857693761843445,-1.069079359039451,0.3223684210526316,0.6158917479397146,1.0,28/83,33.37%,SDCBP;SYK;CD300LF;IL6R;PIBF1;IL18;VEGFA;JAK1;SPRED1;SPRED2;CCL5;CCRL2;IL34;IL27RA;CSF1;TNFSF9;IL6;TYK2;KITLG;IL12RB1;IL2;IL27;TRAF6;SMAD2;CCL25;CCL19;IL13RA1;ERAP1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.3519947856519288,-1.0690369912913216,0.34465195246179964,0.6136029172386854,1.0,16/29,39.01%,ACER3;HPSE;GUSB;NEU1;PGGHG;GANC;ADPRS;CTBS;GANAB;PARG;ACER2;GALC;MGAM;CHIT1;LCT;NEU3
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.3866933106352687,-1.0681826005405233,0.36710963455149503,0.6134118433700811,1.0,7/20,21.99%,USP50;OTUD5;USP9X;SENP3;USP7;COPS5;EIF3H
prerank,TBP-class protein binding (GO:0017025),-0.38130296365047717,-1.067574376460633,0.35578583765112265,0.6124978128377837,1.0,7/21,27.33%,GTF2A1;HHEX;AHR;DR1;GTF2A2;DRAP1;ESR1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.36331045229432646,1.0661357747913256,0.363855421686747,0.64041263822674,1.0,3/21,3.41%,AKAP6;RYR2;WASF1
prerank,exonuclease activity (GO:0004527),-0.3173869307691898,-1.065763716412955,0.3555956678700361,0.6144689917555677,1.0,19/46,21.68%,DCLRE1C;RAD1;REXO5;ISG20L2;REXO4;EXOSC5;EXD1;WRN;EXO1;FEN1;APLF;RAD9A;EXOSC10;ENPP1;CPSF3;ZC3H12A;EXOSC4;FAN1;XRN2
prerank,histone deacetylase activity (GO:0004407),-0.3916008184517902,-1.0607015017483412,0.376271186440678,0.6240615300901947,1.0,7/19,23.02%,SIRT3;SUDS3;HDAC10;HDAC5;MIER1;SIRT2;HDAC8
prerank,protein tyrosine phosphatase activity (GO:0004725),0.2824522116159469,1.0602613177487783,0.34068627450980393,0.6496805901850398,1.0,11/71,8.63%,PTPRD;PTPRG;PTPRN2;PTPRR;PTPRT;EYA2;PTPRK;TNS2;PTPN3;PTPRB;PTPRZ1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.42582913358886065,1.0559754670475634,0.4064665127020785,0.6553336239634563,1.0,3/11,21.97%,PPP1R14C;PABIR1;PPP1R17
prerank,ephrin receptor binding (GO:0046875),-0.3792526103365226,-1.0535040583396358,0.38608695652173913,0.6389444857261536,1.0,4/21,6.59%,LYN;GRB2;CBL;PIK3CG
prerank,chemokine receptor activity (GO:0004950),-0.3621786098551064,-1.0519924342031188,0.3954305799648506,0.6399307301519169,1.0,11/24,38.98%,CCR2;CCR1;CCRL2;CXCR4;CMKLR1;GPR17;XCR1;CXCR2;ACKR3;CCR7;CCR9
prerank,tropomyosin binding (GO:0005523),0.39082092489526843,1.051961903659167,0.3793103448275862,0.6603338842516076,1.0,4/16,11.26%,SMTNL2;NEBL;TNNT2;CALD1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4251176807290117,1.0511579040999972,0.37850467289719625,0.6577026461708914,1.0,2/11,2.25%,TRPC5;TRPC1
prerank,cation transmembrane transporter activity (GO:0008324),-0.3160000752199329,-1.0510904288769873,0.37347294938917974,0.6397276410960104,1.0,24/48,38.50%,SLC38A6;SLC6A6;MFSD12;SLC38A7;SLC36A4;SFXN2;SLC66A1;SLC7A5;SFXN1;SLC6A9;SLC38A2;SLC8B1;SLC15A4;SLC22A3;SLC7A2;SLC36A3;SLC7A1;SLC38A9;SLC7A8;ATP1B4;SLC38A5;SLC22A2;SLC6A14;SLC29A4
prerank,steroid hydroxylase activity (GO:0008395),-0.4105337907800613,-1.049272278889633,0.4007029876977153,0.6416257958229936,1.0,6/16,29.53%,CYP27A1;CH25H;CYP46A1;CYP2R1;CYP1B1;CYP2S1
prerank,neuropeptide receptor binding (GO:0071855),0.3957618579514063,1.048553447076239,0.40046838407494145,0.6594503480096423,1.0,3/14,12.32%,APLN;GHRH;NTS
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.46025912974730304,-1.0485125072908876,0.41081081081081083,0.6410323338641338,1.0,7/10,25.58%,PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;ATM;PIK3C2G
prerank,phosphatase binding (GO:0019902),-0.2698029384305065,-1.0465107421910465,0.3528428093645485,0.6431608018026764,1.0,22/105,13.78%,IQGAP1;MAP3K5;SNX3;STAT3;CD22;STAT6;MTMR3;MAPK14;TRAF3;MVP;CTNNB1;VRK3;SIRPA;CTSC;JAK1;SPRED1;STYXL1;LCK;PPP6R3;HSP90B1;TRAF2;MAST2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.4365091041255844,1.0448722005863376,0.3926940639269406,0.6638231423164965,1.0,4/10,13.04%,IDE;ANKRD13A;FAAP20;DNAJB2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.4033671353763819,1.0441357390837622,0.38961038961038963,0.6608517397134915,1.0,3/15,13.06%,SLC26A3;SLC4A11;SLC26A8
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.36816135523771154,-1.0440167394661373,0.38581314878892736,0.6466251939638772,1.0,5/22,14.35%,APOE;PICALM;DNAJA1;HSP90B1;ANKRA2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.43910711583024986,-1.0421225687971194,0.43602693602693604,0.6484942174258714,1.0,5/11,37.91%,PADI4;ARG2;ARG1;AGMAT;PADI1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.44865028468411744,-1.0412562463951236,0.43014705882352944,0.648195420710642,1.0,4/11,23.15%,SGMS1;GNPTAB;SAMD8;AASDHPPT
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.3493824663600631,-1.0394765259904954,0.3924731182795699,0.6501698250797497,1.0,9/27,21.09%,POLR2F;POLR2L;POLR2A;POLR3B;POLR2G;POLR1F;POLR3A;MED20;POLR2I
prerank,protein tyrosine kinase activity (GO:0004713),-0.266304490227441,-1.038985232890295,0.3652312599681021,0.6490125547242395,1.0,27/108,18.61%,LYN;FGR;SYK;AXL;INSR;IGF1R;PEAK1;FES;ABL2;DYRK2;TEC;FLT1;PTK2B;PKDCC;CAMKK2;JAK1;LCK;DYRK1A;ITK;FRK;TXK;TTK;ZAP70;WEE1;RYK;HCK;PDGFRB
prerank,microtubule minus-end binding (GO:0051011),-0.418670183719235,-1.0372968237323557,0.418018018018018,0.6506298551124803,1.0,7/13,26.81%,MACF1;TUBGCP4;HAUS4;HAUS7;CAMSAP2;TUBGCP2;CAMSAP1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.2166924020280532,-1.0370374290971165,0.30634278002699056,0.648969499247736,1.0,177/830,22.11%,RBPJ;MITF;ZEB2;ELF4;FOXP1;RUNX1;TRPS1;BACH2;TFEB;TCF4;RREB1;REL;LITAF;BCL6;RB1;JUN;ZNF568;MEF2A;ETV6;RUNX3;PPARD;BPTF;ZBTB34;BACH1;DNMT3A;NFE2L2;IRF2;ZNF148;NFIC;NFX1;NFYA;ZSCAN12;ATF3;ELF1;UBP1;PPARG;ELK3;SPI1;GTF2A1;ZNF3;ETV1;STAT3;KLF13;FOXO3;E2F2;IKZF1;LYL1;ZSCAN26;STAT6;DHX9;USF2;NFKB1;HHEX;NLRC5;RUNX2;RARG;MLXIP;IRF5;SARS1;MAF;MEF2B;KLF6;NR1H2;CUX1;BATF;NRF1;TEF;NFATC3;ZBTB2;MYNN;KLF3;STAT5B;STAT4;ATF6;NR2F1;SKI;BHLHE40;E2F1;THAP1;WBP2;CEBPG;E2F3;MEF2D;HIF1A;MEF2C;TFEC;OLIG2;EGR1;ARNT;PROX2;CIART;RELA;ZNF569;IKZF3;ZBTB20;XBP1;ZNF319;OSR1;KLF10;PRDM2;NFE2;SALL3;FOXJ1;ZFP57;FOSL2;TCF7;ZFP41;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;E2F8;TFAP4;BATF3;KLF2;ZBTB46;TCF3;ZNF628;YY1;RELB;NSD1;TFCP2;KLF8;ZNF177;NR4A1;ZBTB12;NRIP1;KLF11;IRX5;IKZF4;SOX10;FOXJ2;ZBTB25;RARA;NFATC1;ZBTB24;ATF5;SNAPC3;NR3C1;TFE3;GATA3;MYB;RPS3;TCF12;PLAG1;GMEB2;CASZ1;MEIS3;HOXD8;MAX;SP9;EHF;CIC;ZFP28;MAZ;PKNOX1;ATF7;STAT1;ZFP2;POU3F1;GTF2IRD1;LRRFIP1;ZSCAN21;HOXB2;ZKSCAN1;ZBTB7A;TBX2;HEYL;SNAI2;CEBPB;EGR2;BBX;ZNF296;BARX2
prerank,C-C chemokine binding (GO:0019957),-0.3653745731439588,-1.0359416028587864,0.4024822695035461,0.6491942498699182,1.0,10/22,39.18%,CCR2;CCR1;CCRL2;CXCR4;XCR1;CXCR2;ACKR3;CCR7;CCR9;ZFP36
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.32943389387196387,-1.0355568628916183,0.40414507772020725,0.6477843006242953,1.0,9/34,16.75%,BIRC6;UBE2R2;UBE2L3;UBE2H;UBE2G1;UBE2T;CDC34;UBE2C;UBE2I
prerank,galactosyltransferase activity (GO:0008378),-0.44023149429180936,-1.0300274812785457,0.4117647058823529,0.6586655110925264,1.0,4/11,19.30%,B4GALT5;B4GALT7;B4GALT3;B4GALT1
prerank,nuclear receptor coactivator activity (GO:0030374),-0.29572124686344703,-1.0283014345760726,0.4013840830449827,0.6601566410442925,1.0,14/52,21.39%,ZMIZ1;PRKCB;SS18;MED24;RNF4;HELZ2;MED4;RBM14;CALCOCO1;ZMIZ2;PPARGC1B;NCOA6;WDR77;KDM1A
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3483004656099923,-1.027860427809789,0.4137291280148423,0.6589065956484154,1.0,3/26,4.06%,SLC16A7;SLC6A6;SLC27A1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.33290581529509516,-1.0256159930893651,0.4079173838209983,0.662171628826332,1.0,8/31,16.52%,BIRC6;UBE2R2;UBE2L3;UBE2H;UBE2G1;UBE2T;CDC34;UBE2C
prerank,methylated histone binding (GO:0035064),-0.2903708170559597,-1.0247799471196921,0.41680395387149916,0.6617506606962613,1.0,21/62,27.23%,BPTF;NCAPG2;KDM7A;DPF2;WDR5;MORC3;TRIM24;SPIN1;CHD8;UHRF1;NCAPD3;LRWD1;ZMYND8;CXXC1;PHF13;MORC4;RRP8;CDYL;RBBP5;CBX8;CBX2
prerank,mRNA 3'-UTR binding (GO:0003730),-0.275550071788805,-1.0239072107386766,0.4091680814940577,0.6615223193072618,1.0,29/79,27.04%,RBMS1;RC3H1;RNF20;SECISBP2;PUM2;LARP4B;DDX5;LARP4;NUDT21;CELF1;BOLL;DHX36;RBMS2;DAZAP1;RNPS1;ZC3H12A;CPEB4;EXOSC4;RPL41;TARDBP;PUM1;PABPC1L;PCBP4;CPSF1;RNF40;RPL5;ANGEL2;ZFP36L1;EXOSC8
prerank,translation elongation factor activity (GO:0003746),-0.40083858116689897,-1.022295134582711,0.42424242424242425,0.6630736920813981,1.0,6/14,18.59%,TUFM;EEF1B2;EEF2;GTPBP1;EEF1A1;GTPBP2
prerank,DNA replication origin binding (GO:0003688),-0.3600182811373786,-1.0221805304955247,0.415929203539823,0.661028147427516,1.0,9/23,24.40%,DHX9;MCM6;MCM9;MCM3;ORC5;KAT7;MCM2;CDC45;MCM5
prerank,single-stranded RNA binding (GO:0003727),-0.30918691471656234,-1.02147784379385,0.4204152249134948,0.6604178604689896,1.0,13/43,20.53%,TLR8;AGO2;TLR7;DHX58;DHX9;DDX60;CNBP;PUS1;POLR2G;HNRNPA1;EXOSC10;DDX3X;RBM11
prerank,ribonuclease P activity (GO:0004526),0.4238608520056658,1.0214683464993772,0.4329411764705882,0.7133820459390171,1.0,6/11,21.45%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,alpha-tubulin binding (GO:0043014),-0.3337101009917147,-1.0191790876365965,0.41946308724832215,0.6635905401873302,1.0,8/31,14.84%,ARL8B;ARL8A;EML4;EFHC2;TAOK1;TBCE;RACGAP1;INO80
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.31752151455887556,-1.0190487608308965,0.4358974358974359,0.6615948706815709,1.0,15/37,33.98%,RARS1;FARS2;SARS1;CARS2;DARS1;KARS1;TARS2;AARS1;DARS2;IARS1;EARS2;TARS3;WARS2;VARS2;RARS2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3862886172552412,-1.0189180858440752,0.4543918918918919,0.6597001476184755,1.0,7/16,19.08%,CD38;MACROD1;NEIL3;BST1;NEIL2;RPS3;ADPRS
prerank,signal sequence binding (GO:0005048),-0.32612847771057774,-1.018607459586481,0.4292845257903494,0.6581886464197593,1.0,10/35,23.00%,KPNA4;IPO5;BABAM2;TIMM22;KPNA3;BRAP;NUP153;CAT;TOMM20L;TOMM70
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3527003580517034,-1.0181985005021752,0.46003552397868563,0.6567966716961194,1.0,9/24,25.76%,RPS14;RPS13;MRPS11;DHX36;NCL;DDX3X;SHMT1;RPL41;RPL5
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.30471000045653146,1.0153104191595521,0.4215456674473068,0.7243200389340102,1.0,6/38,11.93%,SPOCK1;SERPINI1;SERPING1;SERPINB5;WFDC3;SERPINE3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2729639652967556,1.0091119532380792,0.4468599033816425,0.7353025236705423,1.0,17/72,15.09%,FRMPD4;PLCB1;PARD3;SNAP91;MARK1;TIRAP;PLA2G4E;SNX21;PLCZ1;AMER2;GSN;GSDMD;SYT7;SYTL2;OSBPL2;MYO1B;RPH3A
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.4002608166386397,1.0080193806742113,0.4649122807017544,0.7331561085675612,1.0,3/12,5.08%,BMPR1B;ACVR1;LTBP1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.416611135152954,-1.007767336241063,0.44194107452339687,0.6793016721140906,1.0,6/12,19.63%,PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;ATM
prerank,protein phosphatase 2A binding (GO:0051721),0.33007113057662724,1.006218502208743,0.4322250639386189,0.7329051824317504,1.0,4/23,8.49%,ADCY8;GRIN3A;BOD1;SMG5
prerank,NADP binding (GO:0050661),0.310834759889068,1.005943504519898,0.4312796208530806,0.7287252491863538,1.0,13/32,23.35%,CRYZ;DPYD;ME3;DHCR7;HSD11B1;DHFR;ME1;CRYZL1;DUS2;KCNAB1;GMDS;GRHPR;NOS1
prerank,methylation-dependent protein binding (GO:0140034),-0.28746106899034507,-1.0007947112648985,0.47471451876019577,0.6936782867073915,1.0,20/57,27.23%,BPTF;NCAPG2;KDM7A;WDR5;MORC3;TRIM24;SPIN1;CHD8;UHRF1;NCAPD3;LRWD1;ZMYND8;CXXC1;PHF13;MORC4;RRP8;CDYL;RBBP5;CBX8;CBX2
prerank,kinesin binding (GO:0019894),-0.3352062071158656,-0.999603224461096,0.46422018348623856,0.6943190755478753,1.0,10/27,20.29%,PLEKHM2;ACTB;ARHGEF10;AP1G1;NEK6;RAB29;SPAG9;KIF18B;FAM83D;PRC1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.31591030588192487,-0.998640787875889,0.4686411149825784,0.6941459398161821,1.0,18/34,35.12%,NSD3;SMYD2;SMYD3;EZH2;KMT5B;SMYD1;SETDB1;DOT1L;KMT5A;EEF2KMT;SETD6;METTL21A;TTLL12;SETD7;SETD2;ETFBKMT;ANTKMT;SETD4
prerank,calcium-dependent phospholipid binding (GO:0005544),0.2877328916301428,0.9967384175757152,0.4543147208121827,0.7475823321438416,1.0,14/49,15.09%,SYT1;PCLO;SYT10;SYT2;CPNE4;SYT5;PLA2G4E;SYT11;SYT12;CPNE8;DYSF;SYT7;MCTP2;RPH3A
prerank,FMN binding (GO:0010181),-0.4191053142556268,-0.9943323211436651,0.4866785079928952,0.7019353242864146,1.0,6/11,39.06%,POR;PNPO;NOS2;HAO1;NDOR1;PPCDC
prerank,leak channel activity (GO:0022840),0.35854437869123623,0.9942298395511674,0.4512471655328798,0.7492582339865163,1.0,4/18,10.81%,KCNK10;NALCN;KCNK2;TMEM175
prerank,sulfotransferase activity (GO:0008146),0.3113590957657826,0.9921853107068912,0.430952380952381,0.7494320385709966,1.0,8/33,13.79%,GAL3ST3;HS3ST1;CHST5;CHST7;CHST9;CHST8;CHST14;SULT4A1
prerank,ATPase binding (GO:0051117),-0.272025542349145,-0.9895193788135727,0.4486301369863014,0.7109081836107954,1.0,20/71,19.57%,ABCA1;SNX10;ATP6V1E1;TCIRG1;PEX26;ATP1B3;NR1H2;WFS1;ATXN3;SELENOS;ATP6V1G1;DERL1;LCK;BBC3;TOR1AIP1;NUFIP1;TAF9;RALB;UBXN1;PLN
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.3879722004911079,0.988685586817093,0.45742092457420924,0.7536966026986999,1.0,6/14,16.37%,CAPN3;CAPN10;CAPN6;CAPNS2;CAPN5;CAPN2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.29766515720695247,0.9878952962450372,0.4953051643192488,0.7508173497590311,1.0,3/38,0.80%,MAGI2;SORBS1;GRIP1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.4208216075508065,0.986563437399508,0.4783599088838269,0.7493880961055028,1.0,4/10,20.58%,SLC6A1;SLC6A13;SLC6A11;SLC10A1
prerank,microtubule plus-end binding (GO:0051010),0.3483810113947174,0.9857058554928203,0.4671717171717172,0.7467100819636528,1.0,4/20,6.90%,MAPRE3;DST;CLASP2;CLIP4
prerank,protein tyrosine kinase binding (GO:1990782),-0.2733093745586136,-0.9847521870391935,0.47039473684210525,0.7201813185129666,1.0,18/71,14.50%,NEDD9;BANK1;CBL;RNF41;ITGB1;BLNK;PITPNM1;DUSP3;GAS6;SIRPA;FIZ1;ANGPT2;ITGAX;CRK;PCNA;CPNE3;TJP2;CBLB
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4038128951338483,0.9773447630354387,0.4668192219679634,0.7632226978563413,1.0,2/11,10.58%,HCN2;HCN1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.28189163866965816,0.9767703216260768,0.4988610478359909,0.7597385745603289,1.0,7/46,9.73%,MGAT4C;B3GALT1;B3GALT5;HEXB;MGAT3;EXTL1;B3GNT5
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.38013002805326324,-0.9767236888809718,0.5043936731107206,0.7375968247823799,1.0,4/15,14.49%,SH3PXD2B;SNX3;SESTD1;PLA2G4A
prerank,receptor tyrosine kinase binding (GO:0030971),-0.28387056137153827,-0.9750121025046301,0.4753289473684211,0.7392183706826566,1.0,20/56,21.86%,GAB2;CBL;RNF41;BLNK;STAP1;PITPNM1;DUSP3;GAS6;FIZ1;FRS2;ANGPT2;ITGAX;PCNA;CPNE3;CBLB;TOB1;TRADD;PTPN1;RACK1;SOCS5
prerank,palmitoyltransferase activity (GO:0016409),-0.32754084174331244,-0.9731999098910596,0.4855687606112054,0.7410111756322627,1.0,10/28,24.43%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;ZDHHC5;GOLGA7;HHAT;ZDHHC13;ZDHHC6
prerank,transforming growth factor beta binding (GO:0050431),-0.3376855980722002,-0.9730188247175674,0.4958263772954925,0.7389791796081016,1.0,7/23,17.00%,CD36;NRROS;ITGAV;TGFBR1;LTBP4;TGFBR2;VASN
prerank,FAD binding (GO:0071949),-0.33235386821488555,-0.9711060736674335,0.48881239242685026,0.7409056169292002,1.0,9/24,24.95%,CYB5R1;CYB5R3;KMO;MICAL1;MICAL2;MTHFR;NQO2;QSOX1;CYB5R2
prerank,actin binding (GO:0003779),-0.23485792201622474,-0.9704272252471376,0.555735056542811,0.7401739739840398,1.0,52/170,23.92%,IQGAP2;MTSS1;PHACTR2;MYH9;MYO9B;MYO1F;EPS8;CAPZB;GAS2L3;FXYD5;ABL2;PARVB;ITGB1;MACF1;CAP1;UTRN;NRAP;LIMA1;CORO7;LCP1;MSRB1;MICAL1;CCDC88A;ARPC1A;MICAL2;MAEA;SSH3;CAPZA1;SPEF1;TMSB4X;MAP1S;COTL1;ANG;SSH1;CXCR4;TWF2;PDLIM2;NOD2;SYNPO;TNNT3;MYL4;PDLIM5;RUSC1;FLII;VPS16;PHACTR4;MEFV;PDLIM1;HPCA;P4HB;SMTN;SYNE2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.33460700876898486,-0.969287783725278,0.5,0.7405858956286693,1.0,5/23,10.92%,SH3PXD2B;SNX3;KIF16B;HIP1;SESTD1
prerank,growth factor receptor binding (GO:0070851),-0.25325677579449246,-0.9688245165185104,0.5318791946308725,0.739322959631707,1.0,12/95,8.26%,GRB2;SDCBP;SNX2;ITGA5;PTPRJ;ERN1;CD300LF;IL6R;PIBF1;HIP1;VEGFA;FRS2
prerank,nucleotidyltransferase activity (GO:0016779),-0.3597477851336374,-0.9686404866515166,0.5187074829931972,0.7373437079650044,1.0,6/19,17.98%,CGAS;TUT7;MTPAP;MOCS3;PAPSS1;TENT4B
prerank,histone acetyltransferase activity (GO:0004402),-0.31594363644617274,-0.9672538948414886,0.5319148936170213,0.7385256516073252,1.0,11/30,29.42%,CREBBP;ARRB1;NAA50;KAT7;BAZ1A;EPC1;TAF9;TADA3;CLOCK;EP300;EPC2
prerank,telomerase RNA binding (GO:0070034),-0.34578746925832554,-0.9659546268994783,0.5079928952042628,0.7392070728949842,1.0,7/22,18.95%,TEP1;DCP2;DHX36;GAR1;TENT4B;WRAP53;EXOSC10
prerank,channel activity (GO:0015267),-0.2952145129309354,-0.9656090972205124,0.5076923076923077,0.7376431636368359,1.0,10/41,28.54%,BCL2;MCUB;PANX1;TMEM120B;KCNK3;MPV17;TRPV2;PRF1;PDPN;AQP1
prerank,dynactin binding (GO:0034452),0.38175688827955434,0.9642967461883011,0.5093023255813953,0.7874644102165248,1.0,3/12,7.08%,BICD1;BICDL1;HOOK3
prerank,kinase activity (GO:0016301),-0.2480630278233423,-0.9638496598528739,0.5389830508474577,0.7394117419502287,1.0,30/109,21.91%,LYN;ITPKB;DGKZ;CSNK2A1;PANK2;NADK;PIK3CB;PIK3CG;DGKD;PI4KB;COQ8A;MASTL;POMK;TAOK1;SEPHS1;PIK3CA;PRKD3;PIK3CD;PDXK;PIK3C2A;NADK2;DGKG;PAPSS1;SPHK2;PGK1;IP6K3;NMRK1;GSK3B;CDK5;MAP4K4
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.23908868825241303,-0.9558763433663333,0.5667808219178082,0.7559406324584135,1.0,52/134,34.11%,SLC16A7;SLC38A6;CD36;SLC6A6;MFSD12;SLC27A1;SLC25A24;SLC35D2;SLC38A7;SLC36A4;CTNS;SFXN2;ABCC1;SLC25A42;SLC25A25;SLC66A1;ABCC4;SLC7A5;SFXN1;SLC23A1;SLC23A2;SLC6A9;SLC6A8;SLCO5A1;SLC38A2;SLC16A1;SLC25A22;SLC52A2;SLC15A4;SLC25A13;SLC35B3;SLC22A3;SLC17A9;SLC25A18;SLC52A1;PDPN;SLC7A2;SLC4A1;SLC35B1;SLC26A4;SLC2A2;SLCO1B1;SLC4A8;SLC36A3;SLC7A1;SLC19A1;GJA1;SLC38A9;SLC25A17;SLC26A7;SLC7A8;SLC25A1
prerank,serine-type peptidase activity (GO:0008236),-0.25122706906450454,-0.9551463918104953,0.5469798657718121,0.7551890796532696,1.0,31/96,29.48%,PLAU;DPP4;PREP;HGF;PCSK7;RHBDF1;RHBDF2;CTSH;KLK3;PRSS36;F7;FAP;HTRA3;CD5L;TPP1;MMP8;GZMM;F10;RHBDD3;MMP2;HPR;HP;MASP1;FURIN;PRTN3;TMPRSS7;ACR;F11;PRSS53;GZMK;KLK9
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.310169101877749,0.9550740128054981,0.5032397408207343,0.8063631966464234,1.0,6/29,13.06%,SLC1A6;SLC26A3;SLC1A1;SLC13A5;SLC25A11;SLC26A8
prerank,snRNA binding (GO:0017069),-0.29333561983666684,-0.9540546775975696,0.5354058721934369,0.7555904213945485,1.0,20/42,42.09%,SNRNP35;COIL;SF3B3;PRPF8;SNRPA;SART3;SNRNP70;SNU13;RBM22;DDX39B;LARP7;ISG20;TUT1;SNRPA1;SNRPD3;LSM8;DDX21;MEPCE;RBM41;NCBP2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3316470712380221,0.9530348040722637,0.5136986301369864,0.806833958581851,1.0,4/21,15.88%,GRIK2;CHRNA5;CHRNA7;P2RX6
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.2632106589763877,-0.9525935245661639,0.5604203152364273,0.7567788859543286,1.0,25/69,30.70%,CREBBP;ZDHHC7;ZDHHC8;ZDHHC2;DGAT1;ZDHHC12;PLA2G4A;PLAAT3;MCAT;PLAAT1;ZDHHC1;ZDHHC5;NAA16;LPCAT3;ESCO2;HHAT;ZDHHC13;NMT1;ZDHHC6;CERS3;PLA2G15;EP300;SCP2;LPCAT4;AWAT2
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.39825480473782077,-0.9509013182302374,0.5264900662251656,0.75851815485609,1.0,3/12,16.06%,DDI2;CTSE;HM13
prerank,tau protein binding (GO:0048156),-0.295287939916581,-0.949964889898398,0.5306479859894921,0.7582864720601189,1.0,10/40,13.94%,APOE;ROCK1;ACTB;PICALM;TAOK1;PIN1;DCTN1;DYRK1A;HSP90AB1;MARK2
prerank,filamin binding (GO:0031005),0.3851473247566894,0.9486185123854257,0.5114678899082569,0.8131206084987062,1.0,5/11,11.81%,NEBL;TMEM67;SYNPO2;DPYSL4;DPYSL3
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3757813715195154,-0.9482084556419115,0.5367521367521367,0.7599894346205852,1.0,7/15,27.90%,COX4I1;COX10;COX8A;NDUFA4;CYB5A;COX5A;COX6A2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3949178097159753,0.9474516686236257,0.497737556561086,0.8112236584789981,1.0,4/10,13.04%,IDE;ANKRD13A;FAAP20;DNAJB2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.4018493086282643,-0.9451141421014463,0.5466893039049237,0.7647562646403437,1.0,6/12,25.81%,TENT5A;MTPAP;TENT5C;TENT4B;PAPOLA;TENT5D
prerank,aminopeptidase activity (GO:0004177),0.3168188949394769,0.944705809112511,0.5683962264150944,0.8130498187525174,1.0,4/26,5.66%,METAP2;MMP16;TRHDE;MMP15
prerank,calcium channel inhibitor activity (GO:0019855),-0.40178179073414155,-0.9404746618862074,0.5515463917525774,0.7731644654435474,1.0,2/11,5.41%,ITPR1;MCUB
prerank,phospholipase activity (GO:0004620),0.25230565223913454,0.9402538869204479,0.5697115384615384,0.8196315211820184,1.0,9/67,6.71%,PLCL1;ENPP2;PITPNM3;ABHD16A;ABHD3;GDPD1;PLCE1;PLA2G4E;FAM83B
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.40455294281349463,-0.9377025430458217,0.5504424778761062,0.7770892367102082,1.0,4/11,17.06%,SLC5A11;SLC5A3;SLC23A1;SLC23A2
prerank,protein kinase inhibitor activity (GO:0004860),-0.2882930612970225,-0.9376056407196874,0.5799319727891157,0.7749046022996733,1.0,15/42,27.03%,TAOK3;IBTK;TRIB1;SPRED1;SPRY2;SPRED2;CIB1;GMFG;GMFB;DNAJC3;SOCS3;RACK1;ITPRIP;NCK1;SH3BP5
prerank,poly(A) binding (GO:0008143),-0.33044229425388394,-0.933686689158995,0.555921052631579,0.7814597292819988,1.0,8/21,19.06%,RBMS1;RBPMS;HNRNPDL;LARP4;ZC3H14;RBMS2;DDX1;DDX3X
prerank,glutathione transferase activity (GO:0004364),0.3140592392854982,0.9316445039230163,0.5734265734265734,0.8367047796325516,1.0,8/23,22.42%,GSTZ1;GSTP1;GSTK1;GSTM5;LANCL1;GSTA4;GSTT1;GSTT2
prerank,tau-protein kinase activity (GO:0050321),-0.3319496381365511,-0.9305044079722292,0.5489864864864865,0.7861852494050333,1.0,10/20,27.62%,ROCK1;PHKG2;TAOK1;DYRK1A;MARK2;TAOK2;GSK3B;CDK5;SIK3;MARK4
prerank,pre-mRNA binding (GO:0036002),-0.30722030356201807,-0.9301314031055042,0.5677083333333334,0.7845930301063438,1.0,10/28,26.35%,TRA2B;HNRNPL;DDX5;PRPF8;CELF1;ZRSR2;HNRNPA1;SLU7;RBM22;U2AF2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.4087627777578294,-0.9285371576240697,0.5795847750865052,0.7858309913184499,1.0,4/10,17.01%,OTUD5;ATXN3;OTUD4;STAMBPL1
prerank,kinase inhibitor activity (GO:0019210),-0.2975805949325548,-0.9280588349275658,0.5649241146711635,0.784651731397685,1.0,10/33,27.03%,TAOK3;LRP6;TRIB1;GMFG;GMFB;DNAJC3;SOCS3;ITPRIP;NCK1;SH3BP5
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.24790224246543074,-0.9279431257537634,0.5915966386554622,0.7824973169803159,1.0,26/85,28.31%,LIPA;AOAH;ABHD12;PAFAH2;DAGLB;PNPLA7;LPL;ABHD5;PLA2G7;PLA2G4A;PLAAT3;TARS2;PON2;PGLS;PLAAT1;PLA2G6;AARS1;PLA2G12A;LYPLA1;PGAP1;LIPE;PON3;ESD;PLA2G15;LCAT;NOTUM
prerank,MAP kinase kinase activity (GO:0004708),0.3483045332234596,0.9261096061153401,0.5636363636363636,0.8450560541156505,1.0,4/15,5.84%,MAPK10;PAK3;MAP2K6;MAP2K7
prerank,ion gated channel activity (GO:0022839),0.3134313533649346,0.9255771941844076,0.5619266055045872,0.8413397282697176,1.0,4/24,7.83%,KCNT2;ANO4;ANO3;ANO5
prerank,chloride channel inhibitor activity (GO:0019869),-0.40372417116014137,-0.9239710534109878,0.5658783783783784,0.7893832693128467,1.0,2/10,5.15%,STX7;STX8
prerank,chloride transmembrane transporter activity (GO:0015108),0.3513631290940989,0.9218184312441691,0.58,0.8455132567603229,1.0,4/16,13.06%,SLC26A3;SLC1A1;SLC12A5;SLC26A8
prerank,sodium:proton antiporter activity (GO:0015385),-0.390583616388877,-0.9203965523133373,0.553763440860215,0.7951117429546353,1.0,3/11,8.82%,SLC9A9;SLC9A8;SLC9A1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.31916850748872183,0.9179165029243868,0.5862068965517241,0.8504587858631917,1.0,1/20,0.06%,DLG2
prerank,nuclear export signal receptor activity (GO:0005049),-0.38619613891287463,-0.9126406445466627,0.5803108808290155,0.8103249582315207,1.0,3/11,10.33%,NUP42;XPO6;XPO5
prerank,histone methyltransferase binding (GO:1990226),-0.3824259165929961,-0.9093234864487489,0.5919439579684763,0.8153784460695696,1.0,3/11,19.62%,CTNNB1;HSP90AB1;LCORL
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.2766750121228749,-0.9090068130637338,0.6155115511551155,0.813595436646583,1.0,13/42,24.92%,CCNL1;CCND3;CCNY;INCA1;CCNL2;CCNE1;CDKN2C;CNPPD1;CCNK;CCNF;CCNB1;CKS2;CCNB2
prerank,CoA-ligase activity (GO:0016405),0.3529338204131336,0.908982175300612,0.5921052631578947,0.8670417368234226,1.0,4/14,20.06%,SLC27A2;ACSS2;ACSM3;ACSS1
prerank,fatty acid synthase activity (GO:0004312),0.37457353013812533,0.9078345884973407,0.5839243498817966,0.864877037273005,1.0,4/10,22.83%,ELOVL7;ELOVL6;ELOVL2;OXSM
prerank,water transmembrane transporter activity (GO:0005372),0.3719418138081706,0.9054683440345476,0.6022222222222222,0.8659044805731465,1.0,3/11,19.87%,SLC4A11;AQP11;AQP4
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2451307759303419,0.9050309204072188,0.6735159817351598,0.8619504094189168,1.0,5/70,3.49%,MGAT4C;B3GALT1;CHSY3;B3GALT5;HEXB
prerank,cardiolipin binding (GO:1901612),0.38101545389962166,0.9018580986540154,0.5691609977324263,0.8644897293093151,1.0,2/10,11.15%,MME;GSDMD
prerank,carboxypeptidase activity (GO:0004180),-0.2862346733565498,-0.9014522910867676,0.6288659793814433,0.8280889347740646,1.0,4/35,5.55%,CTSZ;PEPD;CTSA;MINDY2
prerank,potassium ion leak channel activity (GO:0022841),0.33941134306672666,0.9005238844401308,0.6129807692307693,0.8628845942739181,1.0,5/15,20.05%,KCNK10;KCNK2;TMEM175;KCNK12;KCNK1
prerank,sialyltransferase activity (GO:0008373),0.32071555137661556,0.8995213436350114,0.6412776412776413,0.8605476609329239,1.0,8/20,19.84%,ST8SIA2;ST8SIA3;ST6GAL2;ST6GALNAC3;ST3GAL6;ST8SIA1;ST8SIA5;ST6GALNAC5
prerank,lysophospholipase activity (GO:0004622),0.31820753531803675,0.8992758105025918,0.5797101449275363,0.8563366477141572,1.0,3/20,6.05%,ENPP2;ABHD16A;GDPD1
prerank,muscle alpha-actinin binding (GO:0051371),0.3299787748252798,0.8977232859951252,0.6264236902050114,0.8552293255186271,1.0,5/15,17.40%,PRICKLE4;SYNPO2;TTN;PDLIM4;PDLIM7
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.2920471115876105,0.8976209169344944,0.6293532338308457,0.8507564466761165,1.0,7/27,13.51%,ZMYM2;RNF144A;UBE3D;SIAH3;RNF217;DCUN1D2;PRKN
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.34482500366349295,-0.8964301913556894,0.6023294509151415,0.8367773590095896,1.0,13/17,43.03%,ACOT9;ACOT13;ACAA2;PLA2G6;ACOT2;ACOT4;PPT1;ACOT11;ACOT6;BAAT;ACSBG2;THEM4;ACOT1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.36814845019118453,-0.8964130847593491,0.6068222621184919,0.8343334831606813,1.0,2/12,14.15%,AGO2;NCBP1
prerank,NAD binding (GO:0051287),-0.3028192026772163,-0.8944984790392649,0.6083916083916084,0.8360019254599617,1.0,8/26,24.63%,ZC3HAV1;PARP9;SIRT3;SORD;QDPR;NNT;SIRT2;NUDT6
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.30134098958324984,-0.8935216855867603,0.6254355400696864,0.8357570747900585,1.0,8/28,17.36%,MAPKAPK3;SGK1;MAPK14;MAP2K5;MAP2K1;TTK;AURKA;MAP2K3
prerank,NF-kappaB binding (GO:0051059),-0.3130324933461228,-0.8927561797527123,0.5963302752293578,0.8349284666670169,1.0,8/24,23.32%,ANXA4;RELA;RNF25;TAF4B;FAF1;GSK3B;MTDH;SETD6
prerank,actin monomer binding (GO:0003785),-0.3147293491465089,-0.8925591058480233,0.613126079447323,0.8328958476378494,1.0,6/22,21.41%,MTSS1;ABL2;LIMA1;TMSB4X;TWF2;MYL4
prerank,BMP binding (GO:0036122),-0.3831018653127368,-0.8908538936318767,0.592391304347826,0.8342596989484435,1.0,4/11,27.20%,GREM1;BMPR2;GREM2;ENG
prerank,disordered domain specific binding (GO:0097718),-0.3079135398571423,-0.890413249683798,0.6247755834829444,0.8327600687758311,1.0,8/23,21.85%,RB1;GAPDH;FN1;HSP90AB1;HSPA1A;HSPA2;PPIL1;BCL2L2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3766250795522518,-0.8885461567336677,0.6286231884057971,0.8344103753006262,1.0,5/10,24.88%,SIRPA;CXADR;JUP;CD47;DSP
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.31793093318120735,0.8881400666297852,0.6067961165048543,0.8685509709801039,1.0,5/20,14.84%,LPCAT2;MOGAT3;AGPAT3;GPAT3;AGPAT2
prerank,O-acyltransferase activity (GO:0008374),0.2821774006627873,0.8874613950837196,0.6482758620689655,0.8652634833623668,1.0,7/30,15.41%,LPCAT2;MOGAT3;GPAM;MBOAT2;DGAT2L6;GPAT3;SOAT1
prerank,endopeptidase inhibitor activity (GO:0004866),-0.23918618240940678,-0.8858715589911001,0.6884176182707994,0.8377557744666363,1.0,15/82,13.71%,ROCK1;BIRC6;GAPDH;ANXA2;UCHL5;TFPI;PROS1;TIMP2;BST2;CAST;SERPINB9;AGT;APP;SERPINE1;CST7
prerank,snoRNA binding (GO:0030515),-0.2919148026882258,-0.8822954273719442,0.6725043782837128,0.8430802135932501,1.0,17/30,40.61%,NOP14;DHX37;GAR1;NUFIP1;UTP6;SNU13;PRKDC;NHP2;NUDT16;IMP4;WDR3;ISG20;TBL3;NUDT1;NUDT5;BMS1;DDX21
prerank,adenyl nucleotide binding (GO:0030554),-0.3763594820186302,-0.8820949001231054,0.6355311355311355,0.8386360941034411,1.0,6/11,32.42%,SIL1;HSPH1;BAG3;GRPEL2;PFN1;HSPBP1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3763594820186302,-0.8820949001231054,0.6355311355311355,0.8386360941034411,1.0,6/11,32.42%,SIL1;HSPH1;BAG3;GRPEL2;PFN1;HSPBP1
prerank,gated channel activity (GO:0022836),-0.3554957317168671,-0.8818954236175577,0.6324786324786325,0.8366016473575668,1.0,3/14,10.19%,PIEZO1;PACC1;TMC6
prerank,symporter activity (GO:0015293),0.37227750567947315,0.8813308781499347,0.6180048661800487,0.87457254518808,1.0,2/10,10.94%,SLC4A4;MFSD2A
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.36662639931394037,0.8806327393253576,0.6139088729016786,0.8713951044974224,1.0,3/10,15.06%,SLCO4A1;SLCO2B1;SLCO3A1
prerank,serine-type endopeptidase activity (GO:0004252),-0.2382092529991633,-0.8791659062640798,0.7236180904522613,0.8400092025018328,1.0,34/80,36.87%,PLAU;DPP4;HGF;PCSK7;RHBDF1;RHBDF2;CTSH;KLK3;PRSS36;F7;FAP;CD5L;MMP8;GZMM;F10;RHBDD3;MMP2;HPR;HP;MASP1;FURIN;PRTN3;ACR;F11;PRSS53;KLK9;F12;RHBDD1;MMP9;GZMB;GZMA;PRSS56;PRSS38;TMPRSS3
prerank,U6 snRNA binding (GO:0017070),-0.34868104728682947,-0.8789055711467755,0.6345811051693404,0.8381640812310099,1.0,7/14,35.19%,PRPF8;SART3;RBM22;DDX39B;LARP7;TUT1;LSM8
prerank,protein phosphatase regulator activity (GO:0019888),0.24591977650776786,0.876918026066751,0.6851385390428212,0.8750619204362903,1.0,11/53,13.27%,PPP2R2B;RCAN2;PTN;BOD1;PPP2R1B;PPP2R2A;PPP1R16B;CALM1;CALM3;CALM2;PPP4R4
prerank,glucuronosyltransferase activity (GO:0015020),-0.32518734363332746,-0.875516186769545,0.6525735294117647,0.8427688967587317,1.0,8/19,31.87%,EXT1;LARGE1;UGT1A7;UGT1A6;UGT1A4;UGT1A8;UGT1A1;CHSY1
prerank,glucose transmembrane transporter activity (GO:0005355),0.328964470277195,0.875472902192578,0.6223277909738717,0.8736380443913917,1.0,3/17,10.00%,SLC2A5;MFSD4A;SLC5A10
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.32823701226692653,0.8749862765621685,0.631336405529954,0.8701406924903822,1.0,4/16,11.27%,SLC1A6;SLC1A1;SLC13A5;SLC25A11
prerank,G protein-coupled receptor binding (GO:0001664),-0.2179149563655595,-0.8733102529551617,0.7480190174326465,0.8449186485574323,1.0,40/132,28.55%,SDCBP;ZNRF3;GNAI3;PDCD6IP;FLNA;GNA12;ARRB2;GRK3;GNA15;LRP6;ARRB1;GNA11;DNAJA1;GNA13;ARHGEF11;CCL5;CCRL2;CALCA;RNF43;GNA14;GPRC5B;HSPA1A;RYK;RSPO1;C1QBP;WNT3;SFRP1;S1PR2;NPB;DVL2;ADM;CCDC88C;WNT7B;FZD1;FZD7;HSPA8;PPY;WNT6;UTS2B;GHRL
prerank,CXCR chemokine receptor binding (GO:0045236),-0.36438262007734334,-0.868261380553469,0.6434634974533107,0.8526767982388184,1.0,1/11,6.05%,PF4
prerank,pyridoxal phosphate binding (GO:0030170),0.3019079620189149,0.8671826604815108,0.6417233560090703,0.8827906490716729,1.0,11/20,27.01%,GLDC;ABAT;CTH;PSAT1;THNSL2;CBS;ACCS;SHMT2;PLPBP;SDS;PYGM
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.31226018332045935,0.8646842091379606,0.6817155756207675,0.8833019132044219,1.0,3/18,5.08%,BMPR1B;ACVR1;LTBP1
prerank,calcium-release channel activity (GO:0015278),-0.32683529957100904,-0.8641615709691507,0.6661129568106312,0.8586231240683339,1.0,4/17,6.51%,RASA3;ITPR1;MCOLN2;MCOLN3
prerank,hexose transmembrane transporter activity (GO:0015149),0.350254232578455,0.8639298369226216,0.6470588235294118,0.8802281760048272,1.0,2/12,6.66%,SLC2A5;MFSD4A
prerank,protein kinase C binding (GO:0005080),-0.2568843621293703,-0.8636253111933391,0.7035775127768313,0.8572981765453159,1.0,12/43,21.60%,PRKCB;PLEK;TOP2A;ITGAV;ADAM9;GRK5;CCDC88A;HDAC5;TWF2;HSPB1;RACK1;PDLIM5
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.37920986896280534,-0.8631545460152598,0.6637478108581436,0.8558420886940569,1.0,2/10,7.77%,KDM7A;KDM2A
prerank,phospholipase A2 activity (GO:0004623),-0.29076606649316866,-0.8594341827991195,0.6660929432013769,0.8606980295796772,1.0,13/26,37.46%,PLA2G7;PLA2G4A;PLAAT3;PLAAT1;PLA2G6;PLA2G5;PLA2G12A;PNPLA8;PLA2G15;PLA2G3;PLA2G4B;PLB1;PLAAT5
prerank,death receptor activity (GO:0005035),-0.36961697965231444,-0.8593877826914016,0.6405693950177936,0.8583893407182431,1.0,6/11,39.50%,TNFRSF1B;TNFRSF25;NGFR;TNFRSF14;EDA2R;TNFRSF11A
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.250172681277757,-0.8570520430287859,0.7142857142857143,0.8604905438818802,1.0,14/53,22.80%,SLC38A6;SLC43A2;SLC7A7;SLC38A7;SLC36A4;CTNS;SLC66A1;SLC7A5;SFXN1;SLC6A9;SLC38A2;SLC25A22;SLC15A4;SLC25A13
prerank,methyltransferase activity (GO:0008168),-0.25821153245764317,-0.8568815674185103,0.6955017301038062,0.8584723207112247,1.0,15/46,27.43%,NSUN3;ARMT1;NSUN4;PRMT1;METTL4;MGMT;PRMT3;COMT;CARNMT1;BCDIN3D;RRP8;NDUFAF7;BUD23;MRM2;METTL3
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.33838202326501854,0.8551047570560905,0.645,0.8940406788331643,1.0,6/14,21.45%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.25121585934241947,-0.8550691920903789,0.7401032702237521,0.8597903772566681,1.0,13/54,23.36%,ACER3;DARS1;SUDS3;TGM2;KLK3;HDAC10;HDAC5;MIER1;SIRT2;ASAH1;AMDHD2;HDAC8;UPB1
prerank,lipase activator activity (GO:0060229),0.36155333040842413,0.8546596444151257,0.6179775280898876,0.8902159030174668,1.0,2/10,7.51%,ARHGAP6;FYN
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.304169861142511,-0.8501373169435348,0.6821305841924399,0.8670093506523193,1.0,5/22,9.82%,OPTN;TAB2;RNF169;MINDY2;PRPF8
prerank,phosphatase activator activity (GO:0019211),-0.33771305501156684,-0.8501067120386024,0.6637478108581436,0.8646636963865919,1.0,7/14,27.18%,FRS2;PHACTR4;PPP2R5B;GTF2F1;PPP2R5A;BMP2;PPP2R5E
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3372927251040192,0.8468796073659054,0.662621359223301,0.9021700299981517,1.0,4/13,14.84%,LPCAT2;AGPAT3;GPAT3;AGPAT2
prerank,chemoattractant activity (GO:0042056),0.2742349426880587,0.8466850425283875,0.7201946472019465,0.8979586109737081,1.0,5/26,12.03%,GDNF;VEGFD;PGF;FGF10;SCG2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.27678324454230263,0.8439289215144361,0.6939759036144578,0.899040234418513,1.0,3/26,5.29%,PPP1R14C;PTN;BOD1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.32799124464833884,-0.8435268863683668,0.7012302284710018,0.8722769733385467,1.0,3/16,8.21%,ANO6;TTYH3;TTYH2
prerank,intracellular chloride channel activity (GO:0061778),-0.32799124464833884,-0.8435268863683668,0.7012302284710018,0.8722769733385467,1.0,3/16,8.21%,ANO6;TTYH3;TTYH2
prerank,RNA stem-loop binding (GO:0035613),-0.35288637699883524,-0.8429935790990415,0.6830985915492958,0.8708676711701833,1.0,5/12,20.90%,DHX9;RC3H1;CSDE1;DDX3X;ZC3H12A
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.35823373253062957,-0.8399182441588846,0.6559714795008913,0.874254409203328,1.0,5/11,18.15%,ALKBH1;NEIL3;APLF;NEIL2;RPS3
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.3494557700130556,-0.8391601374527359,0.6713780918727915,0.8733746770563815,1.0,4/12,13.83%,ITGA5;VEGFA;CCDC88A;GREM1
prerank,pseudouridine synthase activity (GO:0009982),-0.3366353296558443,-0.8377654968367935,0.6854700854700855,0.8736108506743947,1.0,2/13,10.10%,PUS7;PUS1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.3418976640926784,-0.8364184085166197,0.6689419795221843,0.8736264904169656,1.0,3/12,9.27%,SLC25A24;SLC25A42;SLC25A25
prerank,phospholipase binding (GO:0043274),-0.3384447169132586,-0.8361067719338346,0.7017241379310345,0.8718453954611145,1.0,3/13,10.70%,SYK;BLNK;LCK
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.34303578755645414,0.8314692392602115,0.6901408450704225,0.9194834222903137,1.0,2/11,14.82%,CHRNA5;CHRNA7
prerank,phospholipase activator activity (GO:0016004),0.3539439391018712,0.8301467589419029,0.6744186046511628,0.9173576292921858,1.0,2/10,7.51%,ARHGAP6;FYN
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.29678583698657024,-0.8300229312155466,0.686411149825784,0.8805890861362603,1.0,11/21,42.67%,FRS2;FGF18;FGF9;FGF22;FGF20;FGF16;FGF2;FGF23;KLB;FGF7;NPTN
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.312638846782582,0.8263251971977406,0.7026378896882494,0.9198183246896559,1.0,4/15,14.84%,LPCAT2;AGPAT3;GPAT3;AGPAT2
prerank,sequence-specific mRNA binding (GO:1990825),0.34442044678723044,0.8263100683518559,0.6958424507658644,0.9152364550492355,1.0,3/10,14.74%,FMR1;LARP6;DHFR
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.3439993362478927,-0.824752790581886,0.6949458483754513,0.8878311075711371,1.0,3/12,8.82%,SLC9A9;SLC9A8;SLC9A1
prerank,cytokine activity (GO:0005125),-0.20416908054348762,-0.8203613965311495,0.8762214983713354,0.8932023940684275,1.0,47/131,38.63%,IL15;IL18;CKLF;PF4;VEGFA;CXCL16;CCL5;IL34;FAM3C;HMGB1;IL7;CSF1;GDF3;WNT3;INHA;IL6;KITLG;TGFB1;CCL7;WNT7B;BMP2;IL36G;WNT6;CCL24;IL2;IL16;CCL4;CCL25;CCL19;FGF2;TNF;FAM3D;WNT10B;BMP8B;IL12A;CNTF;CCL8;CXCL9;LEFTY1;GDF6;IL12B;WNT11;WNT2;INHBC;CTF1;IL17F;CXCL1
prerank,phosphatase inhibitor activity (GO:0019212),0.2871386516903278,0.8187235510870656,0.684596577017115,0.9249404427149679,1.0,3/20,5.29%,TESC;PTN;BOD1
prerank,platelet-derived growth factor binding (GO:0048407),-0.3484387538932156,-0.8175504701990949,0.7335640138408305,0.8956887711572239,1.0,7/11,43.51%,PDGFRB;PDGFA;COL2A1;PDGFB;PDGFRA;COL1A2;COL4A1
prerank,Hsp90 protein binding (GO:0051879),-0.2666268070134665,-0.8158859202858185,0.7570247933884298,0.8962812499893043,1.0,14/33,33.24%,ERN1;CSNK2A1;AHR;HIF1A;NR3C1;RPS3;NOD2;KDR;HDAC8;AHSA1;TSC2;PPID;STUB1;PPEF2
prerank,ATPase activator activity (GO:0001671),-0.29189418956781804,-0.8142279792575411,0.7318840579710145,0.8967397289539445,1.0,8/20,27.55%,DNAJC1;ATP1B3;DNAJA1;TOR1AIP1;MYBPC3;DNAJB6;AHSA1;FXYD2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.344501919298064,-0.8125635343513911,0.7020905923344948,0.897184186747331,1.0,7/11,33.45%,SLC25A24;SLC25A42;SLC25A25;SLC35B3;SLC17A9;SLC19A1;SLC25A17
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3577245123663467,-0.810093851822506,0.7290552584670231,0.8992144560922899,1.0,2/10,7.39%,PRKAG2;PKIB
prerank,Hsp70 protein binding (GO:0030544),0.2578641192237334,0.8099471684125947,0.7494089834515366,0.9365689502937321,1.0,9/31,16.07%,SACS;GPR37;TSC1;PACRG;HIKESHI;CYP1A1;DNAJB2;PRKN;SNCA
prerank,hormone activity (GO:0005179),0.22672962872729738,0.8080221446335514,0.8375634517766497,0.9353148693952867,1.0,13/54,18.75%,PNOC;SPX;APLN;CORT;EDN1;GHRH;CALCB;INHBB;INHBA;PENK;GRP;INSL6;CRH
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.27684313248984305,0.8060633907124246,0.7648456057007126,0.9340519780362527,1.0,2/22,2.99%,RBMS3;ELAVL4
prerank,phosphoric ester hydrolase activity (GO:0042578),0.23033716351798175,0.8032432250160849,0.7917675544794189,0.9344227942633588,1.0,14/49,17.08%,MPPED2;PXYLP1;GDPD1;ACP6;PLCXD3;ENPP6;DUSP4;DUSP10;DUSP18;APEX1;PLCXD2;DUSP8;PHOSPHO2;PRUNE1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3257710783566661,-0.8010570953143613,0.7356115107913669,0.9116439195882161,1.0,3/13,8.82%,SLC9A9;SLC9A8;SLC9A1
prerank,antiporter activity (GO:0015297),0.278541929817988,0.8000899874242877,0.7628361858190709,0.9351620386070689,1.0,10/20,26.89%,ATP1A3;SLC35E4;SLC25A11;CLCN3;SLC35C1;SLC25A30;SLC35C2;SLC35A1;CLCN4;SLC35E3
prerank,gap junction channel activity (GO:0005243),0.2766249359745872,0.7978923401173846,0.7648514851485149,0.9345255336295315,1.0,6/22,19.00%,GJC3;GJC2;PANX2;GJD2;GJD3;GJC1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.32354202511537755,0.7971732776293686,0.7399103139013453,0.9312870120393627,1.0,2/11,7.69%,WT1;HMGA2
prerank,ankyrin binding (GO:0030506),-0.2949593601973546,-0.7966765581922041,0.7762938230383973,0.9163220748842479,1.0,2/19,9.28%,PTPRC;SLC8A1
prerank,transcription coregulator binding (GO:0001221),0.2288296617835038,0.7957487667264102,0.8158508158508159,0.9292619473852336,1.0,13/50,19.95%,RORA;PGR;THRB;MTF2;CHD6;NR1D1;PER2;WIZ;CTCF;CIT;TERT;PHF1;PER1
prerank,metalloaminopeptidase activity (GO:0070006),0.29392128360223535,0.7953439454714045,0.7728285077951003,0.9254847650925483,1.0,3/16,5.66%,MMP16;TRHDE;MMP15
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2780686307835779,-0.7934074898976295,0.788659793814433,0.9188289308380492,1.0,7/24,24.43%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;GOLGA7;ZDHHC6
prerank,cAMP response element binding (GO:0035497),0.33642219612332497,0.7883880562879167,0.7363420427553444,0.932533651619241,1.0,4/10,12.89%,ATF2;CREB5;HMGA2;CREB3L1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.24361863471418582,-0.7859939338918274,0.8241379310344827,0.9277293927855363,1.0,10/40,23.11%,DNMT3A;ARMT1;METTL4;METTL9;COMT;GNMT;CARNMT1;METTL2B;METTL2A;RRP8
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.22592571914002763,-0.7858288809228755,0.8605042016806723,0.9255823879145203,1.0,19/57,29.35%,NDUFA9;COX4I1;NDUFB2;COX10;NDUFS5;UQCRC1;COX8A;NDUFA1;CYB561A3;NDUFA3;NDUFA4;CYB5A;COX5A;NDUFB8;NDUFC2;COX6A2;NDUFC1;UQCRQ;NDUFS6
prerank,ion channel inhibitor activity (GO:0008200),-0.24604335815588424,-0.7794234197905942,0.8211920529801324,0.9327304679659197,1.0,9/35,21.40%,ITPR1;STX7;STX8;MCUB;NEDD4L;RASA1;SCN3B;WNK1;RACK1
prerank,vinculin binding (GO:0017166),0.32175609489780366,0.7747016578238922,0.7697516930022573,0.9500563802441947,1.0,2/11,7.42%,DMD;SYNM
prerank,transcription corepressor binding (GO:0001222),0.2564196636710766,0.7741058863375588,0.8524229074889867,0.9465177615882095,1.0,4/27,11.88%,RORA;MTF2;NR1D1;PER2
prerank,gamma-tubulin binding (GO:0043015),0.2673655979093149,0.7727127447284452,0.8267898383371824,0.9441992433386504,1.0,11/22,22.31%,ARHGEF7;BRSK1;CDK5RAP2;NDRG1;TUBGCP5;RAD51D;TUBGCP3;DIXDC1;B9D2;PAK1;BRCA2
prerank,mRNA methyltransferase activity (GO:0008174),-0.32483839116748947,-0.7712186200531341,0.8147512864493996,0.9424576908618529,1.0,9/12,44.90%,PCIF1;CMTR2;METTL14;METTL3;TRMT61A;TRMT61B;METTL8;METTL16;TRMT10C
prerank,NADPH binding (GO:0070402),0.30429428620317084,0.7688012274990015,0.765807962529274,0.9455149040242659,1.0,6/13,25.15%,CRYZ;DHFR;DUS2;KCNAB1;GRHPR;DECR1
prerank,solute:proton symporter activity (GO:0015295),-0.2947966002595431,-0.7685586792028829,0.7978910369068541,0.9437627824808679,1.0,5/16,22.75%,SLC33A1;CTNS;MFSD3;SLC11A2;SLC15A4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.3149276338729897,-0.7683772149770577,0.7711267605633803,0.9415938119627946,1.0,3/12,20.94%,GTF2A1;RELA;STAT1
prerank,N-acyltransferase activity (GO:0016410),-0.2512781069010598,-0.7650058288648989,0.837696335078534,0.9439683246840141,1.0,14/32,38.21%,SAT1;TGM2;NAA50;PLAAT3;PLAAT1;SAT2;NMT1;CERS3;EP300;GNPNAT1;CERS2;BAAT;PLAAT5;SATL1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2544995531042502,0.764476230356246,0.8219512195121951,0.947129335137835,1.0,7/24,16.87%,NME2;IP6K2;ITPKA;AK4;PPIP5K2;AK5;AK3
prerank,O-methyltransferase activity (GO:0008171),-0.336361055525943,-0.7627976522490074,0.7592920353982301,0.9447197460331579,1.0,3/10,20.44%,CMTR2;COMT;BCDIN3D
prerank,adenylyltransferase activity (GO:0070566),-0.2725318798720048,-0.7625107244071425,0.8203389830508474,0.9426911248524064,1.0,8/21,20.04%,MTPAP;OASL;OAS3;KARS1;SELENOO;TENT4B;PAPOLA;OAS2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.3249976148448944,-0.7594313979469479,0.7813620071684588,0.9445468327721549,1.0,1/12,1.17%,XDH
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.25435037892650975,-0.7586432395657093,0.8583617747440273,0.9431818118838127,1.0,13/27,32.16%,SLC9A9;SLC9A8;SLC9A1;SLC8A1;CNNM4;SLC23A1;SLC8B1;SLC9A4;ASIC3;SLC9A3;SLC12A3;SLC4A8;SLC9A6
prerank,phosphatase activity (GO:0016791),0.19949133257497215,0.7562875753020635,0.9051282051282051,0.9545819800121824,1.0,22/73,23.83%,PLPP4;PLPPR1;PLPPR4;PXYLP1;ACP6;HDDC2;DUSP4;DUSP10;DUSP18;NOCT;PLPPR2;DUSP8;PHOSPHO2;PRUNE1;PGAM5;BPNT2;NT5M;FRA10AC1;SACM1L;DUSP28;DUSP26;PDXP
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.3163160912424269,-0.7555767944106995,0.7888307155322862,0.9448821680046829,1.0,2/11,10.63%,AMFR;UBE4B
prerank,hydro-lyase activity (GO:0016836),-0.23039678480743303,-0.7535558370925284,0.8599290780141844,0.9450110904176204,1.0,2/41,1.64%,TBXAS1;IREB2
prerank,acetyltransferase activity (GO:0016407),-0.24678640079141279,-0.7525801732288165,0.8446428571428571,0.9438102753949743,1.0,7/31,20.23%,CREBBP;SAT1;PAFAH2;NAA50;SAT2;NAA16;ESCO2
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.2525365711735343,-0.7517917674247447,0.8313253012048193,0.9424249182667049,1.0,14/27,33.27%,ATP2B1;ITPR1;ATP2A3;MAGT1;CNNM4;SLC23A1;SLC11A2;ZDHHC13;ITPR2;AQP1;SLC12A3;SLC4A8;CNNM2;SLC11A1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.27591389466516847,-0.7496503972925613,0.8107202680067002,0.942782189222274,1.0,5/18,21.86%,PIK3R5;WDR91;SOCS6;SOCS3;SOCS5
prerank,active ion transmembrane transporter activity (GO:0022853),-0.23359945099692148,-0.7491487104024483,0.8819672131147541,0.941040822985836,1.0,13/37,30.00%,SLC16A7;COX4I1;COX10;UQCRC1;SLCO5A1;COX8A;NDUFA4;CYB5A;COX5A;SLC4A1;COX6A2;UQCRQ;SLCO1B1
prerank,protein phosphatase 1 binding (GO:0008157),-0.26943262763146125,-0.7480155120871345,0.8274706867671692,0.9400373311131545,1.0,4/21,15.90%,LILRB1;AKAP11;PPP1R3E;PPP1R9B
prerank,AMP binding (GO:0016208),0.3119627905096121,0.7443711208393597,0.7977272727272727,0.9664218476068566,1.0,1/11,1.20%,MPPED2
prerank,telomeric DNA binding (GO:0042162),-0.24302498838818226,-0.7408422770424526,0.8754448398576512,0.9465422826314486,1.0,8/32,23.06%,BLM;UPF2;XRCC6;WRN;TEN1;NCL;KDM1A;SMG1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.30934304046347333,0.739855884040193,0.8037825059101655,0.9681506833460393,1.0,3/11,19.52%,DHRS13;RDH11;RDH14
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.227682828156469,0.7390014505111914,0.8804878048780488,0.9647402624458499,1.0,7/33,13.51%,ZMYM2;RNF144A;UBE3D;SIAH3;RNF217;DCUN1D2;PRKN
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3020189760048396,0.7381898759822285,0.8040089086859689,0.9613918760932242,1.0,2/11,8.10%,NUDT11;NUDT7
prerank,nucleosomal DNA binding (GO:0031492),-0.2625126242003327,-0.7330034924495354,0.8405017921146953,0.9535850425720781,1.0,5/21,22.55%,ACTB;SMARCC2;RBBP4;RCC1;GATAD2B
prerank,diacylglycerol kinase activity (GO:0004143),0.30373519546800887,0.7311041958617008,0.8036117381489842,0.9655869394206362,1.0,1/11,0.91%,DGKB
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.26594937376803707,-0.7274464439582925,0.8641114982578397,0.9578012358228944,1.0,8/18,36.82%,HSD17B7;SRD5A2;HSD17B10;HSD3B2;HSD17B14;DHRS11;AKR1C1;HSD17B3
prerank,sulfate transmembrane transporter activity (GO:0015116),0.2871732293402461,0.7213789664703516,0.8119266055045872,0.9727756023318809,1.0,3/14,13.06%,SLC26A3;SLC25A11;SLC26A8
prerank,anion transmembrane transporter activity (GO:0008509),-0.30043892629769675,-0.7175952208285062,0.8462929475587704,0.9665700998288252,1.0,5/12,38.07%,SLC26A11;SLC22A3;SLC4A1;SLC19A1;SLC22A6
prerank,wide pore channel activity (GO:0022829),0.24453415584344207,0.715214309458796,0.8842364532019704,0.9752140099244653,1.0,6/23,19.00%,GJC3;GJC2;PANX2;GJD2;GJD3;GJC1
prerank,lysine N-methyltransferase activity (GO:0016278),-0.259745034863748,-0.7109617479627072,0.8706739526411658,0.9712263153903372,1.0,10/20,35.12%,SMYD2;KMT5A;EEF2KMT;SETD6;METTL21A;SETD7;SETD2;ETFBKMT;ANTKMT;SETD4
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.31498388317856646,-0.7076969251026612,0.8538732394366197,0.9722161355428187,1.0,2/10,17.90%,INCA1;CDKN2C
prerank,5'-nucleotidase activity (GO:0008253),-0.28694692769328545,-0.7050759282769437,0.8584558823529411,0.9725436991638511,1.0,3/13,30.83%,NT5C2;NT5DC1;ACP3
prerank,death receptor binding (GO:0005123),-0.27430699990071494,-0.7015655242273918,0.8686006825938567,0.9736867197211225,1.0,4/15,22.27%,RIPK1;MYD88;BID;FEM1B
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.2295853739004693,-0.6935716327125004,0.924187725631769,0.9789343488006538,1.0,5/30,19.82%,SLC30A5;ATP7A;SLC31A1;SLC39A3;SLC11A2
prerank,phosphate ion binding (GO:0042301),-0.2995964347408041,-0.6932070626841269,0.8615664845173042,0.9768975386520413,1.0,2/10,10.48%,ADSS1;RELA
prerank,hormone receptor binding (GO:0051427),-0.27583233130292634,-0.6874030196264357,0.8716577540106952,0.9797132583743875,1.0,5/14,29.18%,JAK1;NCOA6;TYK2;VIP;CCK
prerank,hexosaminidase activity (GO:0015929),-0.28345323427365576,-0.6854899353256855,0.8827708703374778,0.9790179185022824,1.0,1/12,0.81%,HEXA
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.25832714714098726,0.6852203667737338,0.8779342723004695,1.0,1.0,2/15,9.63%,PLA2G4E;PLA2G10
prerank,MAP kinase activity (GO:0004707),0.2624689310707327,0.6831374609190368,0.8755760368663594,0.9996141892326226,1.0,5/14,21.27%,MAPK10;MAPK4;MAPK11;NLK;MAPK8
prerank,N-methyltransferase activity (GO:0008170),0.2417810981914113,0.682994678661005,0.8707482993197279,0.9953357843108763,1.0,5/20,15.27%,TRMT1;METTL18;FDXACB1;TRMT11;SETD3
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.2843296947681757,-0.6813048649270511,0.8804920913884007,0.9802084980117279,1.0,3/11,19.72%,NAA25;NAA50;NAA16
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.2881111899221319,-0.6781601091803121,0.870242214532872,0.9804132708662717,1.0,3/10,19.72%,NAA25;NAA50;NAA16
prerank,exoribonuclease activity (GO:0004532),-0.275063503933653,-0.6694961069010547,0.8969465648854962,0.9849718457312422,1.0,5/12,27.04%,EXOSC5;EXOSC10;ZC3H12A;EXOSC4;EXOSC8
prerank,RNA methyltransferase activity (GO:0008173),-0.2484328018664285,-0.6688237517982235,0.906896551724138,0.983171298770768,1.0,10/19,43.96%,METTL4;TGS1;BCDIN3D;MRM2;METTL3;FTSJ1;METTL8;MEPCE;TRDMT1;LCMT2
prerank,copper ion binding (GO:0005507),-0.20431187430577086,-0.6626411107526612,0.9592529711375212,0.9857264661845457,1.0,10/42,30.19%,P2RX4;ATP7A;AOC2;MOXD1;ANG;MT3;DCT;ACR;ATP13A2;ATOX1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.27709934964469585,-0.6621380846952847,0.8956521739130435,0.9837097111607804,1.0,2/12,10.19%,PIEZO1;TMC6
prerank,ribosome binding (GO:0043022),-0.19762866258489128,-0.6584080369975865,0.9536541889483066,0.9840267231767396,1.0,11/46,21.59%,YTHDF3;EFL1;EEF2;EIF2A;MAIP1;NAA16;C1QBP;ZC3H12A;CPEB4;RACK1;BAG6
prerank,fibroblast growth factor binding (GO:0017134),-0.23371703590087223,-0.6506168022234584,0.9044481054365733,0.9871413115762936,1.0,2/21,7.58%,ITGAV;CEP57
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.25698958053222853,-0.6490144410510471,0.8940754039497307,0.9858440729175442,1.0,7/14,36.70%,BLVRB;QDPR;MTHFR;PYCR3;PYCR2;MTHFD1;CRYM
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.23662034362244524,-0.6467764865330857,0.9315068493150684,0.985057123093655,1.0,5/21,24.57%,POLE2;PRIMPOL;POLN;POLB;POLD4
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.243322657589833,0.6449262207652302,0.9196217494089834,1.0,1.0,3/14,14.90%,NME2;AK4;AK5
prerank,MAP kinase phosphatase activity (GO:0033549),-0.2653020620964667,-0.6445199226002626,0.9144851657940664,0.9841675883013586,1.0,4/12,24.05%,DUSP3;DUSP6;DUSP5;DUSP2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.2776404958532772,0.6417300090557111,0.8857808857808858,1.0,1.0,2/10,12.72%,ATF2;NAA60
prerank,alkali metal ion binding (GO:0031420),-0.2570117613126626,-0.6400419916254894,0.8957597173144877,0.9847384443459664,1.0,4/13,33.61%,IMPA1;PDXK;ATP1A1;DRG1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.23176240838573264,0.6378971869495937,0.9334916864608076,1.0,1.0,4/17,16.87%,NME2;AK4;AK5;AK3
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.21516943980616005,0.6243366173055828,0.9565217391304348,1.0,1.0,6/22,16.43%,MTMR2;DUSP19;DUSP4;DUSP10;DUSP18;DUSP8
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.26722932141590816,-0.6195612672088463,0.9215328467153284,0.9944903983715958,1.0,2/10,13.97%,ASH1L;SETDB1
prerank,glycerophospholipid flippase activity (GO:0140333),0.2517534601019877,0.6157512073110882,0.9212962962962963,1.0,1.0,1/11,2.33%,ATP8A2
prerank,anion:anion antiporter activity (GO:0015301),0.2301570530245533,0.6138552913255293,0.9370932754880694,1.0,1.0,3/17,13.06%,SLC26A3;SLC25A11;SLC26A8
prerank,CoA hydrolase activity (GO:0016289),-0.24046032466699438,-0.6104837710097735,0.9477977161500816,0.9968879695297677,1.0,5/16,20.32%,ACOT9;ACOT13;ACAA2;ACOT2;ACOT4
prerank,protein phosphatase activator activity (GO:0072542),-0.24785731354778562,-0.6095605123085259,0.9353146853146853,0.9950570576846709,1.0,6/13,31.16%,IGFBP3;PHACTR4;PPP2R5B;PPP2R5A;PPP2R5E;PTPA
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.2557658058161452,-0.6089950501709018,0.9355400696864111,0.993032252531106,1.0,7/12,36.12%,CBR1;NQO2;NQO1;DHRS4;AIFM2;CBR4;AKR1C1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.17515579811802262,0.6079221802622574,0.9869109947643979,1.0,1.0,19/51,26.89%,SLC4A4;SLCO4A1;SLC35E4;MFSD2A;SLCO2B1;SLC25A11;CLCN3;SLC16A2;SLCO3A1;SLC35C1;SLC25A30;SLC35C2;SLC35A1;SLC28A1;SLC22A8;CLCN4;MCU;SLCO4C1;SLC35E3
prerank,organic cation transmembrane transporter activity (GO:0015101),0.2221587896247718,0.6078870595958058,0.95,1.0,1.0,3/16,14.98%,SLC5A7;SLC18A3;SLC22A5
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.18485424511474835,0.597784397857086,0.9856115107913669,1.0,1.0,6/34,15.54%,NDUFB7;NDUFV2;NDUFA2;NDUFB9;NDUFA8;NDUFV3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.18485424511474835,0.597784397857086,0.9856115107913669,1.0,1.0,6/34,15.54%,NDUFB7;NDUFV2;NDUFA2;NDUFB9;NDUFA8;NDUFV3
prerank,nucleotide diphosphatase activity (GO:0004551),0.2289741808099882,0.5956233212006532,0.9379310344827586,1.0,1.0,3/14,17.45%,NUDT11;ENPP5;NUDT3
prerank,DNA polymerase activity (GO:0034061),-0.21303285541031258,-0.5910100887626143,0.9620689655172414,0.9987296255696,1.0,5/22,24.57%,POLE2;PRIMPOL;POLN;POLB;POLD4
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.19979826003041098,-0.5904037435730274,0.9700704225352113,0.9966342811598666,1.0,8/27,29.40%,SLC26A11;XPR1;GET3;ANKH;SLC25A10;SLC4A1;SLC26A4;SLC5A5
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.23232258757552837,-0.5899240714042012,0.9575551782682513,0.9945028346481153,1.0,4/15,21.86%,PIK3R5;SOCS6;SOCS3;SOCS5
prerank,tRNA methyltransferase activity (GO:0008175),-0.2250493182857788,-0.5873237055475095,0.9470899470899471,0.9932240887576532,1.0,4/16,20.92%,TRMT44;BCDIN3D;METTL2B;METTL2A
prerank,carboxy-lyase activity (GO:0016831),0.20231236326135213,0.5841821129004546,0.9691943127962085,1.0,1.0,8/23,24.52%,PISD;DDC;GGCX;MLYCD;ACOD1;ODC1;MVD;AMD1
prerank,pyrophosphatase activity (GO:0016462),-0.17184953441177245,-0.5818343983161267,0.9927272727272727,0.993058100815674,1.0,24/50,40.69%,DHX9;DCP2;ENTPD6;NUDT14;BNIP2;ENTPD3;DDX3X;ENPP1;NUDT22;BNIPL;NUDT15;NUDT6;NUDT16;ALPL;DCTPP1;NUDT10;ENTPD7;LHPP;NUDT1;CILP;NUDT5;DOLPP1;PLPP1;DXO
prerank,solute:anion antiporter activity (GO:0140323),-0.2340895261179487,-0.581639558891722,0.9663551401869159,0.9908636553592899,1.0,1/14,3.90%,SLC26A11
prerank,peptide hormone receptor binding (GO:0051428),-0.2484683878573156,-0.5798864968027099,0.9534482758620689,0.9891936118654763,1.0,3/11,29.18%,GNRH1;VIP;CCK
prerank,Notch binding (GO:0005112),0.19933649293078023,0.5759700537294875,0.9709443099273608,1.0,1.0,6/22,21.22%,CCN3;DNER;SNED1;ADAM17;SNW1;DLL4
prerank,enoyl-CoA hydratase activity (GO:0004300),0.24311091582449315,0.5752493904638527,0.9496402877697842,1.0,1.0,10/10,75.70%,EHHADH;HSD17B4;AUH;ECHDC1;HADHA;HADHB;ECI1;ECHS1;ECHDC2;ECHDC3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.1870637370564776,0.5725447361065923,0.9808612440191388,0.9989532973658194,1.0,9/28,21.96%,POP7;RPP25;RNASEH1;RPP14;POP4;APEX1;RPP21;RPP38;MRPL44
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.20363763306270666,-0.5703962265613199,0.9775086505190311,0.9902026555651943,1.0,1/20,1.91%,SLC30A5
prerank,leucine zipper domain binding (GO:0043522),-0.24495561905240315,-0.5617621484746521,0.9637681159420289,0.9908356501130733,1.0,2/10,15.46%,DAPK3;AATF
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.17587725600826729,-0.5605308994867916,0.9912587412587412,0.9889767610980996,1.0,7/35,21.70%,ALKBH1;FTO;QTRT1;TARS2;AARS1;BCDIN3D;ELAC2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.22979776039892663,0.5560288417113872,0.971764705882353,0.9961258507110898,1.0,4/10,21.28%,DUSP4;DUSP10;DUSP8;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.22979776039892663,0.5560288417113872,0.971764705882353,0.9961258507110898,1.0,4/10,21.28%,DUSP4;DUSP10;DUSP8;DUSP7
prerank,nucleotidase activity (GO:0008252),-0.21030403228652098,-0.5395217809627043,0.9766606822262118,0.9923528340908415,1.0,3/15,30.83%,NT5C2;NT5DC1;ACP3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.2194736745864351,0.5269971443412069,0.9776674937965261,0.9997536882282531,1.0,4/11,28.81%,SLC22A5;SLC25A47;SLC25A29;SLC22A4
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.1988149480156598,0.5078160054624307,0.986870897155361,0.9993790736646273,1.0,2/13,13.86%,EBP;EHHADH
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.1837547229920516,-0.497372520940007,0.9947183098591549,0.9977775250223897,1.0,6/18,31.15%,TGFBR1;TGFBR2;SMAD7;TGFB1;ENG;SMAD2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.2040284188337368,0.4955621136349661,0.990632318501171,0.9973096977341801,1.0,10/11,58.74%,NABP2;TERF1;RPA2;CTC1;TERF2IP;HNRNPA2B1;RPA1;RAD50;STN1;TERF2
prerank,ribosomal large subunit binding (GO:0043023),0.2011927181418706,0.48820827579036935,0.9885321100917431,0.9942778572519826,1.0,11/11,79.89%,CPSF6;NPM1;MRRF;NMD3;LTN1;DHX33;CPEB2;MALSU1;NEMF;EIF6;RBM3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.19761901529752196,-0.48353222592147044,0.987719298245614,0.997188905774482,1.0,1/13,5.13%,METTL1
prerank,N-acetyltransferase activity (GO:0008080),-0.16983700326946932,-0.4617674951794578,0.9962894248608535,0.9968932694121033,1.0,7/19,38.21%,SAT1;NAA50;SAT2;EP300;GNPNAT1;ATAT1;SATL1
